<?xml version="1.0" encoding="utf-8"?>
<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd"><eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511"><eadid>FA1103A.xml</eadid><filedesc><titlestmt><titleproper type="filing">Rockefeller University collection of The Medical Letter publication, 1996-2004</titleproper><titleproper>A Guide to the Rockefeller University collection of The Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper></titlestmt><publicationstmt><publisher>Rockefeller Archive Center</publisher><address><addressline>15 Dayton Avenue</addressline><addressline>Sleepy Hollow 10591</addressline><addressline>archive@rockarch.org</addressline><addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline></address></publicationstmt></filedesc><profiledesc><creation>This finding aid was produced using ArchivesSpace on <date>2019-09-09 00:04:36 -0400</date>.</creation><descrules>Describing Archives: A Content Standard</descrules></profiledesc></eadheader><archdesc level="collection">
  <did>
    <langmaterial>
      <language langcode="eng">English</language>
    </langmaterial>
    <repository>
      <corpname>Rockefeller Archive Center</corpname>
    </repository>
    <unittitle>Rockefeller University collection of The Medical Letter publication</unittitle>
    <origination label="creator">
      <corpname role="aut" source="naf">Rockefeller University</corpname>
    </origination>
    <origination label="creator">
      <corpname role="aut" source="naf">Medical Letter, Inc</corpname>
    </origination>
    <unitid>FA1103A</unitid>
    <physdesc altrender="whole">
      <extent altrender="materialtype spaceoccupied">131.21 Cubic Feet</extent>
    </physdesc>
    <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
  </did>
  <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
    <head>Processing Information</head>
<p>Minimal processing</p>  </processinfo>
  <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
    <head>Preferred Citation</head>
<p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>  </prefercite>
  <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
    <head>Conditions Governing Access</head>
<p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>  </accessrestrict>
  <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
    <head>File Plan</head>
<p>Former Classification: I 891-U</p>  </fileplan>
  <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
    <head>Other Finding Aids</head>
<p>For additional Medical Letter materials open for research see:</p><p>FA241 Rockefeller University collection of the Medical Lettter publication</p>  </otherfindaid>
  <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
    <head>Scope and Contents</head>
<p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>  </scopecontent>
  <bioghist id="6c159867ba2a2151b8b7399752c3890b">
    <head>Biographical / Historical</head>
<p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>  </bioghist>
  <userestrict id="37e428481bbdbecee9f5c722527c7cfc">
    <head>Conditions Governing Use</head>
<p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>  </userestrict>
  <dsc><c id="722d135ab2e6b9a0415068e6118db069" level="file"><did><unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="24de9da44054a1c99412e1d13c846bd0" label="mixed materials [A0000000075844]" type="box">1</container><container id="7e9671e10016cf90e5efd8aa39c26acc" parent="24de9da44054a1c99412e1d13c846bd0" type="folder">1-4</container></did><accessrestrict id="6413d819e0f61297a55139d343bc6b2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e0dd5900ff39bfca71872aabc11f428" level="file"><did><unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="dcf4cef357b36a13223b20b1485d4f4d" label="mixed materials [A0000000075844]" type="box">1</container><container id="f3002abea9c8996c291493eee52423c3" parent="dcf4cef357b36a13223b20b1485d4f4d" type="folder">5-7</container></did><accessrestrict id="656f8049cade326890b44a882a172390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file"><did><unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="8b59f00b11df5a6dfdd1d41d3faf75b8" label="mixed materials [A0000000075844]" type="box">1</container><container id="d7c22312132c75a117e8c0218e698c3c" parent="8b59f00b11df5a6dfdd1d41d3faf75b8" type="folder">8-12</container></did><accessrestrict id="ca3616172a78ef218806617937be4ae3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="299c68349552c9c16b93a8a4762f739e" level="file"><did><unittitle>TML, 38-35 - New drugs for HIV</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="a6742605edea9e23047fdf28966fb79c" label="mixed materials [A0000000075844]" type="box">1</container><container id="8ef67d65322931e7814e7f8e5e929b55" parent="a6742605edea9e23047fdf28966fb79c" type="folder">13-17</container></did><accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="b023b06ce38bdcca840be27fbcf26203" label="mixed materials [A0000000075844]" type="box">1</container><container id="54f54a3f6dbbc811ebea5d3137cc354d" parent="b023b06ce38bdcca840be27fbcf26203" type="folder">18</container></did><accessrestrict id="6490910db6cb9773d516babe0e3ba2c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="25c672276d8de231f00bfa483bb42cb2" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="62d3802b6a6e70f00aa4aaa66ea54117" label="mixed materials [A0000000075845]" type="box">2</container><container id="bdcf2a30bc9e06d1955cf81e1467b4fa" parent="62d3802b6a6e70f00aa4aaa66ea54117" type="folder">1-3</container></did><accessrestrict id="2d841e9b213eca4386b5020a0f960ab2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="520cba0819f4d1a661ffbae9d84a72d2" level="file"><did><unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="91b61334f09632732083b7e282bb52a9" label="mixed materials [A0000000075845]" type="box">2</container><container id="808952bc009d5ffa5a6520dde98198fb" parent="91b61334f09632732083b7e282bb52a9" type="folder">4-6</container></did><accessrestrict id="391e7265783eb309c372f58724caf420"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b466c2ae20545eb902a029aabfadd4a2" level="file"><did><unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle><unitdate type="inclusive">1996 March 29</unitdate><container altrender="Record Storage Box (Paige)" id="7fc9cca7f5ca9656d4a5fabb054b1421" label="mixed materials [A0000000075845]" type="box">2</container><container id="cef48414a4cd4e6871835f654b581bea" parent="7fc9cca7f5ca9656d4a5fabb054b1421" type="folder">7-9</container></did><accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ef71891079fc8afb056a13746e052f75" level="file"><did><unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle><unitdate type="inclusive">1996 August 30</unitdate><container altrender="Record Storage Box (Paige)" id="9f189ab37038b52c5c05a28d0b28933a" label="mixed materials [A0000000075845]" type="box">2</container><container id="f6d2149f0bd72cd35962a51b7bb3a1e4" parent="9f189ab37038b52c5c05a28d0b28933a" type="folder">10-16</container></did><accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="630284f8fa9310d4604f35f82942ec99" level="file"><did><unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="f720ee52fe26079641eb137a2383c35b" label="mixed materials [A0000000075845]" type="box">2</container><container id="4584453fbf9b57e443e9a0586dd8590f" parent="f720ee52fe26079641eb137a2383c35b" type="folder">17-18</container></did><accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="3b9cf2ed3ca0ee92f8ade653312a3740" label="mixed materials [A0000000075845]" type="box">2</container><container id="5ee762ba7295599bf10d803da97d96b9" parent="3b9cf2ed3ca0ee92f8ade653312a3740" type="folder">19-20</container></did><accessrestrict id="c9d5e1a415d2921805aa74b729504b02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="ee7ecbb6f0adf24cd48a8541ca3c3144" label="mixed materials [A0000000075846]" type="box">3</container><container id="0b532249bea6a46c752c9eb9a1f00cff" parent="ee7ecbb6f0adf24cd48a8541ca3c3144" type="folder">1</container></did><accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e8440ccfa5de303b70df4a8556b7da1" level="file"><did><unittitle>TML, 38-103 - Bone Density Testing</unittitle><unitdate type="inclusive">1996 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="089e4bf598e232905275a7d5b922e481" label="mixed materials [A0000000075846]" type="box">3</container><container id="c619210758b64ebfa01ea00f4955d262" parent="089e4bf598e232905275a7d5b922e481" type="folder">2-3</container></did><accessrestrict id="9371d9820f979006c113e8341494696d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2bc3e056d1f8fa2492e7303d95310131" level="file"><did><unittitle>TML, 37-109 - Dirithromycin</unittitle><unitdate type="inclusive">1995 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="f009aa1f62ee8609b3819aa517ab2d40" label="mixed materials [A0000000075846]" type="box">3</container><container id="ec794d7897effe3e01bf28c5edb49f28" parent="f009aa1f62ee8609b3819aa517ab2d40" type="folder">4-7</container></did><accessrestrict id="70e63df474c05d465a52ed6834a63c2e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="404e68490aeea4bc03276bd2e1972297" level="file"><did><unittitle>TML, 38-108 - Calcium Supplements</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="7067bd122f2ce810437fb656ee906d02" label="mixed materials [A0000000075846]" type="box">3</container><container id="a8d60a1b1704823992995a9d0f9d7f1e" parent="7067bd122f2ce810437fb656ee906d02" type="folder">8-12</container></did><accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="787f855d64193a39aa5fa640c29b09f9" level="file"><did><unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="d9dedc97c31c1d679be1ee97979dec57" label="mixed materials [A0000000075846]" type="box">3</container><container id="6cbd0cd5e43eb50cab5331df1f4062a0" parent="d9dedc97c31c1d679be1ee97979dec57" type="folder">13-16</container></did><accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="6ee9fed32bd765fba31910157fc457da" level="file"><did><unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="596d23397af3682dd3e90637492c91df" label="mixed materials [A0000000075846]" type="box">3</container><container id="1a875a211633d14b1ca54b3694535b82" parent="596d23397af3682dd3e90637492c91df" type="folder">17-19</container></did><accessrestrict id="fe428baa314a27bf86569a7a685bf75c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file"><did><unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="002ecd1293b8550139b11e735c209204" label="mixed materials [A0000000075847]" type="box">4</container><container id="370b9021681a5a6b7eb7f88563efd720" parent="002ecd1293b8550139b11e735c209204" type="folder">1-4</container></did><accessrestrict id="cd47248ae2cfc55d2fb4424654263054"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file"><did><unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="b5e9b2d4f3747663f669c0b971591018" label="mixed materials [A0000000075847]" type="box">4</container><container id="1f249478a5e41a12a9647e679c51842c" parent="b5e9b2d4f3747663f669c0b971591018" type="folder">5</container></did><accessrestrict id="2fb3ed462271aeec0fb14801053de435"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9050bc8c28970ad791e377582e9c079c" level="file"><did><unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle><unitdate type="inclusive">1996 August 2</unitdate><container altrender="Record Storage Box (Paige)" id="5f1a06638a48bbc81aeda71486b31751" label="mixed materials [A0000000075847]" type="box">4</container><container id="7ef82f6b124eae7ebd140385f836f573" parent="5f1a06638a48bbc81aeda71486b31751" type="folder">6-13</container></did><accessrestrict id="88da501863cd117b47bcae321e4b3b00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="5c5e7299af1de05e46453f0fea0e1720" level="file"><did><unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="269d30b19c98d50150fea565f3cd959f" label="mixed materials [A0000000075847]" type="box">4</container><container id="37beb1665ee82b252b04f53ae8343102" parent="269d30b19c98d50150fea565f3cd959f" type="folder">14-18</container></did><accessrestrict id="0f7c6d142759503d2196573bb0b89f9a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0f91362447d7a3cdff68d7ebac520b38" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="b8b7d9a603ad2098cef1324a35c5fcff" label="mixed materials [A0000000075847]" type="box">4</container><container id="73fda1091bd83b9f13be279a8ee94112" parent="b8b7d9a603ad2098cef1324a35c5fcff" type="folder">19-20</container></did><accessrestrict id="4e5c9545497b1cea799d01d6d8e16965"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c714362a04b8f852b521155e586e0af2" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="cc8ac860ad5599ba7a0c51c55d1239dc" label="mixed materials [A0000000075848]" type="box">5</container><container id="0e9711f25c41e76e9372f9645fb18b8d" parent="cc8ac860ad5599ba7a0c51c55d1239dc" type="folder">1</container></did><accessrestrict id="a545b57ddc41b86449988949e310c707"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="484f5bda82347b92c1fd763adae1bf8a" level="file"><did><unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="ddd070a99c19495b25a11c522e330e1c" label="mixed materials [A0000000075848]" type="box">5</container><container id="67c51688fd5dd77f94e97d490ac3c9ee" parent="ddd070a99c19495b25a11c522e330e1c" type="folder">2-5</container></did><accessrestrict id="0ae4223f8a683f538d4cd77c366f1250"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8d0423127d33593f9f53a6262dc9f97c" level="file"><did><unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="c464f5f48fa7429bdaf4660372326a20" label="mixed materials [A0000000075848]" type="box">5</container><container id="8f024ec4a5e26b5acb4bb40631aea868" parent="c464f5f48fa7429bdaf4660372326a20" type="folder">6-8</container></did><accessrestrict id="ed7cc80f5cac6080418667469e63fcc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="a348057f4e83121c70f8e63e18862273" level="file"><did><unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="9518adcc7a3f9dd3da70525c0112c9b4" label="mixed materials [A0000000075848]" type="box">5</container><container id="9b62b1e63993341341027c38a4cdd3c3" parent="9518adcc7a3f9dd3da70525c0112c9b4" type="folder">9-10</container></did><accessrestrict id="9060f4c1941e62cde507283711c42123"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4fb37dc500fa2658eede9f802e9df8f8" level="file"><did><unittitle>TML, 38-95 - Fexofenadine</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="9fd145d8a3dcd12e9ce240181bac20a7" label="mixed materials [A0000000075848]" type="box">5</container><container id="bc2e52b19634f265ad8ce29a09a4ba27" parent="9fd145d8a3dcd12e9ce240181bac20a7" type="folder">11-12</container></did><accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="64be8e3eb6b9a7f019087998bc44abd8" level="file"><did><unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle><unitdate type="inclusive">1995 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="a2d2981cdd4496dcb0d3476b361f8b62" label="mixed materials [A0000000075848]" type="box">5</container><container id="b14fda946cd1feee3e39634bfa522139" parent="a2d2981cdd4496dcb0d3476b361f8b62" type="folder">13-16</container></did><accessrestrict id="695bcbd1bf632b907b932d7960966f9f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="d9a3163717a4c9958c5c7017393d0001" label="mixed materials [A0000000075848]" type="box">5</container><container id="21bd00d03ef81fcf74133c9715d8055a" parent="d9a3163717a4c9958c5c7017393d0001" type="folder">17-21</container></did><accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="35c106caf84841f600db741ede502382" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="f7d05c49e779499ffe4acd13426b56db" label="mixed materials [A0000000075849]" type="box">6</container><container id="1cc2333e1fbe0f099c2844816be7495b" parent="f7d05c49e779499ffe4acd13426b56db" type="folder">1</container></did><accessrestrict id="f54d8351e9c7683733c760ddc9c6386f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9c02c90545e46d220940cf2a507e0a28" level="file"><did><unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="4c717f304798654387975b680babb70e" label="mixed materials [A0000000075849]" type="box">6</container><container id="dc5c76bb1ee0e083455f97da8cec9005" parent="4c717f304798654387975b680babb70e" type="folder">2-3</container></did><accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file"><did><unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="00300518b8b61018fa25c6ac8258c1ae" label="mixed materials [A0000000075849]" type="box">6</container><container id="9d11ec7920c0c87838b4f65f8fc01713" parent="00300518b8b61018fa25c6ac8258c1ae" type="folder">4-6</container></did><accessrestrict id="7105d2dd194378e7c1b806e1786142c0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="237f462175824d3b36e04281c83344ac" level="file"><did><unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="6d572d0692591ff5974446eb636ca737" label="mixed materials [A0000000075849]" type="box">6</container><container id="3b3e0bf0a29cc85c6c4c3abbfa5c01c3" parent="6d572d0692591ff5974446eb636ca737" type="folder">7-8</container></did><accessrestrict id="d0c68415f609b87b8e322217b54f482b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file"><did><unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="ae8e172503aef2956ae2cd9090d18a81" label="mixed materials [A0000000075849]" type="box">6</container><container id="bde23715305af1e06ee108db500557bf" parent="ae8e172503aef2956ae2cd9090d18a81" type="folder">9-13</container></did><accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="df185de80953b9ba72734fc53563026f" level="file"><did><unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle><unitdate type="inclusive">1995 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="7624878cdcd9291a2da02e956633c975" label="mixed materials [A0000000075849]" type="box">6</container><container id="5c8e64ea7c3487518f662dce7927b592" parent="7624878cdcd9291a2da02e956633c975" type="folder">14-16</container></did><accessrestrict id="ee2185b1e98265927be53db9e0fa2dda"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9ea393808d7941a34a9237ff7d3e21d0" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="8240c9e986e3cdfd84df76120a0882e7" label="mixed materials [A0000000075849]" type="box">6</container><container id="e869e0bf71438d4ec7614a613f9fe7bd" parent="8240c9e986e3cdfd84df76120a0882e7" type="folder">17-20</container></did><accessrestrict id="052ebcc34a91845237e97c0df53775e3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b5728f730c61991eb3d049832355c05c" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="e10b3fbbbc8ac73ac3e770b00ee543f2" label="mixed materials [A0000000075850]" type="box">7</container><container id="ab57075dfeb2e09b6d09294ada5e41a7" parent="e10b3fbbbc8ac73ac3e770b00ee543f2" type="folder">1-2</container></did><accessrestrict id="8725ceb0317248c73c37ce2386f5e01b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="34fded3e81407289cef7298c43db888c" level="file"><did><unittitle>TML - Drugs of Choice - Pain</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="372d487cf8dd883f7fae3eacc0709dec" label="mixed materials [A0000000075850]" type="box">7</container><container id="11b8654492cc61b013feb137240bb044" parent="372d487cf8dd883f7fae3eacc0709dec" type="folder">3-7</container></did><accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="73f114dc6e630afb990634a443031d95" level="file"><did><unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle><unitdate type="inclusive">1995 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="967235f4cd720c9dc1ae10588ad8e205" label="mixed materials [A0000000075850]" type="box">7</container><container id="182d5ee0ad77a96e1face30d62aa4795" parent="967235f4cd720c9dc1ae10588ad8e205" type="folder">8-10</container></did><accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3ff759a8063b390ff0175205e40649d" level="file"><did><unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="f37980b4ed14360879a4c8df83b082e5" label="mixed materials [A0000000075850]" type="box">7</container><container id="9f41a0438f6e366de9398ea6312dab40" parent="f37980b4ed14360879a4c8df83b082e5" type="folder">11-13</container></did><accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file"><did><unittitle>TML, 38-17 - Advice for Travelers</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="5e162c1012eb0113da4f834d3d5b0725" label="mixed materials [A0000000075850]" type="box">7</container><container id="8eef61d7deb2e02f87dd6582cc5937de" parent="5e162c1012eb0113da4f834d3d5b0725" type="folder">14-16</container></did><accessrestrict id="c3bea7a676bd5b9981068ccf42242297"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="314ebfe0a12d0bad31002df2bbabf782" level="file"><did><unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle><unitdate type="inclusive">1995 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="ddafaa7953f013e87d12133f24ba658f" label="mixed materials [A0000000075850]" type="box">7</container><container id="4eff1f9fb9ee9e555d21c23f29f8c0f3" parent="ddafaa7953f013e87d12133f24ba658f" type="folder">17</container></did><accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="fa30b8e25d30bd60ee7b9207731748dd" level="file"><did><unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="4fb89d5dc346e220441877bae8ed1723" label="mixed materials [A0000000075850]" type="box">7</container><container id="4a0b1bc54b3fa0596247845097c6f26e" parent="4fb89d5dc346e220441877bae8ed1723" type="folder">18</container></did><accessrestrict id="5726a4d76a933c3152d68d2618f96f58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="76dcb6a56a7b5f83636afb906304e3de" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="434835223ad3ef5954e554e0e2c42201" label="mixed materials [A0000000075850]" type="box">7</container><container id="a48e6af21499f81ec636927288cb227f" parent="434835223ad3ef5954e554e0e2c42201" type="folder">19</container></did><accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="055a2ad26b73005f3516741563af679a" label="mixed materials [A0000000075851]" type="box">8</container><container id="51c1175240d0f64f866a2bdf9a7d0fe8" parent="055a2ad26b73005f3516741563af679a" type="folder">1-4</container></did><accessrestrict id="5afb2bc4dd74607653137719b41bcbd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file"><did><unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="0885af9a2ec1818b366e5f6be7ce0865" label="mixed materials [A0000000075851]" type="box">8</container><container id="051fd20dba6340e7f1824be68c282702" parent="0885af9a2ec1818b366e5f6be7ce0865" type="folder">5-6</container></did><accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c90350a57c09afa4b1edf8990faf82c4" level="file"><did><unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="b424e1d86bfd40f3ddcdb844a199f807" label="mixed materials [A0000000075851]" type="box">8</container><container id="b21473dbe40fda3b27000c96e3628add" parent="b424e1d86bfd40f3ddcdb844a199f807" type="folder">7-10</container></did><accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="838bd206e5b57f1350c9a04ae42f2583" level="file"><did><unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="b6c6bf20733aefce3ff6076e3ee0392e" label="mixed materials [A0000000075851]" type="box">8</container><container id="76a1c9c1098edbbc19bbe9376f793ab1" parent="b6c6bf20733aefce3ff6076e3ee0392e" type="folder">11-14</container></did><accessrestrict id="2e48e9ac6a735700c373ee378f599caa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="45a205e5a189cb71c6708535b75c4937" level="file"><did><unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="876a846556cb39821cc88a3f7dba8b3c" label="mixed materials [A0000000075851]" type="box">8</container><container id="b87234d9be407cc16a33d12c2fedfd6c" parent="876a846556cb39821cc88a3f7dba8b3c" type="folder">15-16</container></did><accessrestrict id="0c7d5401af543b0c0983defbe212a6e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2cbe2967f283fa20d7d713e0125238d8" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="5d1ffc02da4e8d19a35028d233edfffe" label="mixed materials [A0000000075851]" type="box">8</container><container id="572010ab4806b60a9f8f4bf39a15b041" parent="5d1ffc02da4e8d19a35028d233edfffe" type="folder">17-18</container></did><accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f7093bc2141bbd10998f3dc5ff41875b" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="3b3809126e033f5ef4e2147c056c1ad0" label="mixed materials [A0000000075852]" type="box">9</container><container id="c6aa07f34012bd0caa35169016fecfcc" parent="3b3809126e033f5ef4e2147c056c1ad0" type="folder">1-3</container></did><accessrestrict id="5de98fca91cbe16591ff580840223c8c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file"><did><unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="41846a2f202f8ec5e0e674cab3efdf06" label="mixed materials [A0000000075852]" type="box">9</container><container id="902bcee9db219dee833f49a9330e3ef1" parent="41846a2f202f8ec5e0e674cab3efdf06" type="folder">4-7</container></did><accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0ab086d0742f0a6f31a054d358cbefcf" level="file"><did><unittitle>TML, 35-62 - Nedocromil for asthma</unittitle><unitdate type="inclusive">1993 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="b259c8f4f3dec0308c46939605bb900f" label="mixed materials [A0000000075852]" type="box">9</container><container id="c1efdd92badadd24acdaafb84602fca4" parent="b259c8f4f3dec0308c46939605bb900f" type="folder">8-12</container></did><accessrestrict id="d876b6e0e035d2d97ee9711f878a831c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9f3042b173404cf6a3ccd9df900d20c0" level="file"><did><unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="3902af2eeca52eb8d3a15d341e387ca3" label="mixed materials [A0000000075852]" type="box">9</container><container id="6570b47339e2ab21b363fe2d65dfa6b6" parent="3902af2eeca52eb8d3a15d341e387ca3" type="folder">13-18</container></did><accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file"><did><unittitle>TML, 38-53 - Prostatron</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="c87e3d30ceaab4b6ccb9bfd0678d95b8" label="mixed materials [A0000000075852]" type="box">9</container><container id="edd4df2173c226898ea2f4060fa21904" parent="c87e3d30ceaab4b6ccb9bfd0678d95b8" type="folder">19-20</container></did><accessrestrict id="fa8555c81ed0ff184e52c7e939db327c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file"><did><unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="674b97fbe416f4acd1f068d2347c52a7" label="mixed materials [A0000000075853]" type="box">10</container><container id="dfa421b86ae9ded7000922db4332677e" parent="674b97fbe416f4acd1f068d2347c52a7" type="folder">1-3</container></did><accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c1416d4fc58c7899cbc27ca73d15c172" level="file"><did><unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="f708b57dfcd728d606f971c4d2abdf7e" label="mixed materials [A0000000075853]" type="box">10</container><container id="3d2861dff6c95ae555c9ec961d37e0c0" parent="f708b57dfcd728d606f971c4d2abdf7e" type="folder">4-5</container></did><accessrestrict id="76d78aedee8d1ddf219a07affe27bb10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="26af25957e59124a08f91eba499fc700" level="file"><did><unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="c6f1d2e04dbc6ecbfd1dcbe4ea9cef59" label="mixed materials [A0000000075853]" type="box">10</container><container id="abb5f305330d7410d331dd5f6a01bc9b" parent="c6f1d2e04dbc6ecbfd1dcbe4ea9cef59" type="folder">6-7</container></did><accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4273a72d699f99aeabfcab12d5bde513" level="file"><did><unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="6ff9661cb081ac5498d9e616624a56f5" label="mixed materials [A0000000075853]" type="box">10</container><container id="90779b9d1a10fd2d561a420323c42c48" parent="6ff9661cb081ac5498d9e616624a56f5" type="folder">8-11</container></did><accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="afa8fcead3849c57e46148fac07fdf16" level="file"><did><unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="c5bdbdc63a08fab06a5f8fc4cafebf82" label="mixed materials [A0000000075853]" type="box">10</container><container id="5c0956bce842f2eb353b34541e7d78f7" parent="c5bdbdc63a08fab06a5f8fc4cafebf82" type="folder">12-15</container></did><accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e83fc33c009862fb85873ce44225451e" level="file"><did><unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="fda6637bfe4eef41b8b08495b979b824" label="mixed materials [A0000000075853]" type="box">10</container><container id="211c0e60a419afce98d2d6e8e13373ed" parent="fda6637bfe4eef41b8b08495b979b824" type="folder">16-18</container></did><accessrestrict id="f4f4ca0b76dee28258679841660c3e53"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="1d1e2499f47a2c5a2498c508251c060e" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="2861d56dcaeca9778319480360ff74a7" label="mixed materials [A0000000075853]" type="box">10</container><container id="ce057cfb63b84f6f6ac51d0a923abe83" parent="2861d56dcaeca9778319480360ff74a7" type="folder">19</container></did><accessrestrict id="5e026f0f926c42121383574e48a743ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3cd99c272218799e02c72a5e28f33c9" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="22b84c5e382053d4f4a08f6a6381a1a9" label="mixed materials [A0000000075946]" type="box">11</container><container id="897ab3fde0e2b0e357f44a3f949feb9b" parent="22b84c5e382053d4f4a08f6a6381a1a9" type="folder">1-2</container></did><accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2146f075bfb01adf0c99fddbe6268b26" level="file"><did><unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="fb09bab6eaa6ea1698091681cace269e" label="mixed materials [A0000000075946]" type="box">11</container><container id="34cbce928a426e2827a13fa23cfbaa26" parent="fb09bab6eaa6ea1698091681cace269e" type="folder">3-5</container></did><accessrestrict id="a1dd4aa7256167e609397b035b7478d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7a2f268994b16b4876604d64167ade0b" level="file"><did><unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="20a54328cd613e388a2ce3104953667b" label="mixed materials [A0000000075946]" type="box">11</container><container id="7e836516a695370295ba3a468168ebcc" parent="20a54328cd613e388a2ce3104953667b" type="folder">6-8</container></did><accessrestrict id="c284795ebfbae6dd142f49e2c3d64449"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file"><did><unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="6cce2977a61542bb01eb26450d239413" label="mixed materials [A0000000075946]" type="box">11</container><container id="262fa962f9ea668e6b1f9a09cbcf9471" parent="6cce2977a61542bb01eb26450d239413" type="folder">9-11</container></did><accessrestrict id="d93e4e485f03621de43519409ecd0ebb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d2847f832cf8b7dfa8bae10d4079561b" level="file"><did><unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="7b3bd872ccd61dc68a2d8a44644bda6c" label="mixed materials [A0000000075946]" type="box">11</container><container id="bfbb5b108b13ecf009e10b5c6c1a7fe3" parent="7b3bd872ccd61dc68a2d8a44644bda6c" type="folder">12-14</container></did><accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="07f911d357717fedb196ba2a95b08c6f" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="ba26629ba826c0dae472eb419ec005e5" label="mixed materials [A0000000075946]" type="box">11</container><container id="184fc8bb87be1e1bdd479596bd5be40e" parent="ba26629ba826c0dae472eb419ec005e5" type="folder">15-19</container></did><accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="b8584d2b35555f5b780437cfcbfc5b88" label="mixed materials [A0000000075854]" type="box">12</container><container id="08b01be3edc0a03aead41c64cc8c4da4" parent="b8584d2b35555f5b780437cfcbfc5b88" type="folder">1-2</container></did><accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file"><did><unittitle>TML, 38-65 - Drugs past their expiration date</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="ab509b959d9a0be5cfd91b290b11dbab" label="mixed materials [A0000000075854]" type="box">12</container><container id="831cb64eab5a2176890637c860bb8526" parent="ab509b959d9a0be5cfd91b290b11dbab" type="folder">3-4</container></did><accessrestrict id="861175c1c60e1d08ff94909fca12e380"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file"><did><unittitle>TML, 38-38 - Ibutilide</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="ca46f8ab50b7479016288e2a86aeb4e3" label="mixed materials [A0000000075854]" type="box">12</container><container id="ec49e0ac322e00ae351f1c5be006fa57" parent="ca46f8ab50b7479016288e2a86aeb4e3" type="folder">5-6</container></did><accessrestrict id="d854aa1bc446941f011a8970567a2b37"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="93c5ceb8486269a6440d4a1164bd8a19" level="file"><did><unittitle>TML, 38-91 - DHEA</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="78d5da2d35f5f6f501694cf1e741a218" label="mixed materials [A0000000075854]" type="box">12</container><container id="d5badf6c39a804edcf478d227e234d0b" parent="78d5da2d35f5f6f501694cf1e741a218" type="folder">7-9</container></did><accessrestrict id="0b753cb331038a0a1193ae254361f43e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="489aaa51c24f7c3822366d6381860b83" level="file"><did><unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="32c2610c334f03b81d63dee8f79294a2" label="mixed materials [A0000000075854]" type="box">12</container><container id="bc05b68227fa6303a603336f8d7acb2a" parent="32c2610c334f03b81d63dee8f79294a2" type="folder">10-14</container></did><accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="3a54f51aec4a83bee985f1670be2aff6" level="file"><did><unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="7037633f39920ccabbb87dd6fe582512" label="mixed materials [A0000000075854]" type="box">12</container><container id="62764655aca56e7804ed42c36a7911df" parent="7037633f39920ccabbb87dd6fe582512" type="folder">15</container></did><accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="43193a32312eb0204d12fd64fa6b6993" level="file"><did><unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="25bbf70647aafa0b8b03d8040516cef3" label="mixed materials [A0000000075854]" type="box">12</container><container id="dcda172d95b878ec770d062a7516d0fa" parent="25bbf70647aafa0b8b03d8040516cef3" type="folder">16-18</container></did><accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="49b7007dcadc3c636c88f299dc526e0d" level="file"><did><unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="2ce0993a5b41f8248c4dd7efa074ba69" label="mixed materials [A0000000075855]" type="box">13</container><container id="9e00940b1b85bf9fe6cb6f066bed6c37" parent="2ce0993a5b41f8248c4dd7efa074ba69" type="folder">1-3</container></did><accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="61b0c640e3f013a34c64133724020fa2" level="file"><did><unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle><unitdate type="inclusive">1997 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="61b31664ae2f327d89d7ee078be9ded9" label="mixed materials [A0000000075855]" type="box">13</container><container id="fcf4ab6df85e0b67b0ca24c76b3abe95" parent="61b31664ae2f327d89d7ee078be9ded9" type="folder">4-12</container></did><accessrestrict id="84c4988675afd57f7b095139aa7bfdfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="133977107f40fa3272c401b7abcc89de" level="file"><did><unittitle>TML, 39-18 - Zileuton for asthma</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="8e7b814462601b17232ab5f65c4711a9" label="mixed materials [A0000000075855]" type="box">13</container><container id="cd50c4e06fe246848f3444c1131d976d" parent="8e7b814462601b17232ab5f65c4711a9" type="folder">13-14</container></did><accessrestrict id="4717fa288dd120e806e05499350ddf6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be46a606b805462c6cc03b6ec8b2c39e" level="file"><did><unittitle>TML, 39-9 - Zinc for the common cold</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="6a37075e1c917d377e91de8a36b484b3" label="mixed materials [A0000000075855]" type="box">13</container><container id="ad7e22485e5d558cdf63ab4b93f62efb" parent="6a37075e1c917d377e91de8a36b484b3" type="folder">15-17</container></did><accessrestrict id="ad1088be46d6652eb0405e32258a0bf9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="1bcc6026c39e0789cee04bfef8c12e41" label="mixed materials [A0000000075855]" type="box">13</container><container id="a7b8f12afe37ed952740357602260337" parent="1bcc6026c39e0789cee04bfef8c12e41" type="folder">18-20</container></did><accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c3fee2e8cf6e2d58695098807e086dab" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="5d92c6686029883cca40e8e26324e23b" label="mixed materials [A0000000075856]" type="box">14</container><container id="acdd9fcf38f3026d581685aa75705bba" parent="5d92c6686029883cca40e8e26324e23b" type="folder">1</container></did><accessrestrict id="898d939f278bc6e6c335eb092f07c5a8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="393de6e6b75d4f4817695af30349dd68" level="file"><did><unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="d075155fd95d0bfd91fa51dd24b88c0d" label="mixed materials [A0000000075856]" type="box">14</container><container id="6fa7a6cfccfd0e93663a09df8891bbb8" parent="d075155fd95d0bfd91fa51dd24b88c0d" type="folder">2-4</container></did><accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="4be741eb1bacb7f18527f5b2df647302" level="file"><did><unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="341a313e0cf6c5d3b549591491b22d20" label="mixed materials [A0000000075856]" type="box">14</container><container id="d26cb79488d5bd9965f0e52b801fceea" parent="341a313e0cf6c5d3b549591491b22d20" type="folder">5-10</container></did><accessrestrict id="7550d2d00d3b056285daa384c568544b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b81fc7aadd5fecc407e846095655da0e" level="file"><did><unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="e4742d0db1edb22c9f37431b2144d131" label="mixed materials [A0000000075856]" type="box">14</container><container id="2a602392e1a077117c758ec80abaca05" parent="e4742d0db1edb22c9f37431b2144d131" type="folder">11-15</container></did><accessrestrict id="0f1f31dc544a7820b6b3740572840e2c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d6a872b6263ad2beca76d2809d741c78" level="file"><did><unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="4aaf195dc072f72590dad5d1f30e84b8" label="mixed materials [A0000000075856]" type="box">14</container><container id="e9051b5d06a28c20681b6ecc4a992d8b" parent="4aaf195dc072f72590dad5d1f30e84b8" type="folder">16</container></did><accessrestrict id="37b13c54d0d04ba5299304f96256cfc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="62572ae54e7b47c32783a5b7f9f92261" level="file"><did><unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="6fbdedd879ffff4595c19a7e2990cc59" label="mixed materials [A0000000075856]" type="box">14</container><container id="b2fcd79ac22dc761abf729494d333d04" parent="6fbdedd879ffff4595c19a7e2990cc59" type="folder">17-19</container></did><accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bbfc9de7adb6df0701f6173947f38bd2" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="375da1e9153907689514ad8905bd1d5c" label="mixed materials [A0000000075856]" type="box">14</container><container id="e335a04fec1ec8345ecd7777203a9787" parent="375da1e9153907689514ad8905bd1d5c" type="folder">20</container></did><accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6b378b12b2f16c81d85d36343d81a41b" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="45183286fca0fae198770fbd5529bcf3" label="mixed materials [A0000000075857]" type="box">15</container><container id="983b54b18f1856c0df2c8955bea70c7c" parent="45183286fca0fae198770fbd5529bcf3" type="folder">1-2</container></did><accessrestrict id="62290c3388efd25a1b03329c60a4c2c5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bf256a51de793456a4c7d083f141288c" level="file"><did><unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="b24ab9f3bf66593b64c11ff3d7023baa" label="mixed materials [A0000000075857]" type="box">15</container><container id="6cc1d978e1151578835c1a1b7f2fb228" parent="b24ab9f3bf66593b64c11ff3d7023baa" type="folder">3-5</container></did><accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e50c791d98c44790d8141d27cd4cfcab" level="file"><did><unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="1ec4d07e0390ec73707f8cf0d1c3395e" label="mixed materials [A0000000075857]" type="box">15</container><container id="61e61adb4a4456590c31873d08e50a40" parent="1ec4d07e0390ec73707f8cf0d1c3395e" type="folder">6-8</container></did><accessrestrict id="264d6479c0b4544b7007e8c452a7cee5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12444cf584e83734f66bfc290040544a" level="file"><did><unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="6ff01626fee71b4d0ac7475f713735f6" label="mixed materials [A0000000075857]" type="box">15</container><container id="d02d9efbefa44ff45ccc3caffff13239" parent="6ff01626fee71b4d0ac7475f713735f6" type="folder">9-11</container></did><accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="64f0edfa5bd3b5159911a74e751d912b" level="file"><did><unittitle>TML, 39-43 - Valsartan for hypertension</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="f547d7bcc686553b5fd5d7bde6796c8b" label="mixed materials [A0000000075857]" type="box">15</container><container id="626ebd8a8da140ccf64267456479a08f" parent="f547d7bcc686553b5fd5d7bde6796c8b" type="folder">12-14</container></did><accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eb014687998353d0fb60326357526127" level="file"><did><unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle><unitdate type="inclusive">1997 January 3</unitdate><container altrender="Record Storage Box (Paige)" id="ea8ffeaa5b4863871b21c10c07436907" label="mixed materials [A0000000075857]" type="box">15</container><container id="b1dc8becb909568ee345193bb621b031" parent="ea8ffeaa5b4863871b21c10c07436907" type="folder">15-20</container></did><accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3436a17eac9c6f31692eb5d354b51a44" level="file"><did><unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="fa997c080991ab52907fe68ee37b82f3" label="mixed materials [A0000000075858]" type="box">16</container><container id="dbf19f26cea61b6f7340e8880713e056" parent="fa997c080991ab52907fe68ee37b82f3" type="folder">1-4</container></did><accessrestrict id="9f23fe9c137d23133c2b5049c5b64530"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file"><did><unittitle>TML, 39-105 - New drugs for psoriasis</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="571ecbb1e5e7a8ecf1d148c1f48abb62" label="mixed materials [A0000000075858]" type="box">16</container><container id="710f9b67d0a35cd4f25e2237be3b27f7" parent="571ecbb1e5e7a8ecf1d148c1f48abb62" type="folder">5-8</container></did><accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file"><did><unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle><unitdate type="inclusive">1997 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="d7b72915d9ce4bb0963cd8acd109a49b" label="mixed materials [A0000000075858]" type="box">16</container><container id="5df690c25b9ee0bce7fa84584239a9ed" parent="d7b72915d9ce4bb0963cd8acd109a49b" type="folder">9-15</container></did><accessrestrict id="dbaf4673299ed575f189876448054a58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="123a71748e8ade20af228276bab2d8b6" level="file"><did><unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="cdaffb85eab6ee40a8bf0da087c76c58" label="mixed materials [A0000000075858]" type="box">16</container><container id="0547592fa29750699055a3d23003d8fd" parent="cdaffb85eab6ee40a8bf0da087c76c58" type="folder">16-18</container></did><accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="498df0f2d9dce92679b2aa347629be3f" level="file"><did><unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="2a066b2e43ca39a70e093024a2b548a1" label="mixed materials [A0000000075859]" type="box">17</container><container id="d1e55f50ecd0c8a617baf9eabc3dabae" parent="2a066b2e43ca39a70e093024a2b548a1" type="folder">1-2</container></did><accessrestrict id="b2dca34162d6868414a816046edfdff2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file"><did><unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="b1257bc949b840ade832e036dd2932cd" label="mixed materials [A0000000075859]" type="box">17</container><container id="bd7ec10b01cdaab89a6525776de58f20" parent="b1257bc949b840ade832e036dd2932cd" type="folder">3-5</container></did><accessrestrict id="6532d645696e8a65297e0563e103f695"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file"><did><unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="78d8675582133ba326f64abd788c873c" label="mixed materials [A0000000075859]" type="box">17</container><container id="0a972381b954e3eb14b9da0032b44316" parent="78d8675582133ba326f64abd788c873c" type="folder">6-10</container></did><accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fdd2b028e08760f46ba2467c4b638924" level="file"><did><unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle><unitdate type="inclusive">1997 March 14</unitdate><container altrender="Record Storage Box (Paige)" id="ac24e4dcb4231b81ec95283089d362af" label="mixed materials [A0000000075859]" type="box">17</container><container id="603774e4cbbf131d6e35053362ba96fa" parent="ac24e4dcb4231b81ec95283089d362af" type="folder">11-16</container></did><accessrestrict id="28f03f207bd6c378f505103883232f68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="42935bf2b5b11b084838a1252d3b3db8" level="file"><did><unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="67fa1ea394dd23eeaaf3f9e3e9fd6680" label="mixed materials [A0000000075859]" type="box">17</container><container id="11b6be2b3cd507b7479a5f54567a0eb6" parent="67fa1ea394dd23eeaaf3f9e3e9fd6680" type="folder">17</container></did><accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file"><did><unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="f136a320b7a51a33777eb5611a172c97" label="mixed materials [A0000000075860]" type="box">18</container><container id="d964aa9825b4cffb94145af1f2345a13" parent="f136a320b7a51a33777eb5611a172c97" type="folder">1-2</container></did><accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="856acb144bbba7a94b1cb63f73185f43" level="file"><did><unittitle>TML, 39-56 - Pentosan</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="b186368f69ae9be19dc8532a38a1d114" label="mixed materials [A0000000075860]" type="box">18</container><container id="9d770cb81227fda431be98aae5c32e91" parent="b186368f69ae9be19dc8532a38a1d114" type="folder">3-4</container></did><accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="afd34d20934d1be77bfc49f4d1241183" level="file"><did><unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="39f7475384934da0455a0f19643fd3e5" label="mixed materials [A0000000075860]" type="box">18</container><container id="98767804ec9c180a1d1e27b437e63ecb" parent="39f7475384934da0455a0f19643fd3e5" type="folder">5-8</container></did><accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="de42e2f43ebae331da9c0b8180abb87c" level="file"><did><unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="df169b4c2415f3c63b0ae8041f7ac1eb" label="mixed materials [A0000000075860]" type="box">18</container><container id="4c8b1cf4538ff462d61d63989640d64e" parent="df169b4c2415f3c63b0ae8041f7ac1eb" type="folder">9-11</container></did><accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="96ceef3812b648bc28698beed66c5d75" level="file"><did><unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="81fdd8f3298afc774c904bf4125df7cb" label="mixed materials [A0000000075860]" type="box">18</container><container id="4a6d7970a18fcb11ce65c809a961a8a8" parent="81fdd8f3298afc774c904bf4125df7cb" type="folder">12-14</container></did><accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eaedccce6a322747a43e566f8dfc2b7d" level="file"><did><unittitle>TML - Drugs of Choice</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="f236355993159bd67b983b2f139e98c1" label="mixed materials [A0000000075860]" type="box">18</container><container id="0c7cc6ef4a32373f79a5b96d76b73b04" parent="f236355993159bd67b983b2f139e98c1" type="folder">15-17</container></did><accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95b6682482a9d062317fcf262cc7f718" level="file"><did><unittitle>TML, 39-85 - Influenza vaccine</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="7167e4d4e5e8bdbaed770ed283b20e1f" label="mixed materials [A0000000075860]" type="box">18</container><container id="908823ea841d3288d33c4aeb822650f6" parent="7167e4d4e5e8bdbaed770ed283b20e1f" type="folder">18</container></did><accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="9c5534af6d0a227ae1ad47876c813383" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="519feaf10ec1b78b41d8d475d4c9fee3" label="mixed materials [A0000000075860]" type="box">18</container><container id="0e250fe3303e54272af698de1c5b0fcb" parent="519feaf10ec1b78b41d8d475d4c9fee3" type="folder">19</container></did><accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="374fa44e767fc8242a4d9fcf7bae01b4" label="mixed materials [A0000000075861]" type="box">19</container><container id="e2b9e7c9bf1d5249468669c1c3824286" parent="374fa44e767fc8242a4d9fcf7bae01b4" type="folder">1</container></did><accessrestrict id="36454ffdeab70b1b39646403fa3b2960"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0cdb2a091afd3228142c89eb37d2380a" level="file"><did><unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="7fa2523e7088c7b5e0eac2fa749bd6fe" label="mixed materials [A0000000075861]" type="box">19</container><container id="5730e1c3dc75ee8fa99d2211f48f69fa" parent="7fa2523e7088c7b5e0eac2fa749bd6fe" type="folder">2-3</container></did><accessrestrict id="d975c63ad23263fd275260f9460dcf1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f4d2ffb826a588ff6c493adbd06a92be" level="file"><did><unittitle>TML, 39-64 - Drugs for epilepsy</unittitle><unitdate type="inclusive">1997 February 6</unitdate><container altrender="Record Storage Box (Paige)" id="405e28af6f93d766887bde514c484eda" label="mixed materials [A0000000075861]" type="box">19</container><container id="640fd1932cf7bd490514aef10a965bba" parent="405e28af6f93d766887bde514c484eda" type="folder">4-6</container></did><accessrestrict id="c20b70cbd97aa855e62537fb259a09f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="028b89ba84e332c879eab9899c191875" level="file"><did><unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="8c45912a03c4ba9ade3033104d9f8235" label="mixed materials [A0000000075861]" type="box">19</container><container id="a106ffe521d816aa9c0cd5fb0bd7d087" parent="8c45912a03c4ba9ade3033104d9f8235" type="folder">7-9</container></did><accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file"><did><unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="50f0b0f0dd8d0eed2da3735e48c54d92" label="mixed materials [A0000000075861]" type="box">19</container><container id="8d6c5176ecf84f81a29760c3e51de65a" parent="50f0b0f0dd8d0eed2da3735e48c54d92" type="folder">10-13</container></did><accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6bf77dfe11efd36cf8146b826560cb4c" level="file"><did><unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="2481c29d2c4a77294dd2f2e1fdaca73d" label="mixed materials [A0000000075861]" type="box">19</container><container id="45e33556961ec3091f4e0062b4e659de" parent="2481c29d2c4a77294dd2f2e1fdaca73d" type="folder">14-16</container></did><accessrestrict id="58267fbb42c582dd03ac8830411c1803"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f36ff800dacbd73013d42dab42cf5f5b" level="file"><did><unittitle>TML, 38-6 - Drugs for head lice</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="75bf88742265fa37e4b73ca928f66f4d" label="mixed materials [A0000000075861]" type="box">19</container><container id="00a9a4c7ed334649b8b218777255812a" parent="75bf88742265fa37e4b73ca928f66f4d" type="folder">17-18</container></did><accessrestrict id="92296119b0cbe67e59973a003090f421"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e13f3fa0ec576057f7033815a81111e1" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="cc709e4e7550647633eb9d784e73ddd2" label="mixed materials [A0000000075861]" type="box">19</container><container id="620a9137f05766c1807148f6a429370e" parent="cc709e4e7550647633eb9d784e73ddd2" type="folder">19-20</container></did><accessrestrict id="e7cb03a6203eb58d2833529692c66d60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="0065fc2af9639dc0aa8fb6ab1785dd19" label="mixed materials [A0000000075862]" type="box">20</container><container id="206ce2534d0e05399ae090f0775d34ac" parent="0065fc2af9639dc0aa8fb6ab1785dd19" type="folder">1-2</container></did><accessrestrict id="d913972842d3a79acf9b906df7f951e7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95d8be151e4ef26242db019df375f791" level="file"><did><unittitle>TML, 39-94 - Drugs for hypertension</unittitle><unitdate type="inclusive">1997 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="b188a0c9c9175739e6bdf5f4e5152183" label="mixed materials [A0000000075862]" type="box">20</container><container id="2ead98b56b5c3e9d05c323051f72b2b3" parent="b188a0c9c9175739e6bdf5f4e5152183" type="folder">3-5</container></did><accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f8696aa81da52173ff18b97bd7eb4067" level="file"><did><unittitle>TML, 39-19 - Adapalene for acne</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="467055e3c8c8119a690b4d595f755d95" label="mixed materials [A0000000075862]" type="box">20</container><container id="33c1b51b961a9ef991a195ce571a0c2c" parent="467055e3c8c8119a690b4d595f755d95" type="folder">6-7</container></did><accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file"><did><unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="a11867b16a2f864448bd2507bfe19025" label="mixed materials [A0000000075862]" type="box">20</container><container id="23db36d7a5202ffd1839b5f78f1514da" parent="a11867b16a2f864448bd2507bfe19025" type="folder">8-9</container></did><accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file"><did><unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="50ce07e35a73ee4b996ff610e2360395" label="mixed materials [A0000000075862]" type="box">20</container><container id="3724c9e0b2335df2491012ff886f7a8b" parent="50ce07e35a73ee4b996ff610e2360395" type="folder">10-13</container></did><accessrestrict id="2c8bdc164c637c083bf92b35d52554fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="36e76c3b20aacff333ba5d98cfca27de" level="file"><did><unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="d5a9473b9eb8f9b2bc13e50c6cc17321" label="mixed materials [A0000000075862]" type="box">20</container><container id="a05bbc4bb0e9a985b44a867b8fc86f28" parent="d5a9473b9eb8f9b2bc13e50c6cc17321" type="folder">14-15</container></did><accessrestrict id="55bd4c86ccf4811f99aac2673693e945"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e4ca902373c4579a78db0d3b8d513633" level="file"><did><unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="3744784f409e53aa0ea208f38e52b937" label="mixed materials [A0000000075862]" type="box">20</container><container id="99ad5186043b59caeef399157efbe103" parent="3744784f409e53aa0ea208f38e52b937" type="folder">16-17</container></did><accessrestrict id="18bd5ce580d159e1acce03ad34266cc9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file"><did><unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="de596edb9ee34fa25bcec1e6d4157a55" label="mixed materials [A0000000075862]" type="box">20</container><container id="96fd22fa0d8fcc19eea4ce17750c3aee" parent="de596edb9ee34fa25bcec1e6d4157a55" type="folder">18-19</container></did><accessrestrict id="c12a956b010223394c6ca9d2025942d6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="56fc5093674d1372e80ed218ae8bd368" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="e1ae5f0a3810342162073a32a0aebb06" label="mixed materials [A0000000075862]" type="box">20</container><container id="190e2b51dc25695e1a3cf6667a605c67" parent="e1ae5f0a3810342162073a32a0aebb06" type="folder">20</container></did><accessrestrict id="12b089183fda270bbeecc135b190b589"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1f85013ec13e639596b728f22f1aafc4" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="656b5a549ce8fea49177dd01e7a76388" label="mixed materials [A0000000075863]" type="box">21</container><container id="fb619398d0cd0272f770a8a8b13b85ef" parent="656b5a549ce8fea49177dd01e7a76388" type="folder">1-2</container></did><accessrestrict id="8a33d90a046f00da2d8b9b030020c09e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4a11be555144c67db801913b3a95361" level="file"><did><unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="22ae6508602124b45f4a6565308d3c86" label="mixed materials [A0000000075863]" type="box">21</container><container id="b3dc2726bd736c4cd558c80b7928cc51" parent="22ae6508602124b45f4a6565308d3c86" type="folder">3-6</container></did><accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file"><did><unittitle>TML - Dovonex</unittitle><unitdate type="inclusive">1993</unitdate><container altrender="Record Storage Box (Paige)" id="efe4084c3b8ed002a219a1df95d46262" label="mixed materials [A0000000075863]" type="box">21</container><container id="9e2fbeab18dc9a218d97bc259aa91b66" parent="efe4084c3b8ed002a219a1df95d46262" type="folder">7</container></did><accessrestrict id="7ed0890a439df753466be5a70bc31770"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file"><did><unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="d9892d0dc647df8079927d7f01237757" label="mixed materials [A0000000075863]" type="box">21</container><container id="d851273aba0149c838593c6374bfe7b4" parent="d9892d0dc647df8079927d7f01237757" type="folder">8-9</container></did><accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0f25168045c3874b852fc2566864c22b" level="file"><did><unittitle>TML, 37-1 - Drugs for asthma</unittitle><unitdate type="inclusive">1996 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="cd9b94d5f47bedcc546b7b5dda142d29" label="mixed materials [A0000000075863]" type="box">21</container><container id="fc8c28525f7847f907981e2e24cecb53" parent="cd9b94d5f47bedcc546b7b5dda142d29" type="folder">10-14</container></did><accessrestrict id="5124cbd46d2a439f4f59c00468b6016b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="dbe0049fdc51d967d42b54af228c58ae" level="file"><did><unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="a3bbbe8d475dd538cadf1042d433e0b5" label="mixed materials [A0000000075863]" type="box">21</container><container id="d3e8d3d14394f11d50506c860d7e5874" parent="a3bbbe8d475dd538cadf1042d433e0b5" type="folder">15-16</container></did><accessrestrict id="108454fd852ec91b5893f1a78b4694b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3fff697896297fb5b3e546b99c7bb615" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="7508587df5e103d5f56dc56a5013cbc3" label="mixed materials [A0000000075863]" type="box">21</container><container id="7818a50ca6813f993f8e4714d778e1b8" parent="7508587df5e103d5f56dc56a5013cbc3" type="folder">17-21</container></did><accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ac009d8a6eba90db98f499f6852dd496" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="6f308acddfc39185b46cd7120b611b6a" label="mixed materials [A0000000075864]" type="box">22</container><container id="bdd7ba25f61e42b013a6cad27fac694b" parent="6f308acddfc39185b46cd7120b611b6a" type="folder">1-3</container></did><accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="364c7d8d424593144cdef790c4e94d75" level="file"><did><unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle><unitdate type="inclusive">1997 December 12</unitdate><container altrender="Record Storage Box (Paige)" id="9c577532e493786f5a057c809a459107" label="mixed materials [A0000000075864]" type="box">22</container><container id="5affaf1375419cd4aaa1bafff7a6c2ce" parent="9c577532e493786f5a057c809a459107" type="folder">4-9</container></did><accessrestrict id="a96e0ada70322de7df279993ca3ff3a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file"><did><unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1997 October 24</unitdate><container altrender="Record Storage Box (Paige)" id="2fe6bd315d3be58870c2bd19d6dc4685" label="mixed materials [A0000000075864]" type="box">22</container><container id="23ff7b09f508b11a1b738855438bbdb9" parent="2fe6bd315d3be58870c2bd19d6dc4685" type="folder">10-15</container></did><accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6568c1026445dec6f8e364671c21bd39" level="file"><did><unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="1607b2f70956c7e6e35ed10156389a29" label="mixed materials [A0000000075864]" type="box">22</container><container id="db5d82c3ef9ae2648c892daa50883de1" parent="1607b2f70956c7e6e35ed10156389a29" type="folder">16-18</container></did><accessrestrict id="8df589a9af326009da84ebecd5cf8932"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b0b4f71d2ecf84b337ced4a504f89306" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="635c54127d3bd64137e2122ab96ec467" label="mixed materials [A0000000075864]" type="box">22</container><container id="898523ef04a799b41f90c28db240308b" parent="635c54127d3bd64137e2122ab96ec467" type="folder">19</container></did><accessrestrict id="8df622f363be5b50961c92589e209dc4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="e1cd9944d46643758b05c9ba0b12396b" label="mixed materials [A0000000075865]" type="box">23</container><container id="94ef083cd85cf6326419f4954396c90c" parent="e1cd9944d46643758b05c9ba0b12396b" type="folder">1-4</container></did><accessrestrict id="181d3a4b218653d1790e4861871f62dd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file"><did><unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="239ed27ca82895e35a2a307fdded47c4" label="mixed materials [A0000000075865]" type="box">23</container><container id="35ed542914792ddec25b2da4b735fe9c" parent="239ed27ca82895e35a2a307fdded47c4" type="folder">5-9</container></did><accessrestrict id="f5705dc19e306f206ec780b8d160e15c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3f1ba5c10401cadfc440c87da71224cb" level="file"><did><unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="5cd1a0c452a35416e57467928cdfd3d2" label="mixed materials [A0000000075865]" type="box">23</container><container id="c972b374c2c8d5226515d9128d2b3a07" parent="5cd1a0c452a35416e57467928cdfd3d2" type="folder">10-11</container></did><accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6311bd1ab3c17838b525980881eb7804" level="file"><did><unittitle>TML, 38-17 - Drugs for migraine</unittitle><unitdate type="inclusive">1995 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="963b9d8332a6623a0ca5e3ab43e5bbef" label="mixed materials [A0000000075865]" type="box">23</container><container id="4e7dc43d1edad5b53d79f54efa0a12e3" parent="963b9d8332a6623a0ca5e3ab43e5bbef" type="folder">12-16</container></did><accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d46efc5621917384073357b190321659" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="57aa605d5b43756fd6053147ca87480c" label="mixed materials [A0000000075865]" type="box">23</container><container id="de0dc6a3c8ad0bbb54193fbde6d73864" parent="57aa605d5b43756fd6053147ca87480c" type="folder">17-21</container></did><accessrestrict id="663777121320adda427992b307d1db2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="26549fe088bf0e56b93f1fdf46814c60" label="mixed materials [A0000000075866]" type="box">24</container><container id="5986e2d9af8f382f1300ea2368c75324" parent="26549fe088bf0e56b93f1fdf46814c60" type="folder">1</container></did><accessrestrict id="702b01fd73a7deda0a72869d6f566a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="318ae2efe1275c93a47e9ae522f706ea" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="6cea6bd4fd606aca4d9cbd1e46350b2e" label="mixed materials [A0000000075866]" type="box">24</container><container id="be309552ff29cdb9d8bfa83d430c7bb7" parent="6cea6bd4fd606aca4d9cbd1e46350b2e" type="folder">2-3</container></did><accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file"><did><unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="94a5e905bda3bfa40473ef1f64122655" label="mixed materials [A0000000075866]" type="box">24</container><container id="464bd7f6c24d97f779815ea3a79e4b45" parent="94a5e905bda3bfa40473ef1f64122655" type="folder">4-6</container></did><accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file"><did><unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="937bdcdd9471074813b0e0ef289a3796" label="mixed materials [A0000000075866]" type="box">24</container><container id="0835e9e5ea71f1dcf70c800506c470b1" parent="937bdcdd9471074813b0e0ef289a3796" type="folder">7-9</container></did><accessrestrict id="6a61863bdf42f359838de02eb3140260"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c2e1fc197d7490d826da206b516a38a5" level="file"><did><unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="6cfa25c9d5f05777f08fd7ec18d91f3f" label="mixed materials [A0000000075866]" type="box">24</container><container id="e028acf859bb94725dc95589df503e47" parent="6cfa25c9d5f05777f08fd7ec18d91f3f" type="folder">10-16</container></did><accessrestrict id="5d151812a70ad7aab1e31b15864a8198"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fc12244326436c163ce3062f2ee5441e" level="file"><did><unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="711ad405e27f134551c4837ac694bfe4" label="mixed materials [A0000000075867]" type="box">25</container><container id="8345ac7a4c3d3f25c3737c0abde7f5b1" parent="711ad405e27f134551c4837ac694bfe4" type="folder">1-3</container></did><accessrestrict id="010c90cf26351f4881154a4f6ad41ad3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file"><did><unittitle>TML, 40-113 - Citalopram for depression</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="2d3380524f7684448d5377a493c68e5a" label="mixed materials [A0000000075867]" type="box">25</container><container id="f4c18a6f7a8f89bd40da5d84e1633cd0" parent="2d3380524f7684448d5377a493c68e5a" type="folder">4-8</container></did><accessrestrict id="e132e378e63282bf8014cd21bd84bf26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="85788caeb20c27238d916bb497645405" level="file"><did><unittitle>TML, 40-52 - Anthrax vaccine</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="318f47a4f4a7644b5b02e4e6a6344055" label="mixed materials [A0000000075867]" type="box">25</container><container id="2d3d8f549ed2ad0d64e7485781f190e3" parent="318f47a4f4a7644b5b02e4e6a6344055" type="folder">9-10</container></did><accessrestrict id="0a33ad6cdce119b325c656b5c6f11151"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7481cf56a926bcaa665f596bebcba058" level="file"><did><unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="d8f80f175808ff5b9525e5024798daff" label="mixed materials [A0000000075867]" type="box">25</container><container id="aa9a4036002c7de556a6088cf27806a6" parent="d8f80f175808ff5b9525e5024798daff" type="folder">11-13</container></did><accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="276f7a6dda26470f835e467b2e300373" level="file"><did><unittitle>TML, Sildenafil - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="504a6cfc014f0f7360578c09474d2a31" label="mixed materials [A0000000075867]" type="box">25</container><container id="c316f42717487f991a9d39961a7e1223" parent="504a6cfc014f0f7360578c09474d2a31" type="folder">14-16</container></did><accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file"><did><unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="9767b526abfeea5037b0f0f26242f8fa" label="mixed materials [A0000000075867]" type="box">25</container><container id="c0d5e7bd464d94a48da7dbac9cc7f52f" parent="9767b526abfeea5037b0f0f26242f8fa" type="folder">17-19</container></did><accessrestrict id="548bd13d1ee4dd091a7071fb17973086"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e605d151c50d15b7436fa8b95fabcc04" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="a27786511603d26b58784e1e6b8800ec" label="mixed materials [A0000000075867]" type="box">25</container><container id="23932d3b45a47f4dab9f179592726427" parent="a27786511603d26b58784e1e6b8800ec" type="folder">20-21</container></did><accessrestrict id="72272d08b8d2095400f484d84b5c8623"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="5f468e1f665879ef36056f5d84d6226f" label="mixed materials [A0000000075868]" type="box">26</container><container id="69245627bc4e2c4c0a28b3c817ab7830" parent="5f468e1f665879ef36056f5d84d6226f" type="folder">1</container></did><accessrestrict id="e61fbc122231a69d11de05471824b4f7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="58fc0933c16d75f16f20c226741f40fc" level="file"><did><unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle><unitdate type="inclusive">1998 February 13</unitdate><container altrender="Record Storage Box (Paige)" id="4513d28231669f3e61bafb6b710c7d3a" label="mixed materials [A0000000075868]" type="box">26</container><container id="fb3331e0acb9dcda3a54b381a662a821" parent="4513d28231669f3e61bafb6b710c7d3a" type="folder">2-5</container></did><accessrestrict id="cd18c294101a7fb036bca53986751b48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f466040faafb3cd515b6f7e5924186a3" level="file"><did><unittitle>TML, 40-47 - Advice for Travelers</unittitle><unitdate type="inclusive">1998 April 24</unitdate><container altrender="Record Storage Box (Paige)" id="1231974e13bd9ff2f8acb266e94cbea1" label="mixed materials [A0000000075868]" type="box">26</container><container id="91b55ad50c2c18fb0e219cf28ec4d3ba" parent="1231974e13bd9ff2f8acb266e94cbea1" type="folder">6-9</container></did><accessrestrict id="d3ea0598c816f490bd7b26c48572450a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d9d7051c247d055cb3a4caa57119bc34" level="file"><did><unittitle>TML, 40-68 - Fenofibrate</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="62d7749d22d8626161a4ac439dd74771" label="mixed materials [A0000000075868]" type="box">26</container><container id="a5b6c6219ab70e2f3f9f5c5072ddbd7f" parent="62d7749d22d8626161a4ac439dd74771" type="folder">10-13</container></did><accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0902f98f4048374d057a60de2d1b7855" level="file"><did><unittitle>TML, 40-30 - Trovafloxacin</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="a1862f7f7e695abff6155ab8f55d10cc" label="mixed materials [A0000000075868]" type="box">26</container><container id="860bf0c9c5aae9a5fe39880c2a2df544" parent="a1862f7f7e695abff6155ab8f55d10cc" type="folder">14-16</container></did><accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="40a127b41aba4ab1210aebb60355f7eb" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="26c52e5e7d9825a003bcbd995a8c2549" label="mixed materials [A0000000075868]" type="box">26</container><container id="aa3c4314a273b3ffd10a12d52c0928e7" parent="26c52e5e7d9825a003bcbd995a8c2549" type="folder">17-18</container></did><accessrestrict id="aa2e94224c5f71c8078141e7e709d476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2821241f88ab33b4108c2fb8ef546a03" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="8b36803b15b781d29e133ebbb608a079" label="mixed materials [A0000000075869]" type="box">27</container><container id="581121e0f2ca5ff50e9f000aeb6bd4d5" parent="8b36803b15b781d29e133ebbb608a079" type="folder">1-2</container></did><accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a5e3fba9d86330d4c75e3f31b4844108" level="file"><did><unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="1337de2cb7ee0cdfea6da9944522beab" label="mixed materials [A0000000075869]" type="box">27</container><container id="feb52982f5b9fc43060c6a5a0b72adbd" parent="1337de2cb7ee0cdfea6da9944522beab" type="folder">3-4</container></did><accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="41484f1614916c304d00c6a0e2776c25" level="file"><did><unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="adfa344ec9be4c3ff4e4925c6caecb0e" label="mixed materials [A0000000075869]" type="box">27</container><container id="afb34662f507fa89004164f4010ee2a6" parent="adfa344ec9be4c3ff4e4925c6caecb0e" type="folder">5-7</container></did><accessrestrict id="9e54423aecee12c7635588555d8c357f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="18a33071dfc9246e7c9a4f9970fc624f" level="file"><did><unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="9b53d2eb9fea2b05209d9971885a2c07" label="mixed materials [A0000000075869]" type="box">27</container><container id="c9592131eb4b0bd2dd95212e6dbe9a35" parent="9b53d2eb9fea2b05209d9971885a2c07" type="folder">8-9</container></did><accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file"><did><unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="bbebb32ac060eb821141d5c01eae65d6" label="mixed materials [A0000000075869]" type="box">27</container><container id="97b0f65fc685a726ea773944cc7e97c7" parent="bbebb32ac060eb821141d5c01eae65d6" type="folder">10-12</container></did><accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c689105113c5b23ebb896f340bf02ea0" level="file"><did><unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="4417578761579c49cb991a0a77118c7a" label="mixed materials [A0000000075869]" type="box">27</container><container id="f8f8626d607c2c4517c6050f99dbdb1e" parent="4417578761579c49cb991a0a77118c7a" type="folder">13</container></did><accessrestrict id="dc4b7b184944400de9cfe92635a05ead"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="705d7bf07e8ff402ef32c0df389a3828" level="file"><did><unittitle>TML, 40-89 - Antiplatelet</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="630443ce0da7e2415e2550ae752d34c0" label="mixed materials [A0000000075869]" type="box">27</container><container id="e3359fc1814bcfa9c7e6f7a6cc0f35d0" parent="630443ce0da7e2415e2550ae752d34c0" type="folder">14-16</container></did><accessrestrict id="ae0c798c535816e3564f3b350306c0eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="cc4045365330c91030e2afc2941ff362" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="193955d2f5094a4283bfd7fc2aa7d6da" label="mixed materials [A0000000075869]" type="box">27</container><container id="a7db43adea712bdf356694fad3d68dd5" parent="193955d2f5094a4283bfd7fc2aa7d6da" type="folder">17-19</container></did><accessrestrict id="d3830363a0deac040fb1a2187fcc43a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="74cd9f3df4304220a489f3cd523e97f4" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="6980463386c442b0599e849d226a7a74" label="mixed materials [A0000000075870]" type="box">28</container><container id="f325f6b6db5f3a0243b2634cdbccfd40" parent="6980463386c442b0599e849d226a7a74" type="folder">1</container></did><accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8f7886d013678b0f444c0e7ce3af676b" level="file"><did><unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="96bcce9a1f1558a13be33a6a94a7295e" label="mixed materials [A0000000075870]" type="box">28</container><container id="6c851e8d45df592bd25d72a8b5aca798" parent="96bcce9a1f1558a13be33a6a94a7295e" type="folder">2</container></did><accessrestrict id="8e2b80b72a52938a5c321da498c8b722"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="236c02b396ea229adb1f079d93029f01" level="file"><did><unittitle>TML, 40-32 - Sibutramine for obesity</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="200aa3e6a3cdc364651b1e7120ba6d49" label="mixed materials [A0000000075870]" type="box">28</container><container id="541acade433e42f4226ddcf1d9ec3fde" parent="200aa3e6a3cdc364651b1e7120ba6d49" type="folder">3-5</container></did><accessrestrict id="83216716b614ac8cc38fcaa01b43355e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="34d5d1374a9121f748a24968ebe6c128" level="file"><did><unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="20b687f320615f76258e27ac13733dd4" label="mixed materials [A0000000075870]" type="box">28</container><container id="9f83038570995901acc2ecc728b80c0f" parent="20b687f320615f76258e27ac13733dd4" type="folder">6-8</container></did><accessrestrict id="9f78fcde35549e85ae6f6ddddad23091"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file"><did><unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="17a395a78d6494e9edd6e23fceb9cc28" label="mixed materials [A0000000075870]" type="box">28</container><container id="7ab6b46df349867e6eaad17a536e90be" parent="17a395a78d6494e9edd6e23fceb9cc28" type="folder">9</container></did><accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fae1826f224dc5554dd9d77d43d63320" level="file"><did><unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle><unitdate type="inclusive">1998 January 2</unitdate><container altrender="Record Storage Box (Paige)" id="62b0c2e3409e86b2c6796aa97388c1d1" label="mixed materials [A0000000075870]" type="box">28</container><container id="f10adc93b7beb86ae3ff1ad696780a5f" parent="62b0c2e3409e86b2c6796aa97388c1d1" type="folder">10-11</container></did><accessrestrict id="3cf800c016782dc93e3a36b622f7b36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file"><did><unittitle>TML, 40-75 - Vitamin supplements</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="15a6123567d0349cb52bb37d222043fc" label="mixed materials [A0000000075870]" type="box">28</container><container id="c0b200a81e8914a52bfa6f81802b91f9" parent="15a6123567d0349cb52bb37d222043fc" type="folder">12-16</container></did><accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="06914f95afdacb00ca224c63b35cc3e5" level="file"><did><unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="daca43bb9d6a634d5049ee30d186d652" label="mixed materials [A0000000075870]" type="box">28</container><container id="4e8684e70f0c5fb41a5196cdebd322e4" parent="daca43bb9d6a634d5049ee30d186d652" type="folder">17-18</container></did><accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="428c3fa348f8b26b281d145d800e2730" label="mixed materials [A0000000075870]" type="box">28</container><container id="82c4ce7596bcf347806565762f70ddb4" parent="428c3fa348f8b26b281d145d800e2730" type="folder">19</container></did><accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="1a887f7b255ad670672d8cdcc8d96c13" label="mixed materials [A0000000075871]" type="box">29</container><container id="db59cfd34e65c44b1bc2c6e9b2cbb441" parent="1a887f7b255ad670672d8cdcc8d96c13" type="folder">1-5</container></did><accessrestrict id="530223b01deda9e053da32d105382b18"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="559cb584a41d6690a7e856498ab89795" level="file"><did><unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="b440cf986d88a77fdd8421533aaa13d8" label="mixed materials [A0000000075871]" type="box">29</container><container id="52b4158268f6cb34f70296ae39d1a38e" parent="b440cf986d88a77fdd8421533aaa13d8" type="folder">6-7</container></did><accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ece2250f2916521ae284b1830da4848e" level="file"><did><unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="d8bc08771123871e37031c1ee7e11d9a" label="mixed materials [A0000000075871]" type="box">29</container><container id="ef09ea2fdda18d90954ec6bfe9a29ccc" parent="d8bc08771123871e37031c1ee7e11d9a" type="folder">8-11</container></did><accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7dd5458e0da29270a7d0b887632c23ac" level="file"><did><unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="c372e79fd38f1e849c7ea315477e303e" label="mixed materials [A0000000075871]" type="box">29</container><container id="01db8e1583115d7d457b9d8ec2ddd2d9" parent="c372e79fd38f1e849c7ea315477e303e" type="folder">12-14</container></did><accessrestrict id="0b261ea329af56d20325ac31bcf03cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file"><did><unittitle>TML, 40-53 - Dolasetron</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="17e2b3dda8711eea06fbcdb9e4486f08" label="mixed materials [A0000000075871]" type="box">29</container><container id="6e7697beebe2ec265960dcad5ebba66f" parent="17e2b3dda8711eea06fbcdb9e4486f08" type="folder">15-18</container></did><accessrestrict id="2f191b313a6f595b28c9d77fec25b021"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file"><did><unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="df4646ead74284321b0254f70aa799a1" label="mixed materials [A0000000075872]" type="box">30</container><container id="115cb6fe9ae15edb05946fe9194a53e3" parent="df4646ead74284321b0254f70aa799a1" type="folder">1-4</container></did><accessrestrict id="5fe32f0354336c745f49eaad8ec99c60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6332598d843148b2b6fcca7483c23ff2" level="file"><did><unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle><unitdate type="inclusive">1998 March 27</unitdate><container altrender="Record Storage Box (Paige)" id="97a58c98ee29585eaac59eb34bff1809" label="mixed materials [A0000000075872]" type="box">30</container><container id="73e0eee3c2d53f18081aded75a72491a" parent="97a58c98ee29585eaac59eb34bff1809" type="folder">5-8</container></did><accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6062e376e8011b03bf27092730e8219d" level="file"><did><unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="cce1e73e7c8b5e77f1ff5252c0ba9147" label="mixed materials [A0000000075872]" type="box">30</container><container id="be8251f234ed02a93c1300a54c455463" parent="cce1e73e7c8b5e77f1ff5252c0ba9147" type="folder">9-12</container></did><accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="de828b3fc932777396bebd27f5fab7dd" level="file"><did><unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle><unitdate type="inclusive">1998 December 18</unitdate><container altrender="Record Storage Box (Paige)" id="97cdfefb05e3e249ada56aa67094ab74" label="mixed materials [A0000000075872]" type="box">30</container><container id="843f820da148596a23614ab3cc528510" parent="97cdfefb05e3e249ada56aa67094ab74" type="folder">13-16</container></did><accessrestrict id="ec87238d62e4af8195602bcb6756e8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="0efb05a124558b14a07cb2dd8c413c31" label="mixed materials [A0000000075872]" type="box">30</container><container id="856ad47ba750a7d145ddfbd3b2d8dd36" parent="0efb05a124558b14a07cb2dd8c413c31" type="folder">17-19</container></did><accessrestrict id="e69b8784cca126a51aa694fe76fa93ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="13029629c9a2c8c4645ba910bddc0ec5" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="3d703d36828b9a0ae3bd8a1c7bc0f798" label="mixed materials [A0000000075873]" type="box">31</container><container id="f0ecc8f78c2f496ec3c00a355aeeefd8" parent="3d703d36828b9a0ae3bd8a1c7bc0f798" type="folder">1-3</container></did><accessrestrict id="efd535a28d84b26cb3f39bdbca07f951"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c768307fb6b27100b14034cebd5227a9" level="file"><did><unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="f8fc03f3fd6804d45969b23b592f8cca" label="mixed materials [A0000000075873]" type="box">31</container><container id="a74817bc6f3beeb7d45f142073a6422a" parent="f8fc03f3fd6804d45969b23b592f8cca" type="folder">4-8</container></did><accessrestrict id="4fead382cbe8272480e24c54bdac4aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="edbc39d29ce93f5d2d89c1070b90a888" level="file"><did><unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="2687ee345fa2c4356416c1ab2830aaad" label="mixed materials [A0000000075873]" type="box">31</container><container id="d6fa05bb193e8daaec8353c3131733b0" parent="2687ee345fa2c4356416c1ab2830aaad" type="folder">9-10</container></did><accessrestrict id="4761d1070aff6ae3d4f74655713baaa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6d7c66707bdf53045a7ff953d6e108d3" level="file"><did><unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="5f7b20ef3f98b8d4e629057bb6a0b89c" label="mixed materials [A0000000075873]" type="box">31</container><container id="46dce5e4b53e60fe2b324e976ac1a0fd" parent="5f7b20ef3f98b8d4e629057bb6a0b89c" type="folder">11-13</container></did><accessrestrict id="94fdedf900cf20f12d378b25deedc2ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a07a54028f90ac0076d2802b57942911" level="file"><did><unittitle>TML, 40-64 - A new rabies vaccine</unittitle><unitdate type="inclusive">1998 June 14</unitdate><container altrender="Record Storage Box (Paige)" id="a1376499115f11f048e74a88ba9ae8c9" label="mixed materials [A0000000075873]" type="box">31</container><container id="b3f1706099a19fa76cddc5772af70330" parent="a1376499115f11f048e74a88ba9ae8c9" type="folder">14-15</container></did><accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file"><did><unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="543b8f6963732d334e243c26ccc8bf78" label="mixed materials [A0000000075873]" type="box">31</container><container id="292da5e003775de363826d8b7ad5845e" parent="543b8f6963732d334e243c26ccc8bf78" type="folder">16-18</container></did><accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fa4c88d1fa307e4c1c36721c687359e5" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="903499aac4f1187977ecfa7420978544" label="mixed materials [A0000000075873]" type="box">31</container><container id="c0bc8672bbbc1eb39aa9c1eecb673d28" parent="903499aac4f1187977ecfa7420978544" type="folder">19</container></did><accessrestrict id="4326873ad2b2259141a757cbab189cb2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b31307f7682d799e34699487a403a926" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="2b4dc3832b3ffbacbae236d6162f631f" label="mixed materials [A0000000075874]" type="box">32</container><container id="b05efefebef2694e64ce5abba1026887" parent="2b4dc3832b3ffbacbae236d6162f631f" type="folder">1-2</container></did><accessrestrict id="2802926a9875868eb77bbf4162293dea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file"><did><unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="62c5d8b67890039444eab0e7bcabe659" label="mixed materials [A0000000075874]" type="box">32</container><container id="fa1a4d3ab4b9d24690bfc3128d1354a1" parent="62c5d8b67890039444eab0e7bcabe659" type="folder">3-8</container></did><accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fc1c9413add7682bf34765d07e37871c" level="file"><did><unittitle>TML - Cholesterol-Lowering - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="66c837838b6033fb730f4aaea593cdb8" label="mixed materials [A0000000075874]" type="box">32</container><container id="5558a8ec51592a90aef4fd49b50cdaee" parent="66c837838b6033fb730f4aaea593cdb8" type="folder">9-10</container></did><accessrestrict id="263b366a38ae16d96e1447c8e1c8953b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="9212aaed4209e15330e340d1c8675d23" level="file"><did><unittitle>TML - Parasitic Infections - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="b4768c91d381478395c2d56e1d63eaf4" label="mixed materials [A0000000075874]" type="box">32</container><container id="48c070c81461acc50b7090b2598cab04" parent="b4768c91d381478395c2d56e1d63eaf4" type="folder">11-14</container></did><accessrestrict id="5db4f9b0242f10ed336d20896e08899c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="367ee47d6747fc683d4571ad991fcb28" level="file"><did><unittitle>TML - Malaria - Drugs for parastic infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="c38d3adde61f3c22b1d418ac47c6c742" label="mixed materials [A0000000075874]" type="box">32</container><container id="4316131193f301ed83ac7673e41891c2" parent="c38d3adde61f3c22b1d418ac47c6c742" type="folder">15-16</container></did><accessrestrict id="e3f66807c02c01517706efbf9eeaff5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="3e1473215cb13b9457ecd937e57909f5" label="mixed materials [A0000000075874]" type="box">32</container><container id="138f2f6157040aaeaa139f4d1914908e" parent="3e1473215cb13b9457ecd937e57909f5" type="folder">17</container></did><accessrestrict id="f6a6fff3786ff1d521cdf342567849ee"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d41d005cf4c13e14913cd67a32a5047" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="32c79a1d1a52097f2388a0485af90c9d" label="mixed materials [A0000000075875]" type="box">33</container><container id="920ad80917381cf98481ed8b0e92052f" parent="32c79a1d1a52097f2388a0485af90c9d" type="folder">1-2</container></did><accessrestrict id="8075ff059f0d4d931fa3535cefb097fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a70dd9355ee98a30aebc26b8daacffc8" level="file"><did><unittitle>TML - Psychiatric Symptoms - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="1a8d7db62fe44b0441ed796579c423bc" label="mixed materials [A0000000075875]" type="box">33</container><container id="76e5a81fea2eabe8bed46029135114be" parent="1a8d7db62fe44b0441ed796579c423bc" type="folder">3</container></did><accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file"><did><unittitle>TML, 40-109 - Candesartan</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="d02659fb6b0540c555ca57b4ae74378a" label="mixed materials [A0000000075875]" type="box">33</container><container id="61f20651d724ee652740aa8e14bc0732" parent="d02659fb6b0540c555ca57b4ae74378a" type="folder">4-6</container></did><accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e61911867cf616602aa72255f38dc9ba" level="file"><did><unittitle>TML, 40-77 - Interleukin-11</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="cf8a1da83e44b19d989df11efb7e4912" label="mixed materials [A0000000075875]" type="box">33</container><container id="ba96fda0de6b0e9ea5feff75e8e0d30d" parent="cf8a1da83e44b19d989df11efb7e4912" type="folder">7-9</container></did><accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4f7233bf7c77fcfc22d806ea70169968" level="file"><did><unittitle>TML, 40-85 - Cefdinir</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="adb31f2da66a3f482f19cfcc8bfce8b7" label="mixed materials [A0000000075875]" type="box">33</container><container id="37e8ecec8de37f12b9d88306054b020c" parent="adb31f2da66a3f482f19cfcc8bfce8b7" type="folder">10-12</container></did><accessrestrict id="028c35e32d1addf3672d48cb03ad70d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="910ff3d576f61dcba1783abe6210dff1" level="file"><did><unittitle>TML, 40-79 - Drugs for pain</unittitle><unitdate type="inclusive">1998 August 14</unitdate><container altrender="Record Storage Box (Paige)" id="eb2afb087616b8f10a3f27b533158741" label="mixed materials [A0000000075875]" type="box">33</container><container id="b432977f5319b0f0a3668d40b1a6e15e" parent="eb2afb087616b8f10a3f27b533158741" type="folder">13-17</container></did><accessrestrict id="72993e3876c2683037ab6df23f908193"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="960c1722fd9da508635b32ac38c60f80" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="0e95dd355659abbcc9d8a54d1a5a2de7" label="mixed materials [A0000000075875]" type="box">33</container><container id="e438ad822711775f136525ad12ae1a3b" parent="0e95dd355659abbcc9d8a54d1a5a2de7" type="folder">18-19</container></did><accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8e8879c55ee8242081f7f64851b4db08" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="770958f8adbb62a0a8c5e13ea4281504" label="mixed materials [A0000000075876]" type="box">34</container><container id="be6648301b647d9b5de24175624cef10" parent="770958f8adbb62a0a8c5e13ea4281504" type="folder">1-2</container></did><accessrestrict id="54d5c0c828c3316a8382b3f15461804c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="5d664f33dcd2cabbe962a4227379c390" level="file"><did><unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="c7c320ad5371d5ea744eebee7e876df2" label="mixed materials [A0000000075876]" type="box">34</container><container id="13e85e0fd103ba68f0f1a48d7f7294ef" parent="c7c320ad5371d5ea744eebee7e876df2" type="folder">3-4</container></did><accessrestrict id="df311ee9e0d78fb33b148774389da7c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d76a36572332e4c480702f762cc9918" level="file"><did><unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="da2c406db79a9b636ba492dbda0c65f8" label="mixed materials [A0000000075876]" type="box">34</container><container id="02e91417fc690b67b4b5fef7e9a22d31" parent="da2c406db79a9b636ba492dbda0c65f8" type="folder">5-8</container></did><accessrestrict id="c3ab3185c9cf9153482322e821491aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="affe7599f3c787d823e95823bfc0cbfc" level="file"><did><unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November</unitdate><container altrender="Record Storage Box (Paige)" id="8c4b663e232b93d82d27749c6aa1a3a0" label="mixed materials [A0000000075876]" type="box">34</container><container id="0365278c135b41f6de5d596e95125c12" parent="8c4b663e232b93d82d27749c6aa1a3a0" type="folder">9-10</container></did><accessrestrict id="544789c77c743995f3e1041b8e18aab6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2e2e66929019d8531954a7ad095700fb" level="file"><did><unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="95fa1d6987c8bcf76b8e8167531af699" label="mixed materials [A0000000075876]" type="box">34</container><container id="f358c7e18c301422b7582f90c269fc8f" parent="95fa1d6987c8bcf76b8e8167531af699" type="folder">11-13</container></did><accessrestrict id="c00a8622a08054369fa43b3f435559cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4043d39a1cb0cf7a9edea397c7574337" level="file"><did><unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="7e477f6cb8688a1765bfe1f7e4636ebe" label="mixed materials [A0000000075876]" type="box">34</container><container id="46db076b19ac5741883c3ad0e4bec866" parent="7e477f6cb8688a1765bfe1f7e4636ebe" type="folder">14-16</container></did><accessrestrict id="5ed653620eb193653bb7be17c3823301"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e5341af61e6a0539c242e29242b615c6" level="file"><did><unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="f2ac535f33c367817ff9356ed522222a" label="mixed materials [A0000000075876]" type="box">34</container><container id="b73c36e11f4f604dede9577265c131c7" parent="f2ac535f33c367817ff9356ed522222a" type="folder">17-18</container></did><accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3f39fb343e118836671bfce7c8c9e0be" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="9d6267c07428bbba714e020c2e662c4e" label="mixed materials [A0000000075876]" type="box">34</container><container id="b4d5fe3dfba269ed94636d74c12b92ef" parent="9d6267c07428bbba714e020c2e662c4e" type="folder">19</container></did><accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e43a7710b28863a0de4803cfd4c0b542" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="0f5450d0531c20efebccb4c3a8e151a7" label="mixed materials [A0000000075877]" type="box">35</container><container id="5a77cc10e53c2866adfc3c966bc72fbb" parent="0f5450d0531c20efebccb4c3a8e151a7" type="folder">1-2</container></did><accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file"><did><unittitle>TML, 40-103 - Thalidomide</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="596e3411f359ef949f52b8554117d188" label="mixed materials [A0000000075877]" type="box">35</container><container id="74fc104e1f6fedf24f4678e0037106e6" parent="596e3411f359ef949f52b8554117d188" type="folder">3-6</container></did><accessrestrict id="afd021cfb4388a63de5e218998fd47c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="31cfa0b79a02b7866aa0dc7e48743280" level="file"><did><unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle><unitdate type="inclusive">1998 October 9</unitdate><container altrender="Record Storage Box (Paige)" id="811fe3dc011b9539b32f84624332f4ff" label="mixed materials [A0000000075877]" type="box">35</container><container id="6dd97dfc74152565eb92de095e456ec8" parent="811fe3dc011b9539b32f84624332f4ff" type="folder">7-12</container></did><accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35138cee47bea646beb32b2995d4598" level="file"><did><unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="ae0d4c3880e40c7b0586c600accaec86" label="mixed materials [A0000000075877]" type="box">35</container><container id="e7e55fc9f435175231a90ed8d8657dd0" parent="ae0d4c3880e40c7b0586c600accaec86" type="folder">13</container></did><accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7c2b7e050833f74d66d0b600d186eae5" level="file"><did><unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="926642590000285242b1a551212cd9ef" label="mixed materials [A0000000075877]" type="box">35</container><container id="f7f69748dff4b6ecd3b1c83f1fde07e2" parent="926642590000285242b1a551212cd9ef" type="folder">14-16</container></did><accessrestrict id="bcbeeba99d41f442379b4633e1dc7778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a4342729d9ef2567742167972402009f" level="file"><did><unittitle>TML, 39-107 - St. John's Wort</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="859dc814f37ce46ce0feff96e51f7cbd" label="mixed materials [A0000000075877]" type="box">35</container><container id="21cca956d3e487f9de30688715e9d828" parent="859dc814f37ce46ce0feff96e51f7cbd" type="folder">17-18</container></did><accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ddfb397d4b944785854d8ea719c202bd" level="file"><did><unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="cf8923353f57a10022f2a8431b9f5e2c" label="mixed materials [A0000000075878]" type="box">36</container><container id="d9c69811fc9d8d6f9f1adb88cb5d4637" parent="cf8923353f57a10022f2a8431b9f5e2c" type="folder">1-2</container></did><accessrestrict id="854b0f58396665c4e2d4a0465f949fd7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="35b97709b422b46ecdc94c987c5952ec" level="file"><did><unittitle>TML, 41-39 - Advice for travelers</unittitle><unitdate type="inclusive">1999 April 23</unitdate><container altrender="Record Storage Box (Paige)" id="e42e5ce5387f20288973396e06f7aca8" label="mixed materials [A0000000075878]" type="box">36</container><container id="de3e51b2bb8319de1f5aa481e576addc" parent="e42e5ce5387f20288973396e06f7aca8" type="folder">3-4</container></did><accessrestrict id="04ad6f830bf72709637049c7b301499d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="f916a9e5c338ff7fc1707311815267f1" level="file"><did><unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="1246faf685df5d05106707a749ff9e4e" label="mixed materials [A0000000075878]" type="box">36</container><container id="78617f1788c9d43e0f1ae6a7c2230873" parent="1246faf685df5d05106707a749ff9e4e" type="folder">5-7</container></did><accessrestrict id="113f676d893d247079b5e4ff614aec1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2fc16ae414cf9dd501de68ee706014d5" level="file"><did><unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="531a636ca8246e958bbe1c51d500da67" label="mixed materials [A0000000075878]" type="box">36</container><container id="a1985ef66d45587f71472c91e7c890a4" parent="531a636ca8246e958bbe1c51d500da67" type="folder">8-10</container></did><accessrestrict id="17d7935132e18e8bac890aeefcb5960f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3922b9c381c0b19cb3d63cbe803305a6" level="file"><did><unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="acca060c5fbf06cd28ed72c9e2bede13" label="mixed materials [A0000000075878]" type="box">36</container><container id="17c9f795a9e5809528a99b8ca9cf9c13" parent="acca060c5fbf06cd28ed72c9e2bede13" type="folder">11-12</container></did><accessrestrict id="481e161096febedcc11b1ed837e0109b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file"><did><unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="68146b3b114b37e2c6f2d344e275fbab" label="mixed materials [A0000000075878]" type="box">36</container><container id="63f55da8954a357cbe0424fb543c1b29" parent="68146b3b114b37e2c6f2d344e275fbab" type="folder">13-14</container></did><accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="65d972dc57e884b250ec76744f2d84f9" level="file"><did><unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="0fde97ea78773e2ed4646622422bebf6" label="mixed materials [A0000000075878]" type="box">36</container><container id="a47b9a2c61d872141b604d4d6b45a922" parent="0fde97ea78773e2ed4646622422bebf6" type="folder">15-17</container></did><accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file"><did><unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="400e56dc8c380e0815d7dd42c1fca0ab" label="mixed materials [A0000000075879]" type="box">37</container><container id="e34bcf07d0171f47b53b3db84b10343e" parent="400e56dc8c380e0815d7dd42c1fca0ab" type="folder">1-4</container></did><accessrestrict id="b25acf713bbbe8621cf294856e16ba28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ec877eb8397cacf7d82d77f65b127412" level="file"><did><unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="fe3000391c136adf7c216499483c5395" label="mixed materials [A0000000075879]" type="box">37</container><container id="c3fbe068a84bb2aa42121efaf3125804" parent="fe3000391c136adf7c216499483c5395" type="folder">5-6</container></did><accessrestrict id="5090105f2f60079c4d3f971adf860516"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file"><did><unittitle>TML, 41-123 - Temozolomide</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="1d899cfc6a3c386dbc20ec118b43a7df" label="mixed materials [A0000000075879]" type="box">37</container><container id="e7c7426549be040c8764d8d371e01424" parent="1d899cfc6a3c386dbc20ec118b43a7df" type="folder">7-8</container></did><accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file"><did><unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="41cbcea8a0050c71fd3433fff42c09aa" label="mixed materials [A0000000075879]" type="box">37</container><container id="c3b3b2ea0c4af6d22fc1cb2ed4d5d8e8" parent="41cbcea8a0050c71fd3433fff42c09aa" type="folder">9-11</container></did><accessrestrict id="af177345fcae67c9d255185c0a10e870"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="024012e8b7f7de531d716961ead029ce" level="file"><did><unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="33699f1ba0a568682142a929f111fd3a" label="mixed materials [A0000000075879]" type="box">37</container><container id="7a87a9bbf5b7adc152f03524891d69e8" parent="33699f1ba0a568682142a929f111fd3a" type="folder">12-13</container></did><accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a9621527ed50246d7a862b61f10afb79" level="file"><did><unittitle>TML, 41-110 - Rabeprazole</unittitle><unitdate type="inclusive">1999 November 9</unitdate><container altrender="Record Storage Box (Paige)" id="4e4aa52d4f8d4a52baed971a5ae337c7" label="mixed materials [A0000000075879]" type="box">37</container><container id="674e95fd0ae7e1ba9055093844d7043d" parent="4e4aa52d4f8d4a52baed971a5ae337c7" type="folder">14-15</container></did><accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="fcec222c26512f8ebe8b672bf459fbe9" level="file"><did><unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="57f61804eb49c839c06a391655753e30" label="mixed materials [A0000000075879]" type="box">37</container><container id="57f7b91bad56f58219c0b7d82599d111" parent="57f61804eb49c839c06a391655753e30" type="folder">16-17</container></did><accessrestrict id="5eabb94693fe31a0f053df4c9645327d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c2530250616ca691ba7d71e8d92ca5e1" level="file"><did><unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="db45a839dad845ac73eaf5bee5e4802c" label="mixed materials [A0000000075879]" type="box">37</container><container id="b0f4e5880d9b51d845fa99825c89440d" parent="db45a839dad845ac73eaf5bee5e4802c" type="folder">18-19</container></did><accessrestrict id="96db099c24d150d666b7ebe07b50d611"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e80acff708763c79ba27fdf7b90311e5" level="file"><did><unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="dc5efb46c52b55dd807e7565e46ea7f4" label="mixed materials [A0000000075880]" type="box">38</container><container id="c6ea1a5740a595cb14eac2467995e1bd" parent="dc5efb46c52b55dd807e7565e46ea7f4" type="folder">1-3</container></did><accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="703b499487840917db1eeb7a3bbf97c3" level="file"><did><unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="44db373f0991deb82fa25fdef39c80e7" label="mixed materials [A0000000075880]" type="box">38</container><container id="5cb2d2071bbe7b247169d2a54f76644c" parent="44db373f0991deb82fa25fdef39c80e7" type="folder">4-7</container></did><accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file"><did><unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Record Storage Box (Paige)" id="41694a9a2be60fa779f5d3938ac700eb" label="mixed materials [A0000000075880]" type="box">38</container><container id="66e91587525855887cdf6823c11f313e" parent="41694a9a2be60fa779f5d3938ac700eb" type="folder">8-10</container></did><accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="755deaec93a3a8f46413cdb9d38a9847" level="file"><did><unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="ad66e15cf8fbca02341964e076f488e8" label="mixed materials [A0000000075880]" type="box">38</container><container id="e9a75ca5642ba47817d965bb1943a6ee" parent="ad66e15cf8fbca02341964e076f488e8" type="folder">11-13</container></did><accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file"><did><unittitle>TML, 41-20 - Homeopathic products</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="f79727936999d1ed435254731c401588" label="mixed materials [A0000000075880]" type="box">38</container><container id="10b528f7231a9a21f890977ce7127bbe" parent="f79727936999d1ed435254731c401588" type="folder">14-16</container></did><accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f8ace5b9ab967ce17459254fb17ca75" level="file"><did><unittitle>TML, 41-55 - Orlistat for obesity</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="ef3d7ef9848c56b895cfb90674d85396" label="mixed materials [A0000000075880]" type="box">38</container><container id="609f9de5386447a0bb52dd88c8483562" parent="ef3d7ef9848c56b895cfb90674d85396" type="folder">17</container></did><accessrestrict id="3afad4f5d733d9716d22ba16c44983fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="b2928e0b146edbf6a03684604b2f6230" level="file"><did><unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="a9cffeaa86d7166f5c65fa17e4a9dcbf" label="mixed materials [A0000000075880]" type="box">38</container><container id="66fb0815cefe51b29026b089c63d51ff" parent="a9cffeaa86d7166f5c65fa17e4a9dcbf" type="folder">18</container></did><accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e394fdb910a180949b33fcfe30e8b17c" level="file"><did><unittitle>TML, 41-23 - Drugs for hypertension</unittitle><unitdate type="inclusive">1999 March 12</unitdate><container altrender="Record Storage Box (Paige)" id="e1fb28c69a5466a67fdbd419955f7121" label="mixed materials [A0000000075881]" type="box">39</container><container id="90ff469d5a705798f4430204dd214db1" parent="e1fb28c69a5466a67fdbd419955f7121" type="folder">1-6</container></did><accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file"><did><unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle><unitdate type="inclusive">1999 December 3</unitdate><container altrender="Record Storage Box (Paige)" id="df21300a803de0d1b02dc73965e01330" label="mixed materials [A0000000075881]" type="box">39</container><container id="a5e6bf310b45dc32e3c4bed70f5ecea5" parent="df21300a803de0d1b02dc73965e01330" type="folder">7-10</container></did><accessrestrict id="ddc058cf574899e5d0347e37efa9598e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e42d2f63edb58feb20931053061b1339" level="file"><did><unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="2a40fd847da1f8822b1d0f6e3fe40112" label="mixed materials [A0000000075881]" type="box">39</container><container id="2d6e081ccd7f39899f37947fbbbabf2a" parent="2a40fd847da1f8822b1d0f6e3fe40112" type="folder">11</container></did><accessrestrict id="2bf75590065032d73df0e0fa13732a7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="28427104a307e9895b1500110c4ba78c" level="file"><did><unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="b8b318932381bbcee7a1930687fea537" label="mixed materials [A0000000075881]" type="box">39</container><container id="f05a17944d87a863fd59b068273209cb" parent="b8b318932381bbcee7a1930687fea537" type="folder">12-16</container></did><accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4c7b991a97b85bed8305af27776e491" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="c4c1866fe408784e45d8e3a612770581" label="mixed materials [A0000000075881]" type="box">39</container><container id="41af7923ba02d2c1ad0b1bf73442c34e" parent="c4c1866fe408784e45d8e3a612770581" type="folder">17-18</container></did><accessrestrict id="9b77ea87c2f2795c19e71f426864b471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="efd202ef6564adfebc4106108c9561f2" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="d49de4ddf814a9dcbbbfad9aa327c4eb" label="mixed materials [A0000000075882]" type="box">40</container><container id="fc2d2b92800c2f5b36964a6e2cb35d6f" parent="d49de4ddf814a9dcbbbfad9aa327c4eb" type="folder">1-2</container></did><accessrestrict id="6304e26af10a0e94e7ef043fee53ad70"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5422bbde47d91ace2df22b5b7527a0e6" level="file"><did><unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="80c42a77f9f9cf98b17eb39a9f2fb3ca" label="mixed materials [A0000000075882]" type="box">40</container><container id="c10a04b67ca2a113ab3a7fd7a000f433" parent="80c42a77f9f9cf98b17eb39a9f2fb3ca" type="folder">3-6</container></did><accessrestrict id="e16a540da639162df21cb6fa8cf623e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="087aeda452bdc8c1f70b599b752d152a" level="file"><did><unittitle>TML, 41-67 - A new conjugated estrogen</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="29374c7d32eee4f237652336dec58eb8" label="mixed materials [A0000000075882]" type="box">40</container><container id="51ed7cf7531b90301668c8a74b66314b" parent="29374c7d32eee4f237652336dec58eb8" type="folder">7-8</container></did><accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e1ba3784eccce1db97752b63119a9737" level="file"><did><unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="a6e1abe19140bd8b45a3d68a351354c2" label="mixed materials [A0000000075882]" type="box">40</container><container id="6a4e95db461c8d8e3deebffe4b1d1690" parent="a6e1abe19140bd8b45a3d68a351354c2" type="folder">9</container></did><accessrestrict id="a078c6c919634b8920e26478d73bef6a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ee9f72d21997962aa5e1d76e60f28954" level="file"><did><unittitle>TML, 41-68 - Laser hair removal</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="94958c3e6f354fb967f95a4f3ff91c23" label="mixed materials [A0000000075882]" type="box">40</container><container id="ee2544ede1a05845ca77acf82c70df20" parent="94958c3e6f354fb967f95a4f3ff91c23" type="folder">10-11</container></did><accessrestrict id="0797b526bde059f59517ea165bdcb518"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f4d6a53975d9232738144f364667da0" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="d269d893a531b62af5c787079f2f95ee" label="mixed materials [A0000000075882]" type="box">40</container><container id="27c10cae630ac51ede7c6bd2fdd8acd4" parent="d269d893a531b62af5c787079f2f95ee" type="folder">12-16</container></did><accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5db523527161519d86f176dd07137b4b" level="file"><did><unittitle>TML, 41-5 - Drugs for Asthma</unittitle><unitdate type="inclusive">1999 January 15</unitdate><container altrender="Record Storage Box (Paige)" id="aee6f0283b70bba54a194e4b3f84237e" label="mixed materials [A0000000075883]" type="box">41</container><container id="8b2e2e3091639d2d223cfe1d17e3fd4a" parent="aee6f0283b70bba54a194e4b3f84237e" type="folder">1-5</container></did><accessrestrict id="24b467056399b27bd316ca395f5c8a5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3c1f55d592280bce047dbd773f816697" level="file"><did><unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Record Storage Box (Paige)" id="a0ff2926fc9f9bbe6bf09a8004bf8e1f" label="mixed materials [A0000000075883]" type="box">41</container><container id="c20e1ea9b96ebc0d554f4e40a34d8ec7" parent="a0ff2926fc9f9bbe6bf09a8004bf8e1f" type="folder">6-8</container></did><accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a5ef95fdd53a4ad00be13d575b720a90" level="file"><did><unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="29648ef2dafd852494676022638b2a61" label="mixed materials [A0000000075883]" type="box">41</container><container id="f4ca905b7078ebf130dbbb41214e926e" parent="29648ef2dafd852494676022638b2a61" type="folder">9</container></did><accessrestrict id="1246d47b99a5b28275ca7ac909e04e17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c9b5394af1307b91512bebaa47987a03" level="file"><did><unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="2448a6395051cc946001a4acb60b978c" label="mixed materials [A0000000075883]" type="box">41</container><container id="7ce9acee18a5b0c124e79da7a6998176" parent="2448a6395051cc946001a4acb60b978c" type="folder">10-11</container></did><accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9431f5004a39b8a0d9a05be98633933b" level="file"><did><unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="8bd6ee2983623c9934822654d942982b" label="mixed materials [A0000000075883]" type="box">41</container><container id="950e365558a6e3d1e1d09efaf3a9bdb2" parent="8bd6ee2983623c9934822654d942982b" type="folder">12-13</container></did><accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa75d744d2b7b8eae4e0c83305434171" level="file"><did><unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="909dbe42f022bef2cec57cab7d8443ae" label="mixed materials [A0000000075883]" type="box">41</container><container id="b7af0f783f409b4b26eceef1626039b7" parent="909dbe42f022bef2cec57cab7d8443ae" type="folder">14-15</container></did><accessrestrict id="4baffc7980c89aadb8cef585c345f731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12a411c26719cadf670414ea9db35b3a" level="file"><did><unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="20c73a31bd6bf50434d3b158bf4ffaa8" label="mixed materials [A0000000075883]" type="box">41</container><container id="d5b01c84ba237e2eb0534d34fd00fd1a" parent="20c73a31bd6bf50434d3b158bf4ffaa8" type="folder">16-18</container></did><accessrestrict id="f46608e112550ebc9f422dd17a55e3b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="50fdbec047db8cdec50f09ae8f09ce33" level="file"><did><unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="53323e78caf85c0ce8aa4018531d50b2" label="mixed materials [A0000000075884]" type="box">42</container><container id="576afedbcea9018f8fa37d9fa3f7ec50" parent="53323e78caf85c0ce8aa4018531d50b2" type="folder">1-3</container></did><accessrestrict id="ebda9b553416d292abf3337874edf243"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12974761e15d5b5a631f8a1708a1d0e6" level="file"><did><unittitle>TML, 41-107 - SAMe for depression</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="8700ef54ab24732dad1e06f25f847732" label="mixed materials [A0000000075884]" type="box">42</container><container id="122e5c2b89e1fa0998cef417150041a5" parent="8700ef54ab24732dad1e06f25f847732" type="folder">4-7</container></did><accessrestrict id="9f6ccc892b5225ac4e542904aba616bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2891c6463578c91c35a01dfbc0867c34" level="file"><did><unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="5a62abae06279dd52ef22ff6f4b34738" label="mixed materials [A0000000075884]" type="box">42</container><container id="9f944a670da07e69fbfa7bd37c52731f" parent="5a62abae06279dd52ef22ff6f4b34738" type="folder">8-9</container></did><accessrestrict id="b084224a8b4665a510e8da9d5962cae8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file"><did><unittitle>TML, 41:47 - Generic Drugs</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="3f469b4aaad8edccef129a8ad3a7d178" label="mixed materials [A0000000075884]" type="box">42</container><container id="000922e6eba1c22f54f0e30e8f7dfd88" parent="3f469b4aaad8edccef129a8ad3a7d178" type="folder">10-15</container></did><accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d463206ca7312a03520c55b4035d6d7c" level="file"><did><unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="0a74a4550a3f7c1c1a6af7271cb072ba" label="mixed materials [A0000000075884]" type="box">42</container><container id="56826d26d505d0587667720cf48bc052" parent="0a74a4550a3f7c1c1a6af7271cb072ba" type="folder">16-17</container></did><accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="07c8f80728a1051f72ba896f91a56fac" label="mixed materials [A0000000075884]" type="box">42</container><container id="9b06eea53701d9aca214e5b4bb14c0fb" parent="07c8f80728a1051f72ba896f91a56fac" type="folder">18</container></did><accessrestrict id="a555f10f258ebdc237376c5bf299600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="813dc879c0e4261b5ae728f45f81e536" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="891a19b0b06133563a0b52154f7aab35" label="mixed materials [A0000000075885]" type="box">43</container><container id="09822a78ddf2b7dc2b846a249c0df5c7" parent="891a19b0b06133563a0b52154f7aab35" type="folder">1-3</container></did><accessrestrict id="64327b946a10f94bc40f30737c8f1cd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file"><did><unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle><unitdate type="inclusive">1999 October 22</unitdate><container altrender="Record Storage Box (Paige)" id="5afc7410674f213d68f8da2e03b377af" label="mixed materials [A0000000075885]" type="box">43</container><container id="b1b0928171ea7182782a8a06d9316d30" parent="5afc7410674f213d68f8da2e03b377af" type="folder">4-8</container></did><accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file"><did><unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="7479b5e59675fb46bb9de58855d4941d" label="mixed materials [A0000000075885]" type="box">43</container><container id="ed01770dd0200b7c649262db45160570" parent="7479b5e59675fb46bb9de58855d4941d" type="folder">9-12</container></did><accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file"><did><unittitle>TML, 41-29 - Lyme disease vaccine</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="8586e990ae3b0cf1f6ca4aa5eb465440" label="mixed materials [A0000000075885]" type="box">43</container><container id="031a4198416e3b820084810728765ef0" parent="8586e990ae3b0cf1f6ca4aa5eb465440" type="folder">13-16</container></did><accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bb27af27ca7507bfd777f78da0d17147" level="file"><did><unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="94bfc05387c82cc1b6cf68276a0dd03b" label="mixed materials [A0000000075885]" type="box">43</container><container id="76564328dafe2cda0021d975db6b3b01" parent="94bfc05387c82cc1b6cf68276a0dd03b" type="folder">17-18</container></did><accessrestrict id="86662934e660af89d7aeaa4e4d013446"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="78bded88166975c0c978ed64d124df03" label="mixed materials [A0000000075885]" type="box">43</container><container id="50be3507538f0cf71dcb640b42549016" parent="78bded88166975c0c978ed64d124df03" type="folder">19</container></did><accessrestrict id="53ace92e24d776a3c07d0e679ac418eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="98fd7e915d5c04bccf9bfee05be98149" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="72e2b82a4e05f089c8525406d49e6fab" label="mixed materials [A0000000075886]" type="box">44</container><container id="1678867f44edbcf17ae7f57eddf491c0" parent="72e2b82a4e05f089c8525406d49e6fab" type="folder">1-3</container></did><accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47b865bf089a172b75b4d43ce7a1e447" level="file"><did><unittitle>TML, 41-33 - Depression and anxiety</unittitle><unitdate type="inclusive">1999 April 9</unitdate><container altrender="Record Storage Box (Paige)" id="12664c9049174c1010e3a058b68fe5a8" label="mixed materials [A0000000075886]" type="box">44</container><container id="8fad14bb790930ea03035c614d2bcf68" parent="12664c9049174c1010e3a058b68fe5a8" type="folder">4-13</container></did><accessrestrict id="b0f422d658f31862e120da53fa05b6f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="71225c0666898a85e784b2cb281888c6" level="file"><did><unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="9f86bce93de0748c5926192dd328d142" label="mixed materials [A0000000075886]" type="box">44</container><container id="daa10243d462417881e0da105ae9719c" parent="9f86bce93de0748c5926192dd328d142" type="folder">14-16</container></did><accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="8682c7d678490ec824574a4942b1d0a5" label="mixed materials [A0000000075886]" type="box">44</container><container id="5121dc6c847ee056611d57b1d0a6f55f" parent="8682c7d678490ec824574a4942b1d0a5" type="folder">17-18</container></did><accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="9de11d8dd2bf1e0d8ae8f119a07c03eb" label="mixed materials [A0000000075887]" type="box">45</container><container id="28511accaee0d06a71ab721f2fa97514" parent="9de11d8dd2bf1e0d8ae8f119a07c03eb" type="folder">1-3</container></did><accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="8d82b612550e56f5febd997b649248f6" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="b138c6b706bcdaabcb83843ed3208254" label="mixed materials [A0000000075887]" type="box">45</container><container id="5df4fc6de0c45447890d943c2cbdac9c" parent="b138c6b706bcdaabcb83843ed3208254" type="folder">4-9</container></did><accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="729c9bb0e1660ceb032fe6da8350333c" level="file"><did><unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="96a6d07e5c501596935523154d7b00dc" label="mixed materials [A0000000075887]" type="box">45</container><container id="cd1994ae3495d0302c5a764518737905" parent="96a6d07e5c501596935523154d7b00dc" type="folder">10-16</container></did><accessrestrict id="5ad67e35d3361f03756bfe78c6e60019"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="737148b055ba101acbd8ee7df7c07e4c" level="file"><did><unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="d114a171826ea1818472e09c577448ed" label="mixed materials [A0000000075887]" type="box">45</container><container id="644a1f627b9bcc73519ec9cbc6e8c56e" parent="d114a171826ea1818472e09c577448ed" type="folder">17-20</container></did><accessrestrict id="91985532c77a98b2be6619b3829a2c87"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="6e0f28a2b5a8cac84be32ec338816dac" level="file"><did><unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Letter Document Storage Box" id="abaf49236ff80c2b3b2cf44f47609213" label="mixed materials [A0000000075888]" type="box">46</container><container id="fa164c67a47657abedc5d17a61f83ffb" parent="abaf49236ff80c2b3b2cf44f47609213" type="folder">1-4</container></did><accessrestrict id="5220646ffa341e43aaef650d57ef5cbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47ee2aa0e1414311aab659a0b7791d48" level="file"><did><unittitle>TML, 41-61 - Drug interactions</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Letter Document Storage Box" id="d864bd9503df166e029b5847903ecaf4" label="mixed materials [A0000000075945]" type="box">103</container><container id="80626e523cbb8f92cdebe55d704ec98f" parent="d864bd9503df166e029b5847903ecaf4" type="folder">1-4</container></did><accessrestrict id="2310dca3aaada449df04e476753e097f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file"><did><unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="8f5992a9c14fec393101ee82177ed731" label="mixed materials [A0000000075889]" type="box">47</container><container id="f20ae7626924719625b91104d2456e01" parent="8f5992a9c14fec393101ee82177ed731" type="folder">1-2</container></did><accessrestrict id="9580c594e1986354a883d0b4d0b71bc3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4b13f0ecb976a0758dff29129231c5ab" level="file"><did><unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="b8d5c6916444fe3747677d451eda401c" label="mixed materials [A0000000075889]" type="box">47</container><container id="a337012f9532d8599e801c8f93ad1a02" parent="b8d5c6916444fe3747677d451eda401c" type="folder">3</container></did><accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="65fedbec948e0fc83c65d93e86ad6afd" level="file"><did><unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="8ea3cfe9fba8c2f7cd00b13133960093" label="mixed materials [A0000000075889]" type="box">47</container><container id="eea4b80ff6b9d2ae50abcc40fef9ba97" parent="8ea3cfe9fba8c2f7cd00b13133960093" type="folder">4-6</container></did><accessrestrict id="7082abcbc2a52e308ef67322853d8731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file"><did><unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="3c0dc1ea0e9b40da97bb2e9983cb2628" label="mixed materials [A0000000075889]" type="box">47</container><container id="059c05849307d83af6740d7eb3bf8e98" parent="3c0dc1ea0e9b40da97bb2e9983cb2628" type="folder">7-9</container></did><accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file"><did><unittitle>TML, 42-27 - Curosurf</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="137924a551e553a8cfbf1716fb52fea5" label="mixed materials [A0000000075889]" type="box">47</container><container id="2a82f50220d05ed836e97d4530cb01d3" parent="137924a551e553a8cfbf1716fb52fea5" type="folder">10-12</container></did><accessrestrict id="a42091b45287859d025abbb92f4814dc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c1fd925b81d971c06ec273ef08f3cb74" level="file"><did><unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="482589372452c9087edefb1a06543a74" label="mixed materials [A0000000075889]" type="box">47</container><container id="4aae8fd562e32b50309b22de0241afbc" parent="482589372452c9087edefb1a06543a74" type="folder">13-15</container></did><accessrestrict id="25831287c40dd007e7ad4f179aa90da2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="259c3ccf591bab51ffdaba3a9994e765" level="file"><did><unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">2000 July 10</unitdate><container altrender="Record Storage Box (Paige)" id="859c0f962b6bd57577e58c6591df603f" label="mixed materials [A0000000075889]" type="box">47</container><container id="3ace0d87e7b3053afceea00c04816947" parent="859c0f962b6bd57577e58c6591df603f" type="folder">16-20</container></did><accessrestrict id="162cb0e7647f4a98954f5445c257c882"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="62b6871b865b6d75c47266161b21cb21" level="file"><did><unittitle>TML, 42-113 - Phenylpropanolamine</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="9b8161db5533e2bc39311bc494ae1101" label="mixed materials [A0000000075890]" type="box">48</container><container id="936ce31c55c4506d242d2a02cec6e166" parent="9b8161db5533e2bc39311bc494ae1101" type="folder">1</container></did><accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file"><did><unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle><unitdate type="inclusive">2000 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="dfb1914bff258c06c6167433b465550b" label="mixed materials [A0000000075890]" type="box">48</container><container id="c89ffd1736ef59675e25764ec9e78596" parent="dfb1914bff258c06c6167433b465550b" type="folder">2-4</container></did><accessrestrict id="af9a344f43755a6c943435e3e709888a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="505b60f40ff960c724ff856e304ce951" level="file"><did><unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="9be10fcc3404fd9ff5f8d6b5f4ca6939" label="mixed materials [A0000000075890]" type="box">48</container><container id="afcb52d456b963f66f55718b25d01a6c" parent="9be10fcc3404fd9ff5f8d6b5f4ca6939" type="folder">5</container></did><accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="86b41328d3a3f3bd0b39258221d169af" level="file"><did><unittitle>TML, 42-42 - Oral contraceptives</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="935448bcc7482d54edfb83fc481022ad" label="mixed materials [A0000000075890]" type="box">48</container><container id="570ed9f9a87a724068740adb566a6891" parent="935448bcc7482d54edfb83fc481022ad" type="folder">6-11</container></did><accessrestrict id="362a441b3fc8d8a82b31585a57ea0665"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5af9d8711bf691d44ab3b1e5bb256681" level="file"><did><unittitle>TML, 42-17 - Phytoestrogens</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="19d0bb81a8c74927e74f083cf1c08618" label="mixed materials [A0000000075890]" type="box">48</container><container id="193c35b4373ae673dd93f088040db077" parent="19d0bb81a8c74927e74f083cf1c08618" type="folder">12-14</container></did><accessrestrict id="b6923da0f1e80e36ed724d7930240ab0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="408be2b8c6034a613b1211f2ecf9b661" level="file"><did><unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="c7ba5a1d98f5ffbb5eca16df8d7f6511" label="mixed materials [A0000000075890]" type="box">48</container><container id="bad975893527619a4c5d4488f75b7c86" parent="c7ba5a1d98f5ffbb5eca16df8d7f6511" type="folder">15-16</container></did><accessrestrict id="f012aa712ae69a791944518eafe15ae9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3335c85c5f584c0623918d305860bba9" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="c20a49c13c2208214d587c9b50e55878" label="mixed materials [A0000000075890]" type="box">48</container><container id="ab402e25e26f4fba7c4534d6221f6dd0" parent="c20a49c13c2208214d587c9b50e55878" type="folder">17-18</container></did><accessrestrict id="55427e8bb48ad2b8315333c1ff339476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c6d41dc2321b4992a2ce79264290f903" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="2ed9aa026b73907db8b5044bf1655c2e" label="mixed materials [A0000000075891]" type="box">49</container><container id="1db750f6d0d581d900af7df7dee7d6c5" parent="2ed9aa026b73907db8b5044bf1655c2e" type="folder">1</container></did><accessrestrict id="a4945089c03fcb0a219bdaccf387431a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file"><did><unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="a1ffb24335fde71f0264371ed5c515c9" label="mixed materials [A0000000075891]" type="box">49</container><container id="136ee1b0e51eeba8d936ecd48d60e215" parent="a1ffb24335fde71f0264371ed5c515c9" type="folder">2-4</container></did><accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="97e9932d34799dd8520be9e13f8a01ce" level="file"><did><unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="c479f66e68c17643ee9a0e6459b5ead4" label="mixed materials [A0000000075891]" type="box">49</container><container id="53f353d2ed0b367a517c5d86930c6da8" parent="c479f66e68c17643ee9a0e6459b5ead4" type="folder">5</container></did><accessrestrict id="349dee1a0f2981a7afaffa486ad92400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file"><did><unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="0207cc07e35159153fd46d3c3794a09c" label="mixed materials [A0000000075891]" type="box">49</container><container id="1f46784756938566fe90d71947647bc1" parent="0207cc07e35159153fd46d3c3794a09c" type="folder">6</container></did><accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="e0e61fb5a1e14299b5769bb3645966af" level="file"><did><unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="0c89e372ee6f8ab91cc16747c99f5dd4" label="mixed materials [A0000000075891]" type="box">49</container><container id="a660017a5b8ef1b348e28e11f6e0d2af" parent="0c89e372ee6f8ab91cc16747c99f5dd4" type="folder">7-10</container></did><accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3d342507f2c128f34587c4f458c47ae3" level="file"><did><unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="2cd56f5e92a9b4de4580b97cf25c3b11" label="mixed materials [A0000000075891]" type="box">49</container><container id="4745dde7588104135802933d80565dfa" parent="2cd56f5e92a9b4de4580b97cf25c3b11" type="folder">11-14</container></did><accessrestrict id="175706ce1b1be1373cdbf4234daea11e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="89f1be4de95ddec6822bda7f0e83b385" level="file"><did><unittitle>TML, 42-8 - Prevention of malaria</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="bde9120a69607172e60829881811acfd" label="mixed materials [A0000000075891]" type="box">49</container><container id="1d1bd6aefa7f017ae5a0f1afab80e96c" parent="bde9120a69607172e60829881811acfd" type="folder">15</container></did><accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da557a8aeefe93b11b7b65ef3275ee26" level="file"><did><unittitle>TML, 42-37 - Lyme disease</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="87d70c44b474229afe7cc001b03abf5a" label="mixed materials [A0000000075891]" type="box">49</container><container id="928420cacf75718799d2ee36283ed337" parent="87d70c44b474229afe7cc001b03abf5a" type="folder">16-18</container></did><accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9d25758af7747ace6aaf80757aac85f" level="file"><did><unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="d5010e7e4b555e8256341bc37a1e795f" label="mixed materials [A0000000075891]" type="box">49</container><container id="e1b9d0d32827ca072f7226c9754b24c4" parent="d5010e7e4b555e8256341bc37a1e795f" type="folder">19-20</container></did><accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8827ef8acb277df2d477589d43015ed3" level="file"><did><unittitle>TML, 42-73 - Drugs for pain</unittitle><unitdate type="inclusive">2000 August 21</unitdate><container altrender="Record Storage Box (Paige)" id="cb0df6528ffe1515c758a6bd177d746c" label="mixed materials [A0000000075892]" type="box">50</container><container id="4ecb2603b411dafc99caa3aa44729915" parent="cb0df6528ffe1515c758a6bd177d746c" type="folder">1-6</container></did><accessrestrict id="45351d67ab671d76012768894632e65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7ca68fc3cc569b193dc410a094f9a61f" level="file"><did><unittitle>TML, 42-19 - Drugs for Asthma</unittitle><unitdate type="inclusive">2000 March 6</unitdate><container altrender="Record Storage Box (Paige)" id="bba02fe3751c396822f4359d4d4fd4df" label="mixed materials [A0000000075892]" type="box">50</container><container id="de60d863bd28c9c4fd1f3d57fff28971" parent="bba02fe3751c396822f4359d4d4fd4df" type="folder">7-10</container></did><accessrestrict id="843840cc3a1f4f944dcd68fb679ac778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="11f2fac87764b93bfe43bd87321c6e78" level="file"><did><unittitle>TML, 42-49 - Androgel</unittitle><unitdate type="inclusive">2000 June 1</unitdate><container altrender="Record Storage Box (Paige)" id="a2bc23588f59e69679ac73f5637e024c" label="mixed materials [A0000000075892]" type="box">50</container><container id="8afb1b8227a4e95c4fcc3b276df71b52" parent="a2bc23588f59e69679ac73f5637e024c" type="folder">11-13</container></did><accessrestrict id="373b10f2aaf453294914d4fe78b9487f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f519c54c8f624fc16003fa1c04fa88f0" level="file"><did><unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle><unitdate type="inclusive">2000 October 16</unitdate><container altrender="Record Storage Box (Paige)" id="e0998747619bc4bba07457c94808c5d3" label="mixed materials [A0000000075892]" type="box">50</container><container id="30962056ffe9e256f730f37ddf632f6d" parent="e0998747619bc4bba07457c94808c5d3" type="folder">14-18</container></did><accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da9eaff7a676c3ce93fb52a83c4df992" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="9f8b326c18358c5705c8eb3f743420e4" label="mixed materials [A0000000075892]" type="box">50</container><container id="f75008b4d7ceb37972cc5028343bc31b" parent="9f8b326c18358c5705c8eb3f743420e4" type="folder">19-20</container></did><accessrestrict id="0b717ab0083f68384631636b834fec64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f307fe5a6bafa6083a914965f47c224f" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="de57292c4315b8bf0fea625dd299d384" label="mixed materials [A0000000075893]" type="box">51</container><container id="4a7f6893a4a1031144f38347f748335f" parent="de57292c4315b8bf0fea625dd299d384" type="folder">1</container></did><accessrestrict id="dc26934d88198182e177b592f4868a43"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file"><did><unittitle>TML, 42-31 - Bexrotene</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="6298503b8b64b83c42bee19657cf2368" label="mixed materials [A0000000075893]" type="box">51</container><container id="93a6ad8208817402672b29a42d012ef3" parent="6298503b8b64b83c42bee19657cf2368" type="folder">2-4</container></did><accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="78aad480d71976b1ac63856f8414b2de" level="file"><did><unittitle>TML, 42-116 - Portable Defibrillators</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="4a7895dbef712c39db03e6ac6ec540e5" label="mixed materials [A0000000075893]" type="box">51</container><container id="0d610b855a1f6c85cc9f064e25fa94f3" parent="4a7895dbef712c39db03e6ac6ec540e5" type="folder">5-6</container></did><accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8856ac6d297ba039f5f59b8393406463" level="file"><did><unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="2ead752637e70d2418045576ea854666" label="mixed materials [A0000000075893]" type="box">51</container><container id="ca92be95fde18f14bbb67a3219760c0b" parent="2ead752637e70d2418045576ea854666" type="folder">7-10</container></did><accessrestrict id="2247b3013b5d4bd66554d265282ec46f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file"><did><unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="1fa0c9ba36faabe7a2b3acc9ccbf232a" label="mixed materials [A0000000075893]" type="box">51</container><container id="1e5b147aea66501b98a4464fb47025d5" parent="1fa0c9ba36faabe7a2b3acc9ccbf232a" type="folder">11</container></did><accessrestrict id="35757c84324de4837de836a4d664e4bd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="390553fd7a4eea2f5cbee5002f2322bc" level="file"><did><unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="84cd553ee9321e23ad78d65fa1b36952" label="mixed materials [A0000000075893]" type="box">51</container><container id="56b4c978081b5f56959ce41b9aa42405" parent="84cd553ee9321e23ad78d65fa1b36952" type="folder">12-15</container></did><accessrestrict id="717bd1e1f90c70ff656382467cc26f89"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file"><did><unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="3010170b8137242e5e1465fc64814eb0" label="mixed materials [A0000000075893]" type="box">51</container><container id="1cbbc236677b4a1b783ffc9753e740a3" parent="3010170b8137242e5e1465fc64814eb0" type="folder">16-17</container></did><accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="968dfa06d929ab040463fb621fb94e15" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="26d1284745a0fac0b8d27b331e6b3e1a" label="mixed materials [A0000000075893]" type="box">51</container><container id="1838983051bd2bd7a732beb2651c66ee" parent="26d1284745a0fac0b8d27b331e6b3e1a" type="folder">18-19</container></did><accessrestrict id="a7608b2e6d21017e82cac99f4c300d04"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ffb773729eccb5c024461cb32728a1f5" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="3025fc7c8c4460dfcb03f53f6e69ee57" label="mixed materials [A0000000075894]" type="box">52</container><container id="40be9e4dec958a9a7fa00bdc7c4a1a49" parent="3025fc7c8c4460dfcb03f53f6e69ee57" type="folder">1-2</container></did><accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file"><did><unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="ec54191e7a07b227b237087155ab149c" label="mixed materials [A0000000075894]" type="box">52</container><container id="1c56bcb182827b9a53273484ee8f068b" parent="ec54191e7a07b227b237087155ab149c" type="folder">3</container></did><accessrestrict id="97998d665049bfafbdf7f044ef962ac2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c88b481d9cf92fe516e086aa696f2759" level="file"><did><unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="ee3a350ea9ba49371779925758b814be" label="mixed materials [A0000000075894]" type="box">52</container><container id="f6083d172d53792a1cfac09ff784cc9a" parent="ee3a350ea9ba49371779925758b814be" type="folder">4-5</container></did><accessrestrict id="8158423ad1861ed096a1f762bea5ed19"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file"><did><unittitle>TML, 42-52 - Atkin's diet</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="d51fd8c86a5fd031694740c613ece0a0" label="mixed materials [A0000000075894]" type="box">52</container><container id="73993a6d50d9f145768be8775ccd928c" parent="d51fd8c86a5fd031694740c613ece0a0" type="folder">6-8</container></did><accessrestrict id="0024c5f9b90643b42da0ff940f490484"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f039186b802088d6736b63d8692ff877" level="file"><did><unittitle>TML, 42-71 - Hypnotic drugs</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="f1a4c143c3bc0736071cf6734fca7782" label="mixed materials [A0000000075894]" type="box">52</container><container id="113f33ca3b14f0163113b8c646a91056" parent="f1a4c143c3bc0736071cf6734fca7782" type="folder">9-12</container></did><accessrestrict id="66081d4df14137512de48118dd485bfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ddaac639270ba0e3369ea6c5bef18c02" level="file"><did><unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="c0d6cbb0a983ee88b498381da853d293" label="mixed materials [A0000000075894]" type="box">52</container><container id="a59f8ad3d141c19e715ccf0613083fd3" parent="c0d6cbb0a983ee88b498381da853d293" type="folder">13-14</container></did><accessrestrict id="2370a9ec5de5c8b19f6823b89c720366"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3b89f483901c2a204aeb8a707d5f619e" level="file"><did><unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="4bd09b526184fd4176510302b1e4e026" label="mixed materials [A0000000075894]" type="box">52</container><container id="b9e16f29166052080bd7682d66adf00b" parent="4bd09b526184fd4176510302b1e4e026" type="folder">15-17</container></did><accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file"><did><unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="d4cf5bb3e9861b977447c711ce441ad8" label="mixed materials [A0000000075894]" type="box">52</container><container id="50f0b9d73dafb4f2b22110a3ae91765e" parent="d4cf5bb3e9861b977447c711ce441ad8" type="folder">18-20</container></did><accessrestrict id="231c8f3761cd29bf8b9da59c1db76773"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="aafca578cbcbfe074becb8ee0a58b8f1" label="mixed materials [A0000000075894]" type="box">52</container><container id="c5ef34c1ea88f03f30ae6a4bb2124a69" parent="aafca578cbcbfe074becb8ee0a58b8f1" type="folder">21</container></did><accessrestrict id="ecde6f626cda50967973b161a20fcc74"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0670855c3da978011ef91e63b94b8614" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="9e949737f38b438dbbc7b6e3d59e98d4" label="mixed materials [A0000000075895]" type="box">53</container><container id="da52b990c2b93443e05b06f1d3a89bc2" parent="9e949737f38b438dbbc7b6e3d59e98d4" type="folder">1-2</container></did><accessrestrict id="b1545fba52ccf81c38c8688169dab34a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file"><did><unittitle>TML - HAT - Adverse Effects</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="1c4f863a9d4ae5e912a59082ec84f093" label="mixed materials [A0000000075895]" type="box">53</container><container id="6a693ad2316daf5c59f890d0ed4d788a" parent="1c4f863a9d4ae5e912a59082ec84f093" type="folder">3-4</container></did><accessrestrict id="f035a5812a9a5ba9f187b537f909316a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file"><did><unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle><unitdate type="inclusive">2000 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="cd4c679b4b1f833c1de54e271983f66a" label="mixed materials [A0000000075895]" type="box">53</container><container id="b230abb23acf521e39a254692ed4ff8a" parent="cd4c679b4b1f833c1de54e271983f66a" type="folder">5-8</container></did><accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9370ffe6e8855002d778fc797c644238" level="file"><did><unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="42d02419ba00e5f30c82704211a99ac2" label="mixed materials [A0000000075895]" type="box">53</container><container id="44bfd51406111ac36e5758adc043a6dc" parent="42d02419ba00e5f30c82704211a99ac2" type="folder">9-12</container></did><accessrestrict id="a1015b3acc8c847466def1105f15644b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="354614b4cdeb7c25dce7323acfe3837f" level="file"><did><unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="a7daf415053b93d68d68e71cb8e83937" label="mixed materials [A0000000075895]" type="box">53</container><container id="8c438ac8ef8426793788ced7b8dac53b" parent="a7daf415053b93d68d68e71cb8e83937" type="folder">13-18</container></did><accessrestrict id="5bf74d558644f64e23255ce061463c78"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ee26dc57604d2e8beb15f5282094c199" level="file"><did><unittitle>TML, HAT - Antimicrobial Dosage</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="2b60201c357a8ef4beb52c9de60c40bf" label="mixed materials [A0000000075895]" type="box">53</container><container id="6bed4d75a5d84172f24b7209a75b5586" parent="2b60201c357a8ef4beb52c9de60c40bf" type="folder">19</container></did><accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="a088080df443869d26625b88cfb8357c" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="084d532b3f2d6bc8162ad645be915051" label="mixed materials [A0000000075895]" type="box">53</container><container id="4de0eb22861f4c45339b31e88c28562b" parent="084d532b3f2d6bc8162ad645be915051" type="folder">20</container></did><accessrestrict id="204852f90f3648c6b6e5e6274cb652ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="090d99b648097ee1a1fba4e2afcb95f7" label="mixed materials [A0000000075896]" type="box">54</container><container id="3c7fc589446d0eb8a15c15f64594ecbe" parent="090d99b648097ee1a1fba4e2afcb95f7" type="folder">1-2</container></did><accessrestrict id="19470d2540faf3143d53c5e0f0f04553"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ff8898d4bdb05f23855cdb33eaefc878" level="file"><did><unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="2adbc59fc85f574847971bdbd30155e2" label="mixed materials [A0000000075896]" type="box">54</container><container id="e947982de6777f982ded731efb889602" parent="2adbc59fc85f574847971bdbd30155e2" type="folder">3-4</container></did><accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file"><did><unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="bacaf44e1f37408f9039e3582de95afa" label="mixed materials [A0000000075896]" type="box">54</container><container id="ab840c147476a6c9949187f53d6f80fb" parent="bacaf44e1f37408f9039e3582de95afa" type="folder">5-7</container></did><accessrestrict id="aee461894cb0482b20c2792522b46e12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file"><did><unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="49d7f991dba0ae98870b8fcdc3340c97" label="mixed materials [A0000000075896]" type="box">54</container><container id="00c45ff8d0c4ed2a6c67b611b54db2d6" parent="49d7f991dba0ae98870b8fcdc3340c97" type="folder">8-9</container></did><accessrestrict id="df37cebc2f1268161ba89264e0aa24c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f8521e46162fc0e16135537e8fe60e0e" level="file"><did><unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="cdd7d666b5384b497ef12c21879903f5" label="mixed materials [A0000000075896]" type="box">54</container><container id="ad09732b58ccbab85bb5a30a1a40a1b0" parent="cdd7d666b5384b497ef12c21879903f5" type="folder">10-11</container></did><accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="77d873ab9fa6653d75e07ecd29388474" level="file"><did><unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="f148d6af5490136679b2524cc4cabdb0" label="mixed materials [A0000000075896]" type="box">54</container><container id="83bb3d689c2596a38ab00209f1e216b8" parent="f148d6af5490136679b2524cc4cabdb0" type="folder">12-14</container></did><accessrestrict id="c4cc72e54e77645b47ebceda334dae90"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2c3c36361f7d26d6245b10967d53cba6" level="file"><did><unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="198f62726a55bfdab953f68b18699d02" label="mixed materials [A0000000075896]" type="box">54</container><container id="2ce1f162b9683d97ddc7aeb772939b5e" parent="198f62726a55bfdab953f68b18699d02" type="folder">15-18</container></did><accessrestrict id="134bd94a116d4a00868b6be7c821b669"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="61379babc25c5c375ab428d7aa38d59d" label="mixed materials [A0000000075896]" type="box">54</container><container id="84bef3a0762ab9f51e5544280db8b5cd" parent="61379babc25c5c375ab428d7aa38d59d" type="folder">19-21</container></did><accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c29c016865d236b6f578b647c46a6676" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="34bfc42747b06536e473afa6b02de4c8" label="mixed materials [A0000000075897]" type="box">55</container><container id="edb6928417cae8e63c9663c6b3667616" parent="34bfc42747b06536e473afa6b02de4c8" type="folder">1-2</container></did><accessrestrict id="8e3afc9c0897bcf7957059afb787d613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="2f529cb4f4194befc112bb96867ea926" label="mixed materials [A0000000075897]" type="box">55</container><container id="c43c6f9a76c1c16c631a6f130a8967cb" parent="2f529cb4f4194befc112bb96867ea926" type="folder">3-6</container></did><accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file"><did><unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="b293b497f89a0743ee3ec368bb2756e3" label="mixed materials [A0000000075897]" type="box">55</container><container id="6421d6830e8a1f1c428fde7c5a7fa3b3" parent="b293b497f89a0743ee3ec368bb2756e3" type="folder">7-8</container></did><accessrestrict id="b6c3f76765c91d59d07d1942830fb182"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file"><did><unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="13b5449c4342f81086e03d24b4e94844" label="mixed materials [A0000000075897]" type="box">55</container><container id="1406138f67e2c177a5a80bf34e9ae5b4" parent="13b5449c4342f81086e03d24b4e94844" type="folder">9-13</container></did><accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file"><did><unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle><unitdate type="inclusive">2000 September 18</unitdate><container altrender="Record Storage Box (Paige)" id="f74f0bbafa8838359b70867d0a0f4ce1" label="mixed materials [A0000000075897]" type="box">55</container><container id="5d48c4fb1ddedcc4cf97f1bb563a9e77" parent="f74f0bbafa8838359b70867d0a0f4ce1" type="folder">14-18</container></did><accessrestrict id="fdc72de4846ddb965722a850fb816e7f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="85452dc178e1dadec0332fe42563215d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="57a9b711e96ec6a1d523e2e0b949e3aa" label="mixed materials [A0000000075898]" type="box">56</container><container id="08814a0fd4c72af1ad9d80326665e5ac" parent="57a9b711e96ec6a1d523e2e0b949e3aa" type="folder">1-4</container></did><accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file"><did><unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="eaec2f4666773f29f3bd83c14945baf6" label="mixed materials [A0000000075898]" type="box">56</container><container id="e89aeb8379954ade6630d945cc95c022" parent="eaec2f4666773f29f3bd83c14945baf6" type="folder">5-8</container></did><accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41cb55e32ff2281af228fcf98e48db43" level="file"><did><unittitle>TML - Osteoporosis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="8c53c082c7a1d79fb6c7d763c2da0351" label="mixed materials [A0000000075898]" type="box">56</container><container id="d2ca7e4b176c0e5da34f6fd2cf6b5d29" parent="8c53c082c7a1d79fb6c7d763c2da0351" type="folder">9-12</container></did><accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file"><did><unittitle>TML - Asthma - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="3b81346d812ae66499f5b819b6a07cb3" label="mixed materials [A0000000075898]" type="box">56</container><container id="571b22183b0865b7a365692597271f59" parent="3b81346d812ae66499f5b819b6a07cb3" type="folder">13-16</container></did><accessrestrict id="38e2af006895a52bd2de3eb894293ec3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="4551c5337fb48ecf4eaafcdf0d655504" label="mixed materials [A0000000075898]" type="box">56</container><container id="7e7678a95d3ecc52b830eeb9b6115394" parent="4551c5337fb48ecf4eaafcdf0d655504" type="folder">17-20</container></did><accessrestrict id="d8d94d63528159d44953c7215892b5f2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1716a9979d5479baf368216eb3017f50" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Storage Box" id="4b927442a0abcf7088a09d50c5a91c62" label="mixed materials [A0000000075899]" type="box">57</container><container id="c69ef8c5c74dcb5c6e48c2b78ea679f5" parent="4b927442a0abcf7088a09d50c5a91c62" type="folder">1-4</container></did><accessrestrict id="7be18115960dc69ccd463738ce3438d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="296856f8c0a6139989dec83e2967a3f6" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Storage Box" id="1e25c4871aa74eb29406038cd9e3fc39" label="mixed materials [A0000000075899]" type="box">57</container><container id="a284f956d0a9a3b7875354da995a9845" parent="1e25c4871aa74eb29406038cd9e3fc39" type="folder">5</container></did><accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Storage Box" id="01f57f20325985fcd07d91f9e8b4f73e" label="mixed materials [A0000000075900]" type="box">58</container><container id="373666cdd7ee7b07915d39b251946130" parent="01f57f20325985fcd07d91f9e8b4f73e" type="folder">1-3</container></did><accessrestrict id="aae3719b7a851cb67c17470197b044d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8d745390980b9c7fe7639600ac855496" level="file"><did><unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="c2a3c1ba8d3f3279b761b32b056433fd" label="mixed materials [A0000000075901]" type="box">59</container><container id="656ba4c9ac1978cbb727188395d184b3" parent="c2a3c1ba8d3f3279b761b32b056433fd" type="folder">1-3</container></did><accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c8e27cfe3b70673df671446dc0f171dd" level="file"><did><unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle><unitdate type="inclusive">2001 May 28</unitdate><container altrender="Record Storage Box (Paige)" id="370982d724858db49815fff500f2e46e" label="mixed materials [A0000000075901]" type="box">59</container><container id="3da191de143f082cf1a3f422b35a5d80" parent="370982d724858db49815fff500f2e46e" type="folder">4-10</container></did><accessrestrict id="12c485e70ce77057b564f5f005de3180"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b12b140d39cce8b86f62018ce31197dd" level="file"><did><unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="d28292c42c368267e3bee4ac681f64a0" label="mixed materials [A0000000075901]" type="box">59</container><container id="f3d30811091c6271e8e33f34a2e0a40a" parent="d28292c42c368267e3bee4ac681f64a0" type="folder">11-13</container></did><accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file"><did><unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">2001 October 19</unitdate><container altrender="Record Storage Box (Paige)" id="e150514412901d90c8b615b202fb853e" label="mixed materials [A0000000075901]" type="box">59</container><container id="46c0430f8275eece953e106e78bcdbd8" parent="e150514412901d90c8b615b202fb853e" type="folder">14-17</container></did><accessrestrict id="19d192e97e549e2b446276124a3eb6b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="ca48e7a55c876c731f213e0c1cdd8205" label="mixed materials [A0000000075901]" type="box">59</container><container id="a55078b59150b662defd390d4f1a4733" parent="ca48e7a55c876c731f213e0c1cdd8205" type="folder">18</container></did><accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3283e79cbed2dd24ba8423865f0e23c0" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="4a568e2c15ac68b62c0bcc2afdcab03c" label="mixed materials [A0000000075902]" type="box">60</container><container id="0b7db402a280f96d904b60e90fb9d7ad" parent="4a568e2c15ac68b62c0bcc2afdcab03c" type="folder">1</container></did><accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file"><did><unittitle>TML, 43-9 - Beta-Blockers</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="34e73c5b9ce163f981bc9b3ca652c6f4" label="mixed materials [A0000000075902]" type="box">60</container><container id="b8b08e257a3e74f4df1b489c0934493f" parent="34e73c5b9ce163f981bc9b3ca652c6f4" type="folder">2-6</container></did><accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="efb930d3872ae9d77c1298a07d7d5921" level="file"><did><unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle><unitdate type="inclusive">2001 July</unitdate><container altrender="Record Storage Box (Paige)" id="939bc877859f934662771046d06a8a07" label="mixed materials [A0000000075902]" type="box">60</container><container id="f8e8545529477b1af84a93586c90b9d6" parent="939bc877859f934662771046d06a8a07" type="folder">7-9</container></did><accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b522bd1a5159bd2d2194d2263cc22904" level="file"><did><unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="a3403e10ff1a01d1f03e845ceb62bd87" label="mixed materials [A0000000075902]" type="box">60</container><container id="94415810e2c99b6876cf9aeb435630ef" parent="a3403e10ff1a01d1f03e845ceb62bd87" type="folder">10-12</container></did><accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="46514d81205269c17a4b19d49a573235" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="34eae1e349f424b660fa2580f050221e" label="mixed materials [A0000000075902]" type="box">60</container><container id="ac1a803bc2651555d469131c5f8687d5" parent="34eae1e349f424b660fa2580f050221e" type="folder">13-15</container></did><accessrestrict id="0ac715d063832982eec2283c964a4110"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6dc4850ed3f15e6085336df184251532" level="file"><did><unittitle>TML - Drugs of Choice - Osteoporosis</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="2f58713566402fa6e8939aa207406bbf" label="mixed materials [A0000000075902]" type="box">60</container><container id="09b127229ab929477ec2812886cba859" parent="2f58713566402fa6e8939aa207406bbf" type="folder">16</container></did><accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="02fc378d7f3b4b93e45c3eef89379858" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="849fca230ed2397796a33ac3f0955ff3" label="mixed materials [A0000000075902]" type="box">60</container><container id="c800887553b9d41f1e148436b0f060cb" parent="849fca230ed2397796a33ac3f0955ff3" type="folder">17-18</container></did><accessrestrict id="a1e5c73ef6115e61a317948cb85a9927"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c6bff42d1f14c6a829324e9782c498a" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="97981c21e5837d02a10540034fe7a418" label="mixed materials [A0000000075903]" type="box">61</container><container id="8083367b31f3d86324a556f10162dfbc" parent="97981c21e5837d02a10540034fe7a418" type="folder">1-3</container></did><accessrestrict id="5b52a18cd7491854824957b6528aa161"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6bf6928a0695a21bf35c621f43a5b338" level="file"><did><unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="6b66af1d5cd6569f496b967b7c642c1d" label="mixed materials [A0000000075903]" type="box">61</container><container id="e5a5a5eefcaca508347d733b31d2b33c" parent="6b66af1d5cd6569f496b967b7c642c1d" type="folder">4-6</container></did><accessrestrict id="7c855f662c00758a77e6169900e656ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file"><did><unittitle>TML - AIDS - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="b0d7a45167b274925c880c9fcc688b7e" label="mixed materials [A0000000075903]" type="box">61</container><container id="3af99e009d000e4e026f3dbfa050d573" parent="b0d7a45167b274925c880c9fcc688b7e" type="folder">7-11</container></did><accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file"><did><unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="0934c3c82231623d2fa4015b01d9e75b" label="mixed materials [A0000000075903]" type="box">61</container><container id="2f90e0e5fde0246692e6cef3f7b8bafb" parent="0934c3c82231623d2fa4015b01d9e75b" type="folder">12-13</container></did><accessrestrict id="c107fed35cdd31085f732308990ad842"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41aa0763a7e36f6ce380706ce01181e3" level="file"><did><unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="38e8293b6628ea977a7a05535604e133" label="mixed materials [A0000000075903]" type="box">61</container><container id="c444319b49f2b27c67f8e7fdef8f7b21" parent="38e8293b6628ea977a7a05535604e133" type="folder">14-16</container></did><accessrestrict id="10b78f31b326647359759629918503ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21f79f7c6b4acd8a596b33dacb48841b" level="file"><did><unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="7748063aef9b2e3261d8d84af6bf80d4" label="mixed materials [A0000000075903]" type="box">61</container><container id="7a695236db8dd6271f7347fa666d2fda" parent="7748063aef9b2e3261d8d84af6bf80d4" type="folder">17-19</container></did><accessrestrict id="ce544613fec94a632b764ccaa6155e27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2eed515acb400c24339036029a7a8f49" level="file"><did><unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="b4315f40411aa7f1639050093d09e1a8" label="mixed materials [A0000000075904]" type="box">62</container><container id="cff3575cea52f0183ad2f6d694d555c1" parent="b4315f40411aa7f1639050093d09e1a8" type="folder">1-3</container></did><accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ccba2cedcccf56cdefa0e205fc19e877" level="file"><did><unittitle>TML - Drugs of Choice - Cancer</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="a3d1a8228dfb8e280f3e2b5ee7fcc218" label="mixed materials [A0000000075904]" type="box">62</container><container id="217167910a278c12296f440c95ab67c6" parent="a3d1a8228dfb8e280f3e2b5ee7fcc218" type="folder">4-5</container></did><accessrestrict id="d687a473729a78247a1c380123065159"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file"><did><unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="10f8027a89f68e4aeadd42d671db5c5e" label="mixed materials [A0000000075904]" type="box">62</container><container id="e921fc4a0081d1a1a402e03b6c51e913" parent="10f8027a89f68e4aeadd42d671db5c5e" type="folder">6-9</container></did><accessrestrict id="60722a1253dc5c989a1fb84363bf8347"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file"><did><unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="9056e66a239cd99927561e222407f328" label="mixed materials [A0000000075904]" type="box">62</container><container id="357952c3d37ec8565c44fabc1b0ab758" parent="9056e66a239cd99927561e222407f328" type="folder">10-13</container></did><accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file"><did><unittitle>TML, 43-17 - Drugs for hypertension</unittitle><unitdate type="inclusive">2001 March 5</unitdate><container altrender="Record Storage Box (Paige)" id="b126c1bdb9a5b7d710fbe160a9b040e1" label="mixed materials [A0000000075904]" type="box">62</container><container id="f364512de1077a046ad90d61b33287a2" parent="b126c1bdb9a5b7d710fbe160a9b040e1" type="folder">14-18</container></did><accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="41052a6f51cb0d6e3bc2eb8f90797526" label="mixed materials [A0000000075904]" type="box">62</container><container id="639311b993d5b3634727967e101e6bd1" parent="41052a6f51cb0d6e3bc2eb8f90797526" type="folder">19</container></did><accessrestrict id="bedf8436e8ecc88cef43b4466703321f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2a3e11c7291578855058677f583ba4cc" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="5161ca7153dc2abd7dd8a8205a7c1420" label="mixed materials [A0000000075905]" type="box">63</container><container id="753b0fb49d33798d346850cfb91e4f63" parent="5161ca7153dc2abd7dd8a8205a7c1420" type="folder">1-2</container></did><accessrestrict id="1faf2fbe4c747499b17f777c7da8d367"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="7aeba34ec44547fe9581d43a0fc4043e" level="file"><did><unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle><unitdate type="inclusive">2001 January 27</unitdate><container altrender="Record Storage Box (Paige)" id="2f05e1c320dad136df9fa6a6046b3b18" label="mixed materials [A0000000075905]" type="box">63</container><container id="036b38be3bfa4758abac1ce4b1e4943b" parent="2f05e1c320dad136df9fa6a6046b3b18" type="folder">3-7</container></did><accessrestrict id="d1f83bcd9d1dba630ab83fe624589365"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9011b2319d9d385461bdca83ff03a269" level="file"><did><unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="145d015f475c753050bb2751dc4e907d" label="mixed materials [A0000000075905]" type="box">63</container><container id="136a90dcd5ac0a2c90b1e96985829ee3" parent="145d015f475c753050bb2751dc4e907d" type="folder">8-10</container></did><accessrestrict id="d1142cfc576dc71445c5513786f60e47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="43f128e719abd7716a8b552dab41b4ca" level="file"><did><unittitle>TML, 43-84 - Cord Blood Banks</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="b3dd7463fe8d2def6c5b9ba0b008de3d" label="mixed materials [A0000000075905]" type="box">63</container><container id="ae670820f46abe984928b52d744f14c5" parent="b3dd7463fe8d2def6c5b9ba0b008de3d" type="folder">11-14</container></did><accessrestrict id="d355e32a24f6cffb35162f5a565f8aad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2ca4ec46f32a50a21f55760304d5080b" level="file"><did><unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="84b933bd214c3694d92695b2f95dfca4" label="mixed materials [A0000000075905]" type="box">63</container><container id="aebfbd0180145cbc3e5dead7345b0e09" parent="84b933bd214c3694d92695b2f95dfca4" type="folder">15-16</container></did><accessrestrict id="12449f363aa33b967622999d1c656f25"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f4881e412a79293a02fce06ab7ada62d" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="5c9470fd32cb4fa0a8505f4ac6c79228" label="mixed materials [A0000000075905]" type="box">63</container><container id="e3a7f4a7e00298d362d5e01c906a1aa7" parent="5c9470fd32cb4fa0a8505f4ac6c79228" type="folder">17-20</container></did><accessrestrict id="762520a711ae5cf2f881c37d75c585e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="076a7f8b55c4644de3dc62c6db843a72" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="de2b82aa5e4c708e5a606c077e1a7a00" label="mixed materials [A0000000075906]" type="box">64</container><container id="b9fe8f7d658f7e47bf5272757eaf6593" parent="de2b82aa5e4c708e5a606c077e1a7a00" type="folder">1-2</container></did><accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="98d5e522f0e12ef676f68b6296b375c4" level="file"><did><unittitle>TML, 43-61 - Lung Cancer screening</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="1a013b5c6ba33459f2079ec223c461e1" label="mixed materials [A0000000075906]" type="box">64</container><container id="e4ad2fd4aad84ace00ab5557da3a7c88" parent="1a013b5c6ba33459f2079ec223c461e1" type="folder">3-5</container></did><accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bbfbf04fd92af083cfe5f2803138df54" level="file"><did><unittitle>TML, 43-7 - Mirena</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="424028b436756b00287f06151c9ccebb" label="mixed materials [A0000000075906]" type="box">64</container><container id="a678ef59b71851e9bf7b466261e3528b" parent="424028b436756b00287f06151c9ccebb" type="folder">6-8</container></did><accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b86dfd5896dc8ed385111ad16cbd218" level="file"><did><unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="d74c1da110fbe53b648cf6d22c65827c" label="mixed materials [A0000000075906]" type="box">64</container><container id="942b2251f08101b95c86c2a5590d399d" parent="d74c1da110fbe53b648cf6d22c65827c" type="folder">9-10</container></did><accessrestrict id="f505d3982f99b3e642ccbf40fbd75883"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0f9927bdf850374dd901cc030c68dc7c" level="file"><did><unittitle>TML - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="f1c8112eb704e14360c8236bb7ca251b" label="mixed materials [A0000000075906]" type="box">64</container><container id="7912f33b47b7274e5d08e06689c4b5d2" parent="f1c8112eb704e14360c8236bb7ca251b" type="folder">11-14</container></did><accessrestrict id="6be4b2a90096d23f4c7270994aa74f17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="97fc093a6a8e4909bb2c604168b0b754" level="file"><did><unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="5f7d58734c334a035b98d3591b42d0fe" label="mixed materials [A0000000075906]" type="box">64</container><container id="89c4e4d92dea89c6854cafca1068131f" parent="5f7d58734c334a035b98d3591b42d0fe" type="folder">15-18</container></did><accessrestrict id="f836855e02f4d6fe9f63b628886a4c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6da20ff4a72dc0604ae511c5634291e7" level="file"><did><unittitle>TML, 43-55 - A new snake antivenin</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="0b76d45ce0e844bece276fccbc5b389a" label="mixed materials [A0000000075906]" type="box">64</container><container id="31724484a92884c7f623809c0031ff44" parent="0b76d45ce0e844bece276fccbc5b389a" type="folder">19-20</container></did><accessrestrict id="f08173f37c2607c4d273372be7fedab1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ede8d569017eb650ffb86947aa817ebe" level="file"><did><unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="4567137ecf4addb3bddb4a3252c5a555" label="mixed materials [A0000000075907]" type="box">65</container><container id="ad90d685e8117ead5ce8991d109536af" parent="4567137ecf4addb3bddb4a3252c5a555" type="folder">1-3</container></did><accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file"><did><unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="1624a81b7d37afb442a6af109f21ee6d" label="mixed materials [A0000000075907]" type="box">65</container><container id="869a8fe06140e0a8170025ffbfcf1611" parent="1624a81b7d37afb442a6af109f21ee6d" type="folder">4-7</container></did><accessrestrict id="810ad5d825ba01f69c55af09b52e33af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8068f52546b65b321ac2f5fa6a731f4c" level="file"><did><unittitle>TML, - Drugs for depression and anxiety</unittitle><unitdate type="inclusive">2001 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="b630525ad24a9cac5e1370da9f24a872" label="mixed materials [A0000000075907]" type="box">65</container><container id="f26a2382731c97b39722910a0e793aa4" parent="b630525ad24a9cac5e1370da9f24a872" type="folder">8-10</container></did><accessrestrict id="67940cb71724cb07bb1c047808a223cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="55a8ca16b598343eb87537a2d296ecd1" level="file"><did><unittitle>TML, 43-15 - PC-Spes</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="c6a2117594ea2ec23766752225d9867f" label="mixed materials [A0000000075907]" type="box">65</container><container id="0e61845f6c1457d325e41c32340af530" parent="c6a2117594ea2ec23766752225d9867f" type="folder">11-12</container></did><accessrestrict id="75c2794ebd1f11660bcef03019daccd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file"><did><unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="25321630d609505f49f89b0d34eff835" label="mixed materials [A0000000075907]" type="box">65</container><container id="5116742e318a105e1890adde6ac633fc" parent="25321630d609505f49f89b0d34eff835" type="folder">13-16</container></did><accessrestrict id="07f8b933648e23ed47138c1bef096df8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="833ebff3fb7c7c45c0c064414304d04f" level="file"><did><unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="c632aeaf0e2fb7cce46f776c4bb759ce" label="mixed materials [A0000000075907]" type="box">65</container><container id="d9a21fc87b6bc7efdb7d5d9259977342" parent="c632aeaf0e2fb7cce46f776c4bb759ce" type="folder">17-18</container></did><accessrestrict id="8a48c9bb323707808cd2699c098b90df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="ea2758a254661a718e526862d325b5e7" label="mixed materials [A0000000075907]" type="box">65</container><container id="90796dda49fa8218d42c7d4698d965b0" parent="ea2758a254661a718e526862d325b5e7" type="folder">19</container></did><accessrestrict id="5b72b0c715fd854e87ba957e71353a88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="9ccdd8e5af6b4eb95b18febbb9a750ed" label="mixed materials [A0000000075908]" type="box">66</container><container id="f9109522ee03dcf97f497c993e811de1" parent="9ccdd8e5af6b4eb95b18febbb9a750ed" type="folder">1</container></did><accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a3e98844edbadfd1126f96dcee9fa072" level="file"><did><unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle><unitdate type="inclusive">2001 October 15</unitdate><container altrender="Record Storage Box (Paige)" id="3d668560e303419257c737622c9f0207" label="mixed materials [A0000000075908]" type="box">66</container><container id="d79d4f3c266e34002632c20783cd9b4f" parent="3d668560e303419257c737622c9f0207" type="folder">2-3</container></did><accessrestrict id="95db9e419544c222951aae12dd139e45"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2330e815d4bdfd9c12c459306864dcca" level="file"><did><unittitle>TML, 43-103 - Drugs for HIV infection</unittitle><unitdate type="inclusive">2001 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="5eca36ff7b93096660b3265f52841f16" label="mixed materials [A0000000075908]" type="box">66</container><container id="534cee581783d54a630cab8af0afc718" parent="5eca36ff7b93096660b3265f52841f16" type="folder">4-7</container></did><accessrestrict id="ba5d1519c239af0bb83357cd9431cc00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file"><did><unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="3be661cfff1e1a0be96ef73b2f092485" label="mixed materials [A0000000075908]" type="box">66</container><container id="76a9ec67a976341480dafad935e8448e" parent="3be661cfff1e1a0be96ef73b2f092485" type="folder">8</container></did><accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9f44342b0f523de0bfcb639e0134e8" level="file"><did><unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="200d239cc75331066919f9319ecd0a2a" label="mixed materials [A0000000075908]" type="box">66</container><container id="357b204f735667ee927ea0375807b703" parent="200d239cc75331066919f9319ecd0a2a" type="folder">9-10</container></did><accessrestrict id="9d4ad8765f4f79883181f256eb7f9879"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file"><did><unittitle>TML, Drugs of Choice - Pain</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="c3d2d3cf3904bb0abf7e6d6e7a6c9b9b" label="mixed materials [A0000000075908]" type="box">66</container><container id="a07e8d9802bd56bc7d0406b756b4de89" parent="c3d2d3cf3904bb0abf7e6d6e7a6c9b9b" type="folder">11</container></did><accessrestrict id="3b2728fff814b6aa47a93b6386e34381"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="468e734f765a9be3853dd86c21c17c5d" level="file"><did><unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="c289af0742dc57087a9dc9ab60c4bcef" label="mixed materials [A0000000075908]" type="box">66</container><container id="7cd1b134ac043dfef93a77b54580b73c" parent="c289af0742dc57087a9dc9ab60c4bcef" type="folder">12</container></did><accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d63b61dd440fbe48748ed3adaaa153a3" level="file"><did><unittitle>TML, 43-13 - Palivizumab update</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="6d891222c87abadc61a74eb08ca5204e" label="mixed materials [A0000000075908]" type="box">66</container><container id="6afefe814574c030e0c1d44d7ef0891e" parent="6d891222c87abadc61a74eb08ca5204e" type="folder">13-14</container></did><accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="07c5a88addbecee925056539789a95ce" level="file"><did><unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="36e279f1bd1cee2ca67c7ce8ccac1d40" label="mixed materials [A0000000075908]" type="box">66</container><container id="f36a6512200189714069babf6e92e012" parent="36e279f1bd1cee2ca67c7ce8ccac1d40" type="folder">15-17</container></did><accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3c99102c3cbe6573776800745f8ae469" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="05b168f43857077a1f07de3b596a8de9" label="mixed materials [A0000000075908]" type="box">66</container><container id="f0082be292c09acef4228eb2cc58c929" parent="05b168f43857077a1f07de3b596a8de9" type="folder">18-20</container></did><accessrestrict id="0e83e8dd8e86709df7f972ac81515598"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6baca4f86fe997597684780a50afb04" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="1c135a114d1325e5ff18b658afeb6dcd" label="mixed materials [A0000000075909]" type="box">67</container><container id="861720578dc3cd21d6b75a9fbba6a0d0" parent="1c135a114d1325e5ff18b658afeb6dcd" type="folder">1</container></did><accessrestrict id="a04d9293e94b60a9e39c9b4189abc925"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21563c371ed6d15964e3cc6b122e8325" level="file"><did><unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="ef59c8890fab54a1649b59e65ebee522" label="mixed materials [A0000000075909]" type="box">67</container><container id="b1274c59e91c125356454390cb51a2df" parent="ef59c8890fab54a1649b59e65ebee522" type="folder">2-5</container></did><accessrestrict id="591f5ce0464ac805e58c930e1f206114"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a56fc8ba008f5ec96cb059f94525d216" level="file"><did><unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="3560f7b5ac9c152f05c5fb07cb3de82b" label="mixed materials [A0000000075909]" type="box">67</container><container id="9dde9479c5e2328217fe3906d086f4c7" parent="3560f7b5ac9c152f05c5fb07cb3de82b" type="folder">6-8</container></did><accessrestrict id="516c40c3c42f23a1ef834fac3280423d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file"><did><unittitle>TML, 43-57 - Levothyroxine</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="d19c01a493581aa0016d9852363bf8d6" label="mixed materials [A0000000075909]" type="box">67</container><container id="35ebf9cc9962f725a4b30957a6985b7c" parent="d19c01a493581aa0016d9852363bf8d6" type="folder">9-11</container></did><accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d2d95b76affb3a4c9b22a381ae08576d" level="file"><did><unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="fd30bdf6cd3f2979dc34e122c6b154bb" label="mixed materials [A0000000075909]" type="box">67</container><container id="191bed48027861de8aebdb0f7c449966" parent="fd30bdf6cd3f2979dc34e122c6b154bb" type="folder">12-13</container></did><accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file"><did><unittitle>TML, 43-27 - Prozac Weekly</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="bca9af9fc70b194db503dbc8b5b3adcf" label="mixed materials [A0000000075909]" type="box">67</container><container id="c6fb4225df1d07215ce70e7d7fbd586f" parent="bca9af9fc70b194db503dbc8b5b3adcf" type="folder">14</container></did><accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="265b08842d8ac8ea34569e29104683cc" label="mixed materials [A0000000075909]" type="box">67</container><container id="6a77df340d08a0c9484887c6fb191736" parent="265b08842d8ac8ea34569e29104683cc" type="folder">15-17</container></did><accessrestrict id="81584269571599c2534c39747bee7f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="ef9f2099f8e3b4f2460a29c1b56dc963" label="mixed materials [A0000000075910]" type="box">68</container><container id="5819231e07d68d354d61f535e91051d1" parent="ef9f2099f8e3b4f2460a29c1b56dc963" type="folder">1</container></did><accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file"><did><unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="be0b7822fcaf589affe980d034859c32" label="mixed materials [A0000000075910]" type="box">68</container><container id="ff3cb71e079bf4305addbaae2b657286" parent="be0b7822fcaf589affe980d034859c32" type="folder">2-4</container></did><accessrestrict id="c860c07bca67d0f682cba26ca6577767"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="50348bc86f79794dd7d3880f772dc9fb" level="file"><did><unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="202bc178c7912d9059dd8054c9dd2129" label="mixed materials [A0000000075910]" type="box">68</container><container id="b156d61113476b9c43046b9710b66746" parent="202bc178c7912d9059dd8054c9dd2129" type="folder">5-8</container></did><accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file"><did><unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle><unitdate type="inclusive">2001 April 16</unitdate><container altrender="Record Storage Box (Paige)" id="ff4e55e92d8c90c5069960c3e6c928f4" label="mixed materials [A0000000075910]" type="box">68</container><container id="d88df8a1ac65f392c0035c0db6052ae3" parent="ff4e55e92d8c90c5069960c3e6c928f4" type="folder">9-12</container></did><accessrestrict id="524857adc52fa0f183b069d3ae7050b5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41122ea5a6e7981f0132dc387c47d526" level="file"><did><unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="c2344fe5ac78bea6c1e018662a5e0233" label="mixed materials [A0000000075910]" type="box">68</container><container id="81a365cef1e11e2517d8c309f7e29470" parent="c2344fe5ac78bea6c1e018662a5e0233" type="folder">13-14</container></did><accessrestrict id="8a2f04b8e85fd19c93d31127f994912c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file"><did><unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="d24b5a4dd66bcaa236dbd2d227601882" label="mixed materials [A0000000075910]" type="box">68</container><container id="5f35b4e9631094eeed58bda27f41ecc5" parent="d24b5a4dd66bcaa236dbd2d227601882" type="folder">15-17</container></did><accessrestrict id="ed26092ce8449e46cf63b80b2a291816"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c5905505fca4831e512fb2648100be7" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="7bb52d1e72f6fb79ca1f8d94a9a7e1fd" label="mixed materials [A0000000075910]" type="box">68</container><container id="1ce3691b61731996cd86010442ddae84" parent="7bb52d1e72f6fb79ca1f8d94a9a7e1fd" type="folder">18</container></did><accessrestrict id="75c6bb282a1bebd46a6a30af50403e35"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d83158c1d6d2339140e8e837daa705b4" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="983738635394d942c8e25b51b887fa7c" label="mixed materials [A0000000075910]" type="box">68</container><container id="df714ce59a84afdd9faf61df3025d152" parent="983738635394d942c8e25b51b887fa7c" type="folder">19-21</container></did><accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="514a563873b791d43a08c60e162065d8" label="mixed materials [A0000000075911]" type="box">69</container><container id="4d9a84b72c10968e8b0313f8f8f553c6" parent="514a563873b791d43a08c60e162065d8" type="folder">1</container></did><accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="4cdec89511203afd4fe2dc98bb7107a3" level="file"><did><unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="2fc4cc2d54884ef47d27f70206a0321a" label="mixed materials [A0000000075911]" type="box">69</container><container id="c063259fdd1aba1e22df99227c5e6a6f" parent="2fc4cc2d54884ef47d27f70206a0321a" type="folder">2-4</container></did><accessrestrict id="721d15062edf16474f8c9615e7343c9b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c93f14bdbe03244367dc9260f841c8a" level="file"><did><unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="3af909e5090f9ea7790ea6153469d2dd" label="mixed materials [A0000000075911]" type="box">69</container><container id="1729724b6dab8d2674c2dc5a73f50212" parent="3af909e5090f9ea7790ea6153469d2dd" type="folder">5-8</container></did><accessrestrict id="0834865471315b83cd87445af0b5d964"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c1db8b64ee78c1dea2315fd90476615" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="2dc04149403f13ac611a27faa6b13463" label="mixed materials [A0000000075911]" type="box">69</container><container id="6cc24697a3ab3dfddce9e4c47cd6d842" parent="2dc04149403f13ac611a27faa6b13463" type="folder">9-12</container></did><accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file"><did><unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="40bd6d6a38305826b4944ede8eb4fb44" label="mixed materials [A0000000075911]" type="box">69</container><container id="f3f94eef0cdedbe9e4f664f1c690b093" parent="40bd6d6a38305826b4944ede8eb4fb44" type="folder">13-14</container></did><accessrestrict id="cc2db5a946dc97445662edf403135cfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dde7a8f4a1c15dd762a0160728804b73" level="file"><did><unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="795ca5f771716b2938ee7ba38eaa6bd3" label="mixed materials [A0000000075911]" type="box">69</container><container id="c49a8d99a814de565c5256299a65dea0" parent="795ca5f771716b2938ee7ba38eaa6bd3" type="folder">15-17</container></did><accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9666394f9b7e1594ab6d9d740833bf6d" level="file"><did><unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="1351ee92498e704506747bc435645d2a" label="mixed materials [A0000000075911]" type="box">69</container><container id="64439bdc7f7d796ac8063d1ff4b56f4c" parent="1351ee92498e704506747bc435645d2a" type="folder">18-20</container></did><accessrestrict id="64351c947d34d22cef39ad4007296824"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9e514faa1eb026a69873e6b610137535" level="file"><did><unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="b8096b22d23b140cab1798c86a69ff17" label="mixed materials [A0000000075912]" type="box">70</container><container id="2b87f738112d203fa623d249baf5ae2f" parent="b8096b22d23b140cab1798c86a69ff17" type="folder">1-4</container></did><accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file"><did><unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="4da078a97afc4369f77e14798bb53c7a" label="mixed materials [A0000000075912]" type="box">70</container><container id="c4353c08642155439f6547f8520b19be" parent="4da078a97afc4369f77e14798bb53c7a" type="folder">5-7</container></did><accessrestrict id="753a55d97a80d113ee2476718a3d1661"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="4c1344a1bbc78c4500a4a9878158f55b" label="mixed materials [A0000000075912]" type="box">70</container><container id="d5aa0e2ceb2275a2734266c4b2cf1072" parent="4c1344a1bbc78c4500a4a9878158f55b" type="folder">8-10</container></did><accessrestrict id="d504ebc62c5421f5e1d907042650019a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="28985057e383ceb12ff871b5d26e61da" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="071c8a328976625a562ff80ea8807720" label="mixed materials [A0000000075912]" type="box">70</container><container id="990eb499aaa101f95e331eaa27bc83a4" parent="071c8a328976625a562ff80ea8807720" type="folder">11-13</container></did><accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file"><did><unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="f7fe903ac0a5507f4f0c7a659ae00237" label="mixed materials [A0000000075912]" type="box">70</container><container id="0e408c32259da3fd2cc2c42d3dab0f1e" parent="f7fe903ac0a5507f4f0c7a659ae00237" type="folder">14-15</container></did><accessrestrict id="b5d06faa04330361ca1ca75b21c017fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a8579ee641a8d372e5b92c341780d2f0" level="file"><did><unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="54b1d02db63a3d6fcc04c857f030307a" label="mixed materials [A0000000075912]" type="box">70</container><container id="d59e129b6594390270e5fddf338da041" parent="54b1d02db63a3d6fcc04c857f030307a" type="folder">16-17</container></did><accessrestrict id="85e3914a93c77fea32c035bd079cdf38"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file"><did><unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="b8d30655d65266c40031773c2d864ae6" label="mixed materials [A0000000075913]" type="box">71</container><container id="60750dfd5fbbc6ef3e188de8cd5fdecc" parent="b8d30655d65266c40031773c2d864ae6" type="folder">1-4</container></did><accessrestrict id="5e9a358af553725b2b7a0e754e583db4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a52ad11ec1e3f4d9273267e959212194" level="file"><did><unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="a3d248889e45e98746f23166747cffd1" label="mixed materials [A0000000075913]" type="box">71</container><container id="29f77f4e7d8a5bc5578bb22b26e229de" parent="a3d248889e45e98746f23166747cffd1" type="folder">5-8</container></did><accessrestrict id="44f937981b03e47fe5b48832e2bc3c06"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="524bcd1ef0983fc228db57fdceccbd8a" level="file"><did><unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle><unitdate type="inclusive">2002 January 7</unitdate><container altrender="Record Storage Box (Paige)" id="e3e6a3b24adaf7e32f9934469723b2b4" label="mixed materials [A0000000075913]" type="box">71</container><container id="a75e98fbc24e7cea088c4009048f7d70" parent="e3e6a3b24adaf7e32f9934469723b2b4" type="folder">9-11</container></did><accessrestrict id="41a008738c8b0cf8972cf6b24432d838"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bad1e6f9e4ec0f760e77c31253787c34" level="file"><did><unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="cba2dc501e4e2267490c36ec1b9396fd" label="mixed materials [A0000000075913]" type="box">71</container><container id="75d402be4a039325db7cee146c1079ce" parent="cba2dc501e4e2267490c36ec1b9396fd" type="folder">12-13</container></did><accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ba78803aaafb030f1962308400163490" level="file"><did><unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="491c36b11963cdbd1b70c9438828b3e0" label="mixed materials [A0000000075913]" type="box">71</container><container id="1ad7c1b129a25631371d9baf064e4d55" parent="491c36b11963cdbd1b70c9438828b3e0" type="folder">14-16</container></did><accessrestrict id="261eac7e701cc4253a133eadd4895b0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file"><did><unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="612aaa6fe6650ad634cf7daf5860d0a1" label="mixed materials [A0000000075913]" type="box">71</container><container id="aa34a5306e650af403094b48b2742bf1" parent="612aaa6fe6650ad634cf7daf5860d0a1" type="folder">17-19</container></did><accessrestrict id="06663a53b51c9f32469146874e6a53fd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a4e45a144c74f16ab14378047e5576f1" level="file"><did><unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="9f1c834c1a6225064e80b2977b2d0319" label="mixed materials [A0000000075913]" type="box">71</container><container id="a5fc5ab1548fa14c38b12739b4480afa" parent="9f1c834c1a6225064e80b2977b2d0319" type="folder">20-21</container></did><accessrestrict id="344623fd522ad204005bd4713a3a7eaa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9f13d0adec34e41920a5e68ddd64292c" level="file"><did><unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="79f98200fd04ebfec3824318d8a73b4a" label="mixed materials [A0000000075914]" type="box">72</container><container id="27d9859f5eeea899a66ccdfa025423aa" parent="79f98200fd04ebfec3824318d8a73b4a" type="folder">1</container></did><accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9263ee3a396996d1f6c92f91c990e8b4" level="file"><did><unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="05f6877c78a047a6776d762f0b1f6cb6" label="mixed materials [A0000000075914]" type="box">72</container><container id="2019028a043c2c53484dc68246848c29" parent="05f6877c78a047a6776d762f0b1f6cb6" type="folder">2-7</container></did><accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fec2a29720e66cc581b066877ffa632d" level="file"><did><unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="904178b2134184b22f31b365734eee23" label="mixed materials [A0000000075914]" type="box">72</container><container id="09b40ee26759378a4605592b580d9f82" parent="904178b2134184b22f31b365734eee23" type="folder">8-9</container></did><accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ea19cfea9c41aa789e87a27139849cc9" level="file"><did><unittitle>TML, 44-42 - Copyright violations</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="83965e8950b69b22c74eca1ce64343a8" label="mixed materials [A0000000075914]" type="box">72</container><container id="e2ef4bd3eb3e7847c1e6765b7ddd820a" parent="83965e8950b69b22c74eca1ce64343a8" type="folder">10</container></did><accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="573b9aa7949c2b6064549d58f22d1ef4" level="file"><did><unittitle>TML, 44-89 - Generic drugs</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="c737eb7fe9ed7005d0bef7f8f0892409" label="mixed materials [A0000000075914]" type="box">72</container><container id="c4b695823207c22ad735dfccb0fc4df1" parent="c737eb7fe9ed7005d0bef7f8f0892409" type="folder">11-13</container></did><accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="eca6e6e8880da77ade266c114c4c3ef8" level="file"><did><unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="7fece29363b3eb9d10aba90f98893836" label="mixed materials [A0000000075914]" type="box">72</container><container id="b98cb2b203c382e1bbed47ba864fdabf" parent="7fece29363b3eb9d10aba90f98893836" type="folder">14-16</container></did><accessrestrict id="e52979497dde6f1c31a59d9d3764a403"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file"><did><unittitle>TML, 44-103 - GHB for nacolepsy</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="22c42ea075aa11fcf3fa5dd51cc7bd71" label="mixed materials [A0000000075914]" type="box">72</container><container id="c03cb9244fd2d430438f67a6c353a411" parent="22c42ea075aa11fcf3fa5dd51cc7bd71" type="folder">17-19</container></did><accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="5f1f43a60e3a918e61f1524dd78e1670" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="f19f5beb371b830efeb202866289171b" label="mixed materials [A0000000075914]" type="box">72</container><container id="5e615340ec11f04d0b35787ace0d9ab0" parent="f19f5beb371b830efeb202866289171b" type="folder">20</container></did><accessrestrict id="43b31e9dd0e56b4393c587638541da8a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d0277fd8830f2d769496c88f15bb859c" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="33d3508b17bb89d7d9ed135532eb4175" label="mixed materials [A0000000075915]" type="box">73</container><container id="e49369a3307642af2a45b16de8e2a9b5" parent="33d3508b17bb89d7d9ed135532eb4175" type="folder">1</container></did><accessrestrict id="0374c695f899676ae2f0f4ab46c32079"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="38f15317a1ab04ccab7ddf87c59865ca" level="file"><did><unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="92cac134eb3d3604994957dfd0979734" label="mixed materials [A0000000075915]" type="box">73</container><container id="a5782a828c12cee11b867eec03034570" parent="92cac134eb3d3604994957dfd0979734" type="folder">2-4</container></did><accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c2dd44962d67176662e4db78dd0a66d1" level="file"><did><unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="c15a286ff74bc044d8bd4350e3076698" label="mixed materials [A0000000075915]" type="box">73</container><container id="c7efc115bdb6d98f67da11ce94369fb5" parent="c15a286ff74bc044d8bd4350e3076698" type="folder">5-7</container></did><accessrestrict id="a137a040fd97e7017313ae9a82d2fe86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="70993f6f906adca6d28b7cec87c5cbab" level="file"><did><unittitle>TML, 44-93 - Drugs past their expiration date</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="3f0142b5a8ba3e24c21f41f5a32e8fe7" label="mixed materials [A0000000075915]" type="box">73</container><container id="c339a4b95076aeba5915b2a7fab95fb0" parent="3f0142b5a8ba3e24c21f41f5a32e8fe7" type="folder">8-10</container></did><accessrestrict id="e06690c5813977cdcc6c8a5a7653718f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f9bc602671296cc3d2de922401f1986e" level="file"><did><unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="50252fd14eba59ead82c200bf8f9409f" label="mixed materials [A0000000075915]" type="box">73</container><container id="d1cdf9f08fa3a8362ecff83b9861b564" parent="50252fd14eba59ead82c200bf8f9409f" type="folder">11-12</container></did><accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="88bf2c423e244a87d79645badbf2e9f3" level="file"><did><unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="0f9ac4cdc045b5b852308df69db533e3" label="mixed materials [A0000000075915]" type="box">73</container><container id="b256c0200cf49a7ea84fd597c46bbb3b" parent="0f9ac4cdc045b5b852308df69db533e3" type="folder">13-15</container></did><accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="05b64e3022467a23598c9201bc74dfdf" level="file"><did><unittitle>TML - Cefepime</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="9e590ab604a6e152ad5e0e14a77dd0de" label="mixed materials [A0000000075915]" type="box">73</container><container id="8f79501e46aac2c1a32c30b0decdf2fc" parent="9e590ab604a6e152ad5e0e14a77dd0de" type="folder">16-18</container></did><accessrestrict id="394b3115bcff39760eac5c39dc81bdb6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0b79a2b45ac5a48beb03988b3255f34c" level="file"><did><unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="96f6d230de523af86e3f3d3986a48d50" label="mixed materials [A0000000075915]" type="box">73</container><container id="882cd54df76297fff935dd68426d7a8e" parent="96f6d230de523af86e3f3d3986a48d50" type="folder">19-21</container></did><accessrestrict id="556a688586b09ef7523a269879e4d606"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file"><did><unittitle>TML - Echinacea</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="d30e230d41983f3de07f5ff03907fae4" label="mixed materials [A0000000075916]" type="box">74</container><container id="a6906f5d198006f578b7002eb10d2433" parent="d30e230d41983f3de07f5ff03907fae4" type="folder">1-3</container></did><accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="af85bd11efe07fd729751c8c218f32d2" level="file"><did><unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="bf1195f4340f4bd3c06f1afceb9297a5" label="mixed materials [A0000000075916]" type="box">74</container><container id="7ed3822a2bbaf95e8e600951767fa902" parent="bf1195f4340f4bd3c06f1afceb9297a5" type="folder">4-6</container></did><accessrestrict id="e67c688500af00baeca0146003fa4b6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45aa8fe42fd0ddc4536be77350df4b57" level="file"><did><unittitle>TML - Fungal Infections - Reprints</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="0b5218f55c4dae832ee4668d3b2e9e60" label="mixed materials [A0000000075916]" type="box">74</container><container id="a14778b4e09966634756688d7f69e154" parent="0b5218f55c4dae832ee4668d3b2e9e60" type="folder">7</container></did><accessrestrict id="1f1099e38699970b363bae0c6975a70b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2e47b4ee1607009a90bcdea23b07a404" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="cc66469180f01a2fa293dc774f95a9b9" label="mixed materials [A0000000075916]" type="box">74</container><container id="dd0986b2bfeee99e7b704438401ccd13" parent="cc66469180f01a2fa293dc774f95a9b9" type="folder">8-19</container></did><accessrestrict id="831283e78ef78563e6f6b9e3060a60fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="7f3c6bd4ce066fe1638d0ec0dee84c3f" label="mixed materials [A0000000075917]" type="box">75</container><container id="a01651faa4f83bb381b9d290fb9e6eea" parent="7f3c6bd4ce066fe1638d0ec0dee84c3f" type="folder">1-2</container></did><accessrestrict id="37075cc131616efa32d821ddec70e19a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0785dbde88fe25acb019e68e53796851" level="file"><did><unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="ecd72191f2e5981f8ffb17bf660ffa9b" label="mixed materials [A0000000075917]" type="box">75</container><container id="06d1d2a9a643026fe316df8835ba4fa7" parent="ecd72191f2e5981f8ffb17bf660ffa9b" type="folder">3-4</container></did><accessrestrict id="423a699022dfc41e5a19356b8ede358f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daec721a5877ed667e3be025c5b3972b" level="file"><did><unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="ea7b210287e9b2810ee3e2779f0023f8" label="mixed materials [A0000000075917]" type="box">75</container><container id="4e0d31493dd77f11719b393e8839c52e" parent="ea7b210287e9b2810ee3e2779f0023f8" type="folder">5-6</container></did><accessrestrict id="65275a0edfafc2779f6f3b12b167613d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file"><did><unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="7340d15f6fbc727225fc4983120d0ec8" label="mixed materials [A0000000075917]" type="box">75</container><container id="100ed9b5b86624b0489c51f98066bf89" parent="7340d15f6fbc727225fc4983120d0ec8" type="folder">7-10</container></did><accessrestrict id="66fca14cfc643877b243d938549ef683"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6c5c80d095e7afd1c721854326e0f8cc" level="file"><did><unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle><unitdate type="inclusive">2002 February 4</unitdate><container altrender="Record Storage Box (Paige)" id="b3ec84d8a3b1e07bce69a1941a94a26e" label="mixed materials [A0000000075917]" type="box">75</container><container id="5444f025c981666cfbd16d159ecbe992" parent="b3ec84d8a3b1e07bce69a1941a94a26e" type="folder">11-17</container></did><accessrestrict id="bdf05fc38d86db9b72f37658b33c4730"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bcfed60146a9353c15a7810e066eb562" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="e7274c13a55aaa8fb27a2e080a4ba6d7" label="mixed materials [A0000000075917]" type="box">75</container><container id="2e673ca0acf91d6bacc89608cfa3650f" parent="e7274c13a55aaa8fb27a2e080a4ba6d7" type="folder">18-19</container></did><accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="26f9f680797154013e700d36b1ee02cc" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="a4afdc792774caa0a72b0714bac3c989" label="mixed materials [A0000000075918]" type="box">76</container><container id="d2ad53f00f2df63eaf5c2a84e4b59d96" parent="a4afdc792774caa0a72b0714bac3c989" type="folder">1-2</container></did><accessrestrict id="538e6db36155fc336b5cd7453b267830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file"><did><unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="4e8e50fe35f36c7d49a57b405a84a7b9" label="mixed materials [A0000000075918]" type="box">76</container><container id="738fe4506f328d8856f57b6a99a63a19" parent="4e8e50fe35f36c7d49a57b405a84a7b9" type="folder">3-5</container></did><accessrestrict id="009827e7a43d5b337cbe6459416c7913"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4e2f11c3afbd278cc01889db51cc3594" level="file"><did><unittitle>TML - Safety of antimicrobials in pregnancy</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="1447a22523715eb2fd1e10ad5aef036c" label="mixed materials [A0000000075918]" type="box">76</container><container id="94312bae73552e10f9924d6c15ea47a6" parent="1447a22523715eb2fd1e10ad5aef036c" type="folder">6-9</container></did><accessrestrict id="4077280e1fc84a55fa2f33342e312820"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d9af5da201c75753edd17152b98006c9" level="file"><did><unittitle>TML, 44-63 - Voriconazole</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="0855d74ab5e852a1747ac42724ba97ca" label="mixed materials [A0000000075918]" type="box">76</container><container id="e7f5429cd2cf88bc06779fe752fb65c9" parent="0855d74ab5e852a1747ac42724ba97ca" type="folder">10-14</container></did><accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file"><did><unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 December</unitdate><container altrender="Record Storage Box (Paige)" id="ba59ecb6332ce74377d0f9f65deb3588" label="mixed materials [A0000000075918]" type="box">76</container><container id="98e0b5efc6928e9f71dce4c65f416645" parent="ba59ecb6332ce74377d0f9f65deb3588" type="folder">15-20</container></did><accessrestrict id="d78727a12815fb45316cee4c1bb66369"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4536f53d88709a34f9764f238002f522" level="file"><did><unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="83268a3f7d3503b186986ec840dfabf4" label="mixed materials [A0000000075919]" type="box">77</container><container id="e90078ff311409c6a34e536fb9cdaa93" parent="83268a3f7d3503b186986ec840dfabf4" type="folder">1-4</container></did><accessrestrict id="3f564956f49faf84f827624973a86572"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8319ac1e74f3772c55f953d49d1fe802" level="file"><did><unittitle>TML - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="68f62bb07c5d6efeb936a60df25dea18" label="mixed materials [A0000000075919]" type="box">77</container><container id="8f90236a413a91019c8ae1522fda0c19" parent="68f62bb07c5d6efeb936a60df25dea18" type="folder">5-8</container></did><accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c61123a9a767eb2a2f0665b7e710f056" level="file"><did><unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="54660e93b5acd74fb9e04130c8944a28" label="mixed materials [A0000000075919]" type="box">77</container><container id="106866693c58ccffa7904737efa82172" parent="54660e93b5acd74fb9e04130c8944a28" type="folder">9-11</container></did><accessrestrict id="96d0a14409c624606417824206c572f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file"><did><unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle><unitdate type="inclusive">2002 July 8</unitdate><container altrender="Record Storage Box (Paige)" id="dc2c733aeac62d20d7dc103835c7e682" label="mixed materials [A0000000075919]" type="box">77</container><container id="92f07e5548ceb2de0ba68f999a06a998" parent="dc2c733aeac62d20d7dc103835c7e682" type="folder">12-16</container></did><accessrestrict id="049b266831555277c80bf92411b09f0b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file"><did><unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="12acbffb17f0d7cf58ef16a11588ad6e" label="mixed materials [A0000000075919]" type="box">77</container><container id="668072e11674964876bae013fc0706d4" parent="12acbffb17f0d7cf58ef16a11588ad6e" type="folder">17-19</container></did><accessrestrict id="6b6e7ca2998642d620f912e4ae273e58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="702df7b3933e28f25249b7010b1efc23" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="c13af46fdbb50dd323ee894afb708dd7" label="mixed materials [A0000000075919]" type="box">77</container><container id="d75893f5c0285e9738981ef8a8187047" parent="c13af46fdbb50dd323ee894afb708dd7" type="folder">20</container></did><accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="8b0c209ec0ce2beaf1c840bdffac77ae" label="mixed materials [A0000000075919]" type="box">77</container><container id="af337fce12526bd2061fb1beaecf15c2" parent="8b0c209ec0ce2beaf1c840bdffac77ae" type="folder">21</container></did><accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="3238875c71befee0c843bfb578b0af6f" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="9e0e24fe24ff960bf08472f88ffee792" label="mixed materials [A0000000075920]" type="box">78</container><container id="1319b0f676be8a0623b85ca51e1d9aa6" parent="9e0e24fe24ff960bf08472f88ffee792" type="folder">1-3</container></did><accessrestrict id="f07baa851539686de763d2f786c2177e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0f73f901dbd4ead91b01d80ceed67c30" level="file"><did><unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="2223089249dd6b29a050d72dfa1c868f" label="mixed materials [A0000000075920]" type="box">78</container><container id="bf788ea4cd079970682b3855c0994274" parent="2223089249dd6b29a050d72dfa1c868f" type="folder">4-6</container></did><accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="23ee674858aa228c8597cb11a5363b5d" level="file"><did><unittitle>TML, 44-33 - Advice for travelers</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="95000d9658b28bd4e6db3ea519507e2a" label="mixed materials [A0000000075920]" type="box">78</container><container id="850289f886485b8dc795b4177206db59" parent="95000d9658b28bd4e6db3ea519507e2a" type="folder">7-9</container></did><accessrestrict id="687d9c16855007cc90b89408873e9116"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c3ff86733b644974c019ea29b403f49f" level="file"><did><unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="2532f8ae8296d85df31ea45d247953dd" label="mixed materials [A0000000075920]" type="box">78</container><container id="d138b442a059ac32663ea4e9df8c5d18" parent="2532f8ae8296d85df31ea45d247953dd" type="folder">10-11</container></did><accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="24af9a9128ef19b87942303f71c93a4b" level="file"><did><unittitle>TML, 44-91 - Acetaminophen safety</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="b95363506fd1dd7990a025baab373fa0" label="mixed materials [A0000000075920]" type="box">78</container><container id="12f5b3602a0e1c7c659174ac45ea21d3" parent="b95363506fd1dd7990a025baab373fa0" type="folder">12-16</container></did><accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="cb78df07fbaff326eeed8544708b063f" label="mixed materials [A0000000075920]" type="box">78</container><container id="3e3cba11298f737a44db696ae776183c" parent="cb78df07fbaff326eeed8544708b063f" type="folder">17-19</container></did><accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8104e8da1a3aff8455ce0008f38fee5a" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="1e5a884981a244948e313be02d4c8b34" label="mixed materials [A0000000075921]" type="box">79</container><container id="a01d769975263b5f574d73bf1d116b37" parent="1e5a884981a244948e313be02d4c8b34" type="folder">1-2</container></did><accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="02479e2c1173076c05f34aa17007ba49" level="file"><did><unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle><unitdate type="inclusive">2002 March 4</unitdate><container altrender="Record Storage Box (Paige)" id="e39c63bd13f94e5a14d8f675263c7627" label="mixed materials [A0000000075921]" type="box">79</container><container id="988b1c9988c5a5ccf672bb27226da333" parent="e39c63bd13f94e5a14d8f675263c7627" type="folder">3-6</container></did><accessrestrict id="c95f7f827b4be73752d104280c14ae0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d1098818233489d81f3ee9a35c491fda" level="file"><did><unittitle>TML, 44-71 - Tests for drug abuse</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="9c1a78bf5744e1f67449d172b4a45e42" label="mixed materials [A0000000075921]" type="box">79</container><container id="1cd4009e958eee0eaa4d5edb6e41dee3" parent="9c1a78bf5744e1f67449d172b4a45e42" type="folder">7-10</container></did><accessrestrict id="6b5deed194656d7a78e4584eaf23da1c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a2d97df9926c22348169dc85fc2da466" level="file"><did><unittitle>TML, 44-82 - Accutane</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="0ff826588e400b5a56ea61c94ae370bd" label="mixed materials [A0000000075921]" type="box">79</container><container id="06c4908500813a210013099a774d7686" parent="0ff826588e400b5a56ea61c94ae370bd" type="folder">11-12</container></did><accessrestrict id="811a73112a0f3db0c61460c6f50c3a83"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="77f6dda8f57e4d024c751d9255cb8084" level="file"><did><unittitle>TML, 44-50 - Spinal Manipulation</unittitle><unitdate type="inclusive">2002 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="fed4248b8472a0b459e6f63ddc57a300" label="mixed materials [A0000000075921]" type="box">79</container><container id="3b8c9daf474a42e61ec1917e68fa3771" parent="fed4248b8472a0b459e6f63ddc57a300" type="folder">13-15</container></did><accessrestrict id="c6a5678b6a97ed4390bd98a720535a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="f8b88950ad1bd11f348ab602ba37f9f4" label="mixed materials [A0000000075921]" type="box">79</container><container id="931cb5a730943d58ba03b99ae1f022c0" parent="f8b88950ad1bd11f348ab602ba37f9f4" type="folder">16-17</container></did><accessrestrict id="1fde5116b8525bf37872775d4c998b9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2af7784d4333e1386ceb5387b0141573" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="23808f7532c3f60e23121745f8a5aab3" label="mixed materials [A0000000075922]" type="box">80</container><container id="935750481671ef82d1b42476040fbe0b" parent="23808f7532c3f60e23121745f8a5aab3" type="folder">1-2</container></did><accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45b86f5c46903225f479639e02061c91" level="file"><did><unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="d730b6ab38f4ae1dcaab0d6f939afd22" label="mixed materials [A0000000075922]" type="box">80</container><container id="4dfff4f55e87579923c0801b05ce1363" parent="d730b6ab38f4ae1dcaab0d6f939afd22" type="folder">3-7</container></did><accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file"><did><unittitle>TML, 44-78 - Hormone replacement therapy</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="ea66286d2024e22e8f48d54321bb3bfa" label="mixed materials [A0000000075922]" type="box">80</container><container id="6a1a1fb96022842e7f768a9aa954acb8" parent="ea66286d2024e22e8f48d54321bb3bfa" type="folder">8-9</container></did><accessrestrict id="25fbac45d92806e8263c700a8600b817"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="79ecc959704f5a99033f6383c71d5e2b" level="file"><did><unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="1161dd7232ec91fed1c5fce24feef107" label="mixed materials [A0000000075922]" type="box">80</container><container id="9aa966012fe4ffa6e414a7606a98720d" parent="1161dd7232ec91fed1c5fce24feef107" type="folder">10-12</container></did><accessrestrict id="c218a513a6535a5ceb72241f53f1083c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file"><did><unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="75e1c056f8fc7ec37e6e12223f88c39a" label="mixed materials [A0000000075922]" type="box">80</container><container id="81a8e1efd37356519c028757534ff1e1" parent="75e1c056f8fc7ec37e6e12223f88c39a" type="folder">13-14</container></did><accessrestrict id="daa9fc43588271721e9668e6387b1ecc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9cf28c7502d38a3253794dc0aff81d12" level="file"><did><unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="8fd0d8ea6de3480c0fe79766eb2826d9" label="mixed materials [A0000000075922]" type="box">80</container><container id="058bfde4200ef437883abd6108f4b90a" parent="8fd0d8ea6de3480c0fe79766eb2826d9" type="folder">15-16</container></did><accessrestrict id="9343665bbaab14cdc391de9fbda39aab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="037a4523e063f09b403c4b86b056b0b9" level="file"><did><unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="d24fca8b5424ff0195d604e584017303" label="mixed materials [A0000000075922]" type="box">80</container><container id="7d72d12e1050b64ac8996b027e56968b" parent="d24fca8b5424ff0195d604e584017303" type="folder">17-19</container></did><accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file"><did><unittitle>TML, 44-96 - Rasburicase</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="537e56b21d6e7d361708f3bc779826e4" label="mixed materials [A0000000075923]" type="box">81</container><container id="d9537ac90fac8cfe27b82a5b93682da4" parent="537e56b21d6e7d361708f3bc779826e4" type="folder">1-2</container></did><accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file"><did><unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="c73a93c08e337af6bfb1b0c8eb248a89" label="mixed materials [A0000000075923]" type="box">81</container><container id="346bb63d9f29ac9eac0d6b397cfbe816" parent="c73a93c08e337af6bfb1b0c8eb248a89" type="folder">3-6</container></did><accessrestrict id="de5073ebce08ff223cdc3bac4b44096d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="cd35b74adb66fbee3caa77d502914319" level="file"><did><unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="6b347b3924d36d6e816d496dc10a7815" label="mixed materials [A0000000075923]" type="box">81</container><container id="2b70aa6089db3b728fa7b205b2d36d15" parent="6b347b3924d36d6e816d496dc10a7815" type="folder">7-9</container></did><accessrestrict id="44a756d7626a6484624c170f3c9fe601"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file"><did><unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="233242a44ce07e11db29f362f32c57f7" label="mixed materials [A0000000075923]" type="box">81</container><container id="16afde2ce43bebdea3fe9fd9d5d110f4" parent="233242a44ce07e11db29f362f32c57f7" type="folder">10-13</container></did><accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0cdc8024ee854934a00a2e6cc658127c" level="file"><did><unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="797e157fb32de4861c8f79c23d4a6cf1" label="mixed materials [A0000000075923]" type="box">81</container><container id="80264fc734464e2a6933056dbdb137eb" parent="797e157fb32de4861c8f79c23d4a6cf1" type="folder">14-15</container></did><accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6373e1ea574b03380381b604f8f317ea" level="file"><did><unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="044c2947ee0143de1b1c4a8eefc6ade8" label="mixed materials [A0000000075923]" type="box">81</container><container id="2672727b8c89c902a757ada28795d365" parent="044c2947ee0143de1b1c4a8eefc6ade8" type="folder">16-17</container></did><accessrestrict id="c8982cc8907e5273994dc146b1a74168"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file"><did><unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="742c7efb9d7e84063eba7051f4824d55" label="mixed materials [A0000000075924]" type="box">82</container><container id="76dde2c9447ea6681af0d06e18cece2e" parent="742c7efb9d7e84063eba7051f4824d55" type="folder">1-3</container></did><accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file"><did><unittitle>TML, 44-27 - Desloratadine</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="ef16237be6b0a53a921a7fac2ef36c3c" label="mixed materials [A0000000075924]" type="box">82</container><container id="2b8b242968138758829c733900ee1db2" parent="ef16237be6b0a53a921a7fac2ef36c3c" type="folder">4-6</container></did><accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b7991b9a56fe105d30e6587c04553698" level="file"><did><unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="dcd06ac3bd8877fa618c226c39919c2c" label="mixed materials [A0000000075924]" type="box">82</container><container id="f5b09c918b1818976bdfc8458c94bc83" parent="dcd06ac3bd8877fa618c226c39919c2c" type="folder">7-8</container></did><accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="e886d7140f04a51e798f5685595d8a64" level="file"><did><unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="277538a416c099bb50e2679dcaa3115a" label="mixed materials [A0000000075924]" type="box">82</container><container id="484e7b39c5072ca9c6849fc75824ff96" parent="277538a416c099bb50e2679dcaa3115a" type="folder">9-12</container></did><accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="d8442f6e4f2fc2bf7eac53096b3b16c8" label="mixed materials [A0000000075924]" type="box">82</container><container id="71f5468400b4a909621db8ecdfd61d5b" parent="d8442f6e4f2fc2bf7eac53096b3b16c8" type="folder">13-16</container></did><accessrestrict id="a1761f494a6aadd735240b5f6234da0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file"><did><unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="3901280e83352f3df7f16e5317a72dc6" label="mixed materials [A0000000075924]" type="box">82</container><container id="502e0296e9d3450a15b0382ac6288969" parent="3901280e83352f3df7f16e5317a72dc6" type="folder">17-19</container></did><accessrestrict id="a69e5af2889f08c295264781d0dc1080"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f777550cceb72905734014265970ba2d" level="file"><did><unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="26a67d92d821d3fa3a4afe3eb155a579" label="mixed materials [A0000000075925]" type="box">83</container><container id="0d4a3368f1a5b1d2bfdb06603a42c0fd" parent="26a67d92d821d3fa3a4afe3eb155a579" type="folder">1-3</container></did><accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="755a5cb278c5674c278d62217583d0dc" level="file"><did><unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="f92d4dea935f8f2ca1ca3b72e2e0244b" label="mixed materials [A0000000075925]" type="box">83</container><container id="7e2ec451db3be183d7e6b3de02dfa109" parent="f92d4dea935f8f2ca1ca3b72e2e0244b" type="folder">4-6</container></did><accessrestrict id="a72cbce0a6c64d80126a119167b5dc50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file"><did><unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="bb6dbf8f9b5c3d5a9c919080b3cab7ad" label="mixed materials [A0000000075925]" type="box">83</container><container id="c6882478ec8e96d50b8f05331945bc90" parent="bb6dbf8f9b5c3d5a9c919080b3cab7ad" type="folder">7</container></did><accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="32827b05df08c432fb2cbb3d952c316a" level="file"><did><unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle><unitdate type="inclusive">2003 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="ee8f84e1be082240abf091a664a99842" label="mixed materials [A0000000075925]" type="box">83</container><container id="3168e68b10ec9ee9b6deeb884746e4aa" parent="ee8f84e1be082240abf091a664a99842" type="folder">8-10</container></did><accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2dcb5260bf184933786c79514811276a" level="file"><did><unittitle>TML, 45-5 - Augmentin XR</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="82992f24e9128423037958095fcab018" label="mixed materials [A0000000075925]" type="box">83</container><container id="be362c03dcbef783a2e03a7d8a689673" parent="82992f24e9128423037958095fcab018" type="folder">11-13</container></did><accessrestrict id="352c7f8bef5faa523d50be8830568d03"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="6719542efa0dd7e6ff2199fb0fc45784" level="file"><did><unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="cb4f53e1ebd7ae67bc5ef394e70db0ca" label="mixed materials [A0000000075925]" type="box">83</container><container id="4bb4335bab39695e131fde63a0ad0e54" parent="cb4f53e1ebd7ae67bc5ef394e70db0ca" type="folder">14-15</container></did><accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="face99254c656f96b64bf580e5f85bcf" level="file"><did><unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="065e0b67a836ef839bc23f5de34c6c5b" label="mixed materials [A0000000075925]" type="box">83</container><container id="34fa48d4b38c65fb246918a28aded576" parent="065e0b67a836ef839bc23f5de34c6c5b" type="folder">16-18</container></did><accessrestrict id="5b737b9395121e3828a6f6fa407666da"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9ec231ed3611900061caae3128c95513" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="80c45829eedd37a5b4a0efc23289ad40" label="mixed materials [A0000000075925]" type="box">83</container><container id="b0fb7106a02e6003a74966357257a734" parent="80c45829eedd37a5b4a0efc23289ad40" type="folder">19</container></did><accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c6404194bb02ecf2496bacd146a0cc60" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="eecdcd0c5bd2db76993b344774c69ca4" label="mixed materials [A0000000075926]" type="box">84</container><container id="6e17d01231118a44dea59fe937318f61" parent="eecdcd0c5bd2db76993b344774c69ca4" type="folder">1-3</container></did><accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2ddbc741772355d7dce54b4b63ef6749" level="file"><did><unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="0a8627d146ada902c339f49e36e7de45" label="mixed materials [A0000000075926]" type="box">84</container><container id="ee46a42556bf11c8706a03ec53c40239" parent="0a8627d146ada902c339f49e36e7de45" type="folder">4-5</container></did><accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0f45b082b3a08c7cce74229a00644b02" level="file"><did><unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="f2414030cdff6b504f020e677f954160" label="mixed materials [A0000000075926]" type="box">84</container><container id="e3f77530f5795e65a780e760fbba24a0" parent="f2414030cdff6b504f020e677f954160" type="folder">6-8</container></did><accessrestrict id="f517a35e209156fcce5cddbc43b68b14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="94948e6e42424f89ec840de91511a768" level="file"><did><unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="480a388ab454713a8bce5390d138d130" label="mixed materials [A0000000075926]" type="box">84</container><container id="6785153f9015970e3c3a3e1bc8bd1180" parent="480a388ab454713a8bce5390d138d130" type="folder">9-11</container></did><accessrestrict id="a3551a188d335a0b903727fcd2a48fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="48f4b3c522fa705a3ae202735e45ac3b" level="file"><did><unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="6fd405634dd572adfd8263f7cab46aeb" label="mixed materials [A0000000075926]" type="box">84</container><container id="5c59e85ccace70a37a06c2ccd3f7ae79" parent="6fd405634dd572adfd8263f7cab46aeb" type="folder">12-14</container></did><accessrestrict id="3229644ce53e8795f97a65d5d61f18e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="780d425bdbd53ceafd83133223d279a7" level="file"><did><unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="497c8bc14757201a6895234a5caa6f30" label="mixed materials [A0000000075926]" type="box">84</container><container id="9d3f1c69763102407fc4ee523f1c9cba" parent="497c8bc14757201a6895234a5caa6f30" type="folder">15-18</container></did><accessrestrict id="12994eea68e1f09108df54e255ae8cff"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e27a4c127b0269848618ade1805962f" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="544f47d3252908b120512032b3bcd73d" label="mixed materials [A0000000075926]" type="box">84</container><container id="2336c5b9dc1d91d6ede7073339b40e3e" parent="544f47d3252908b120512032b3bcd73d" type="folder">19</container></did><accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="732aaf61ce82ace45c4354ea0038b752" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="c2fe53a4b658b2c39e9beb90ff5fbdb2" label="mixed materials [A0000000075927]" type="box">85</container><container id="628b08c6ce42e6c3b06dd27968de3711" parent="c2fe53a4b658b2c39e9beb90ff5fbdb2" type="folder">1-2</container></did><accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c4617feb74a721aa21a7112babed977f" level="file"><did><unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="2926be340a08e80ee483ea823917a10c" label="mixed materials [A0000000075927]" type="box">85</container><container id="1a5931a5e583e7f607413d781f70ed38" parent="2926be340a08e80ee483ea823917a10c" type="folder">3-4</container></did><accessrestrict id="09ded828b852ae6c86297bc23c88adc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file"><did><unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="4fbe0573853d7a8b14ece8d2785781f4" label="mixed materials [A0000000075927]" type="box">85</container><container id="91b6bb5b7edbee05d3fabd808e3f6b99" parent="4fbe0573853d7a8b14ece8d2785781f4" type="folder">5-8</container></did><accessrestrict id="9d74192e21e6502b4dff990dec4cbb50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file"><did><unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="5ae764fb0f40a886e14e3622ae683ba6" label="mixed materials [A0000000075927]" type="box">85</container><container id="ece442f5f281305bbb4857ac88e620cb" parent="5ae764fb0f40a886e14e3622ae683ba6" type="folder">9-12</container></did><accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fdd62d893c6f422fd7c183e65efa7835" level="file"><did><unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="fafb7818f9b1aaf4aedb0105d282e9e2" label="mixed materials [A0000000075927]" type="box">85</container><container id="306e2ddfe6997e3798c9419d886a6fe0" parent="fafb7818f9b1aaf4aedb0105d282e9e2" type="folder">13-15</container></did><accessrestrict id="36610a7149adbc1f92cfdc7751128db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="35402d0a4356ba61f6f491a96f89217a" level="file"><did><unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle><unitdate type="inclusive">2013 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="470a6efcf1690adbff490443e3618c46" label="mixed materials [A0000000075927]" type="box">85</container><container id="ab6c03397c6f6811f7d7e7e8946542e3" parent="470a6efcf1690adbff490443e3618c46" type="folder">16-20</container></did><accessrestrict id="136a1315a2303fa111e5d01cb0517e7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file"><did><unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="657e595d495c369158447506622fa043" label="mixed materials [A0000000075928]" type="box">86</container><container id="37bf669616b5b40fc59cccced71ddc87" parent="657e595d495c369158447506622fa043" type="folder">1-3</container></did><accessrestrict id="aab1089a7327f8fc78a2fc319190599a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file"><did><unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="6470735a3aa84f90310de14fec2b1a5a" label="mixed materials [A0000000075928]" type="box">86</container><container id="dd2e8bae2cfbef71a9db43fe80c97e9c" parent="6470735a3aa84f90310de14fec2b1a5a" type="folder">4-6</container></did><accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="19fc064c09e3806caaddbb51b70e4090" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="cf24680f547221afa8e1c563a3940575" label="mixed materials [A0000000075928]" type="box">86</container><container id="3434e8de29330e03f136938263ab6582" parent="cf24680f547221afa8e1c563a3940575" type="folder">5A-6A</container></did><accessrestrict id="60b6213d43e89633056c4a067f8c54e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="b78f3a9a651c99a62bdd4ea3a6fa2fba" label="mixed materials [A0000000075928]" type="box">86</container><container id="87b1c995b31a0d5d60d204d75fb2754b" parent="b78f3a9a651c99a62bdd4ea3a6fa2fba" type="folder">7-9</container></did><accessrestrict id="7a45da012d9d8375ab9c62d057d20b13"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d1e93fdc68ebf64e073b0d53c908f073" level="file"><did><unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="e4b79d7959d7c87ed1ce7355df3f3700" label="mixed materials [A0000000075928]" type="box">86</container><container id="6939e21ece7df52279a009f8219240d7" parent="e4b79d7959d7c87ed1ce7355df3f3700" type="folder">10-11</container></did><accessrestrict id="a187e298156d35ecb24bf62acbaa2162"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file"><did><unittitle>TML, 45-95 - Tattoo Removal</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="4adf469f30a4d438d31c3cb2b9f71af6" label="mixed materials [A0000000075928]" type="box">86</container><container id="f8d0ed975ce3c3bc1c6969ce790504e3" parent="4adf469f30a4d438d31c3cb2b9f71af6" type="folder">12-13</container></did><accessrestrict id="1cb8774dfbec0195c1be0234b77205c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a857cbd537b23d5351b0c89499d70d8e" level="file"><did><unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="b8837dcbc2a50507c6a422cdf616d019" label="mixed materials [A0000000075928]" type="box">86</container><container id="024e0d496e10b1230dc4cad8a8456f9c" parent="b8837dcbc2a50507c6a422cdf616d019" type="folder">14</container></did><accessrestrict id="4b2308536bb701384ee28edb8995985a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1ed11b7c73752bdb0689383a30c1baf5" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="7e4047829ed2b8cc2bcbb0a3befed34c" label="mixed materials [A0000000075928]" type="box">86</container><container id="b26f9b1a2739ce8a36b4403c19216998" parent="7e4047829ed2b8cc2bcbb0a3befed34c" type="folder">15-16</container></did><accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c48f05a528d95bdfee4855de30cb54e2" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="14881530e920ef86597dda572720279e" label="mixed materials [A0000000075929]" type="box">87</container><container id="55609ce7c3f0283b453add7e593e4666" parent="14881530e920ef86597dda572720279e" type="folder">1</container></did><accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file"><did><unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="84f5c998489eb9754f1bf8f000613817" label="mixed materials [A0000000075929]" type="box">87</container><container id="a579ef7b3b96c1bbf6afdf013e384246" parent="84f5c998489eb9754f1bf8f000613817" type="folder">2-4</container></did><accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7d40fbe976113721e79b64dd1d00e27d" level="file"><did><unittitle>TML, 45-3 - OTC Loratadine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="565333a20e1870ab5c7d4ab72d3d2fb3" label="mixed materials [A0000000075929]" type="box">87</container><container id="0d6bdf6c0d2025bc7eaf8358d810a72e" parent="565333a20e1870ab5c7d4ab72d3d2fb3" type="folder">5</container></did><accessrestrict id="68d83db5324a44659c1dd3f51c2e2864"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1823eedc9d0074c8a4265ac61efdfda5" level="file"><did><unittitle>TML, 45-41 - Insect repellents</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="98206d9926e82e86a55445b4c8e40564" label="mixed materials [A0000000075929]" type="box">87</container><container id="9fb87833d912e5897485884efe6566af" parent="98206d9926e82e86a55445b4c8e40564" type="folder">6-8</container></did><accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2f3bcea3a484b983f63233e648e58d71" level="file"><did><unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="d2b5195ae200d6bc34235ab78a87e320" label="mixed materials [A0000000075929]" type="box">87</container><container id="7a84dd1593cb789e2fddbc2a02cfa050" parent="d2b5195ae200d6bc34235ab78a87e320" type="folder">9-12</container></did><accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file"><did><unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="f656e16ddec3dc440123e71c95b4b596" label="mixed materials [A0000000075929]" type="box">87</container><container id="6f2a87c22d8d5097405e171726bec4b5" parent="f656e16ddec3dc440123e71c95b4b596" type="folder">13-15</container></did><accessrestrict id="68c074ca5c7b85d99e37109be8f03f26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file"><did><unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="fe921b983c02ab78cf16e819a6d76fe8" label="mixed materials [A0000000075929]" type="box">87</container><container id="89f8b4dbc9b6ade439c826b6fd362089" parent="fe921b983c02ab78cf16e819a6d76fe8" type="folder">16-18</container></did><accessrestrict id="349dea74056b705fe12a6e58b6be4a61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="11bdec471c430a38763f1ea9a86eab38" level="file"><did><unittitle>TML, 45-58 - Treatment of heat injury</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="00664d6e1f5ea6bcce1e16f147321409" label="mixed materials [A0000000075930]" type="box">88</container><container id="77b9695b47517139e3daedc6c0e9ac98" parent="00664d6e1f5ea6bcce1e16f147321409" type="folder">1-2</container></did><accessrestrict id="b32e89185eafe8ec72db09448de5ce28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="806d8942533d66de734e65e88b3304ee" level="file"><did><unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="b0c071153cccd2c49d4cc2125c26ddad" label="mixed materials [A0000000075930]" type="box">88</container><container id="6a199d06060f8467d62f7f87fa7e12c4" parent="b0c071153cccd2c49d4cc2125c26ddad" type="folder">3-6</container></did><accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="04dee614a81cacb32c43ef5b0a88af03" level="file"><did><unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="da09e5dd00888713ae8dcda11e86358f" label="mixed materials [A0000000075930]" type="box">88</container><container id="2f5ddc4c8f3a40890387c8220526cbc2" parent="da09e5dd00888713ae8dcda11e86358f" type="folder">7-8</container></did><accessrestrict id="b53a56596e6cd54c520d93ec764edd68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9233509af152396c7a0be4f4a4690cec" level="file"><did><unittitle>TML, 45-46 - Drug Interactions</unittitle><unitdate type="inclusive">2003 June 9</unitdate><container altrender="Record Storage Box (Paige)" id="bd4eea932a7d73517179f5538f519e31" label="mixed materials [A0000000075930]" type="box">88</container><container id="04a51db5f677188d3d1cfea5ad0e8ae6" parent="bd4eea932a7d73517179f5538f519e31" type="folder">9-12</container></did><accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="95a2b9eb73be12648888070a03ead474" level="file"><did><unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="54b5c6b03b213adb67476272a62df25e" label="mixed materials [A0000000075930]" type="box">88</container><container id="b3a2fc0802512e50da048be8a3ef65ad" parent="54b5c6b03b213adb67476272a62df25e" type="folder">13-17</container></did><accessrestrict id="150bc9e4636bdbb6ef444d31120758f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dad27947e40b662edd3cc5a90a0be625" level="file"><did><unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="a330b276a7148d5870fba7f2574b480d" label="mixed materials [A0000000075930]" type="box">88</container><container id="69517ad543f42140635fe3b95d27f43c" parent="a330b276a7148d5870fba7f2574b480d" type="folder">18-19</container></did><accessrestrict id="7bacb749d5cace7b77c6d20686088469"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e617e6eea5f9996628c705dd200e1ffa" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="f6ebf3770457293c6861c5bf27af1d7f" label="mixed materials [A0000000075930]" type="box">88</container><container id="684aa475a4a172e24bf36bcc3e33380d" parent="f6ebf3770457293c6861c5bf27af1d7f" type="folder">20</container></did><accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="dc478938d4711635e484277d6920a9dd" label="mixed materials [A0000000075931]" type="box">89</container><container id="959bcb2f7dce6e3eb725c74f821b59ae" parent="dc478938d4711635e484277d6920a9dd" type="folder">1-4</container></did><accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="edaf8bc319227fe95dce9ce1973f3621" level="file"><did><unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="74652fb51e320479c49d1f51b1e5449e" label="mixed materials [A0000000075931]" type="box">89</container><container id="6173d7a432165d197ee14b850477e851" parent="74652fb51e320479c49d1f51b1e5449e" type="folder">5-9</container></did><accessrestrict id="a9e5f083314a82f3692a841eac51a5ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f8dc69e4bf109c9986cc722051633070" level="file"><did><unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="9843e14af9bef07b5eb5f080786117f1" label="mixed materials [A0000000075931]" type="box">89</container><container id="8b4a3221cb5131d84894478e3c1083f4" parent="9843e14af9bef07b5eb5f080786117f1" type="folder">10-11</container></did><accessrestrict id="e59f218612780c21cd1831f3c38ec08e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="cc9f06be346fedef1f6102477bee9cb2" level="file"><did><unittitle>TML, 45-78 - Influenza Prevention</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="58f8f8ea9850af1658b10e1ea9e19e1e" label="mixed materials [A0000000075931]" type="box">89</container><container id="9bbfeb7bb5a7685c837dfcd31e1213aa" parent="58f8f8ea9850af1658b10e1ea9e19e1e" type="folder">12-14</container></did><accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="39d9d76dedec7d6057d3eb65d8744ded" level="file"><did><unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="7fc6170824a7d5e57e76dca32c2f138b" label="mixed materials [A0000000075931]" type="box">89</container><container id="836f5107e055b5c10c20c201096c0e8e" parent="7fc6170824a7d5e57e76dca32c2f138b" type="folder">15-16</container></did><accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file"><did><unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="161ad7714490987c113775be1a7b75f8" label="mixed materials [A0000000075931]" type="box">89</container><container id="3c1b30dd7cf7f3e0ef64c9ce10113e93" parent="161ad7714490987c113775be1a7b75f8" type="folder">17-20</container></did><accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e809ce901af88811ad1fd0cb5bc5882c" level="file"><did><unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="47e4f4dab955ac2467cf76df63f9bb3b" label="mixed materials [A0000000075932]" type="box">90</container><container id="5308c4124fd0a7d414a407b14331c5e9" parent="47e4f4dab955ac2467cf76df63f9bb3b" type="folder">1-4</container></did><accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="acd944256fa6e191f50b1c636b7b7bf4" level="file"><did><unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="45785ff4c923e4307361984a2092dc30" label="mixed materials [A0000000075932]" type="box">90</container><container id="5b2cd46ef684efbc9c9d8e47ed238938" parent="45785ff4c923e4307361984a2092dc30" type="folder">5-8</container></did><accessrestrict id="56655a641344d4055a005097ec27c5cb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file"><did><unittitle>TML, 45-1 - Smallpox vaccine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="222164a5bfa1d3dfd49caa3bc73aeb69" label="mixed materials [A0000000075932]" type="box">90</container><container id="7e134ca621c972bb5932ec82ca1b9822" parent="222164a5bfa1d3dfd49caa3bc73aeb69" type="folder">9-12</container></did><accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d9642438ec124cd82d8e135b0198ede7" level="file"><did><unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="571514bdf32e8202690209d9c558d1ac" label="mixed materials [A0000000075932]" type="box">90</container><container id="338638f7d41a81b82c86e445e83d8399" parent="571514bdf32e8202690209d9c558d1ac" type="folder">13-16</container></did><accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="58a18ac79fa4aa68dac81e6b4374e66c" label="mixed materials [A0000000075932]" type="box">90</container><container id="ef06e594f86e8474264899e823b4a6fb" parent="58a18ac79fa4aa68dac81e6b4374e66c" type="folder">17-19</container></did><accessrestrict id="91472bcb765db5980f76960bca69f7bb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="e75d102b6431defbdb35abae4c40d13d" label="mixed materials [A0000000075933]" type="box">91</container><container id="681371399e7268e5893ef2be7ccc135f" parent="e75d102b6431defbdb35abae4c40d13d" type="folder">1</container></did><accessrestrict id="ad37cdcd99a2044624e749e1cd39779d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f9a9c4fc1896553a888be142b1758016" level="file"><did><unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle><unitdate type="inclusive">2003 August 4</unitdate><container altrender="Record Storage Box (Paige)" id="fba81309ba5300cf57ed096b21d5f7ce" label="mixed materials [A0000000075933]" type="box">91</container><container id="668f22ba519ccf14ceca46a9addc229a" parent="fba81309ba5300cf57ed096b21d5f7ce" type="folder">2-3</container></did><accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="839fb8691411f959bd1aac5c4ebf7d26" level="file"><did><unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="6f25b67b50d0f09071ab8c206c3df7d7" label="mixed materials [A0000000075933]" type="box">91</container><container id="5993f12e928b7e1661ec2a0de6d1e01d" parent="6f25b67b50d0f09071ab8c206c3df7d7" type="folder">4-5</container></did><accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="55365ce4b3ea2d58db64e9416965cb4e" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="dd1a0fa9fc951ec5d50759305d97b1f1" label="mixed materials [A0000000075933]" type="box">91</container><container id="9a15ceade9a0987dbc23b027e1b80988" parent="dd1a0fa9fc951ec5d50759305d97b1f1" type="folder">6-17</container></did><accessrestrict id="0ed20f41fac45d1a638a3740752cb703"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="668d7e7e07b5750eb2c823e11c095964" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="eb7ca9bc0483f88691261b580bee4bc6" label="mixed materials [A0000000075934]" type="box">92</container><container id="229ca0d59d8574f9f96aa671b42face4" parent="eb7ca9bc0483f88691261b580bee4bc6" type="folder">1-4</container></did><accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file"><did><unittitle>TML - Weight Loss - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 December</unitdate><container altrender="Record Storage Box (Paige)" id="a5e026bb6b81affe5d68dbdbfd2afc81" label="mixed materials [A0000000075934]" type="box">92</container><container id="2dd1f92fc8b44192a90951e30df14bb7" parent="a5e026bb6b81affe5d68dbdbfd2afc81" type="folder">5-13</container></did><accessrestrict id="6dd9eece4a3c89e40bca2442781a600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ee60c4bf66a25475983425024da14c39" level="file"><did><unittitle>TML - Heart Failure - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 April</unitdate><container altrender="Record Storage Box (Paige)" id="354e27e10a66b536a1e322e0c8884725" label="mixed materials [A0000000075934]" type="box">92</container><container id="6edd2b39b8c514f6f9ae7c4fd21babbc" parent="354e27e10a66b536a1e322e0c8884725" type="folder">14-18</container></did><accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file"><did><unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="cb3b329a7ef4ad485151e3d66a5cad02" label="mixed materials [A0000000075935]" type="box">93</container><container id="0a0d78ab588b20bfc61645b234d8853e" parent="cb3b329a7ef4ad485151e3d66a5cad02" type="folder">1-7</container></did><accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c0978c508033828e366f1d55950a308e" level="file"><did><unittitle>TML - Drugs for Psychiatric Disorders</unittitle><unitdate type="inclusive">2003 July</unitdate><container altrender="Record Storage Box (Paige)" id="8dd8c70d8f74b08f66ae20f0a5d8a29a" label="mixed materials [A0000000075935]" type="box">93</container><container id="f4dd95062d27a83911d4ad426f51f658" parent="8dd8c70d8f74b08f66ae20f0a5d8a29a" type="folder">8-18</container></did><accessrestrict id="03781a219ff982acf63e0290b3b87f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a9906d72f32382fa1bb39c1ccd388091" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="f333dc09604b043b17d9e84726ac8359" label="mixed materials [A0000000075935]" type="box">93</container><container id="2930bbbfa7d3236e316ebf154358de09" parent="f333dc09604b043b17d9e84726ac8359" type="folder">19</container></did><accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="5fe43740e009499d1e3f53824c732e44" label="mixed materials [A0000000075936]" type="box">94</container><container id="7befc2da7a2a6027e37aaa0de9952820" parent="5fe43740e009499d1e3f53824c732e44" type="folder">1-4</container></did><accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="380c664090534851fbc806e0558fde2f" level="file"><did><unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 October</unitdate><container altrender="Record Storage Box (Paige)" id="629a574511372e080f79cb47fab56fc9" label="mixed materials [A0000000075936]" type="box">94</container><container id="b5ceaae278be626a1f5e71e31d447aa9" parent="629a574511372e080f79cb47fab56fc9" type="folder">5-13</container></did><accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dfe820ca0d9eb165533f652cbc41ee32" level="file"><did><unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 February</unitdate><container altrender="Record Storage Box (Paige)" id="3c1136039e999a8b695b929033291901" label="mixed materials [A0000000075936]" type="box">94</container><container id="53f97b83cd6cfcfcc7ced893edeac332" parent="3c1136039e999a8b695b929033291901" type="folder">14-17</container></did><accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3ce9ce08c457fba44042e2deea5066f7" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="883f71c22543c9390009028f222ddf58" label="mixed materials [A0000000075936]" type="box">94</container><container id="db6997d359dfa54af094e1525c072733" parent="883f71c22543c9390009028f222ddf58" type="folder">18</container></did><accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d475b54c5095880adce7b8263966fe2d" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="85f8941c1f2b4fc612459ccf34d06c42" label="mixed materials [A0000000075937]" type="box">95</container><container id="0b6d1ce7bcf67b80ea76cee8d49111ba" parent="85f8941c1f2b4fc612459ccf34d06c42" type="folder">1-8</container></did><accessrestrict id="d727ecc0d3636f553591f418559bc721"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file"><did><unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 May</unitdate><container altrender="Record Storage Box (Paige)" id="78c78fd0acbd4bdeefd7070211db0237" label="mixed materials [A0000000075937]" type="box">95</container><container id="696d568a5b255b0f35f9a87fd8ee0e06" parent="78c78fd0acbd4bdeefd7070211db0237" type="folder">9-14</container></did><accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file"><did><unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 August</unitdate><container altrender="Record Storage Box (Paige)" id="fd31bca168b96124b48df2e4bb75aa2c" label="mixed materials [A0000000075937]" type="box">95</container><container id="88df61ec8b2458b00c655b9ba03bd1ab" parent="fd31bca168b96124b48df2e4bb75aa2c" type="folder">15-18</container></did><accessrestrict id="334e64660b4fc298f4d1c26e9a76a343"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="62de8a2c6f00d747daccbd6d67a2f3b1" label="mixed materials [A0000000075937]" type="box">95</container><container id="1253b976a93a4b357c48d9ae5d69f235" parent="62de8a2c6f00d747daccbd6d67a2f3b1" type="folder">19</container></did><accessrestrict id="7cdf942787e0cbed8326189a2020f299"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ddf6b73987ce0637989f66584610c6ea" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="9b52d2b0a7fbcc6b3a00d6ca21ffb508" label="mixed materials [A0000000075938]" type="box">96</container><container id="94c7b077c7a2145560c56b5b54c237b4" parent="9b52d2b0a7fbcc6b3a00d6ca21ffb508" type="folder">1</container></did><accessrestrict id="2b960cecbba771988110df8a9cd33742"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file"><did><unittitle>TML, 45-93 - Which SSRI</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="c6e98b8c87a52184e16ced10ad14e12a" label="mixed materials [A0000000075938]" type="box">96</container><container id="926080254706165fbd08c39dce5252f0" parent="c6e98b8c87a52184e16ced10ad14e12a" type="folder">2-5</container></did><accessrestrict id="72e10bfbf01df945876de61f8480a08b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1e5a72f232d4e116685aff32e9ed9f87" level="file"><did><unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 November</unitdate><container altrender="Record Storage Box (Paige)" id="b6f0bcecee980a7f78980f81fd1c639a" label="mixed materials [A0000000075938]" type="box">96</container><container id="633cc002e74f976745da34b68ae57f55" parent="b6f0bcecee980a7f78980f81fd1c639a" type="folder">6-9</container></did><accessrestrict id="ce922dcf8bde445758a34a54106e0ec6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7621ca9e85272fb03e367f6102650bf9" level="file"><did><unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 September</unitdate><container altrender="Record Storage Box (Paige)" id="8a483d2ef85b8c4321600bec2611d7f1" label="mixed materials [A0000000075938]" type="box">96</container><container id="5fc08d5cd6fe979e6e7916432395fc4c" parent="8a483d2ef85b8c4321600bec2611d7f1" type="folder">10-17</container></did><accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="68e729c691bb49c8be35f332fbb1e32b" level="file"><did><unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="50ec0646171396bd2c5b294ad908eeac" label="mixed materials [A0000000075939]" type="box">97</container><container id="6d550e4bb558b3dc0ce6a02ea05c3567" parent="50ec0646171396bd2c5b294ad908eeac" type="folder">1-10</container></did><accessrestrict id="084a4278da0f4581918db07f8eb825b4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="07f19737b5f6d3009e9e85a8b0528533" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="26d73a175639088389833d480ac7dd79" label="mixed materials [A0000000075939]" type="box">97</container><container id="83b78706a65db0fa338ad98b2e6cbafb" parent="26d73a175639088389833d480ac7dd79" type="folder">11-18</container></did><accessrestrict id="8f26a61c71898392ee05f246c39c61b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="c099bb967206188345dcdbf9c2975e6d" level="file"><did><unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="50b4fa8f4da7343ef412998a022fd8b3" label="mixed materials [A0000000075940]" type="box">98</container><container id="ca8d928f34189d68291f26280b16ae46" parent="50b4fa8f4da7343ef412998a022fd8b3" type="folder">1-9</container></did><accessrestrict id="e0b7814bc924716eb27275e9522cf9ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="237497500e700200226282634e319af9" level="file"><did><unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="ad5f88da7555c3a122d344de494b1de9" label="mixed materials [A0000000075940]" type="box">98</container><container id="2df52f274a7ce71a7394c5df9362f192" parent="ad5f88da7555c3a122d344de494b1de9" type="folder">10-15</container></did><accessrestrict id="00d75b64dab2398628516bc88ce53406"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="423b8c383be805c9a485a8fecfe9ddb1" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="5a3a7e722a6eb970009a5766c051f3e1" label="mixed materials [A0000000075940]" type="box">98</container><container id="cec0bc25872a1b04e6d1e25afd72ea5f" parent="5a3a7e722a6eb970009a5766c051f3e1" type="folder">16</container></did><accessrestrict id="98f8b37e529ccb193a51c645e7d19af9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="26700edc7d4dff9bb83e29c005e8dedd" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="6562298bd81c05c9ecbbb7fd8581aa0e" label="mixed materials [A0000000075941]" type="box">99</container><container id="3db70febea80c962355487c35f404dd8" parent="6562298bd81c05c9ecbbb7fd8581aa0e" type="folder">1-5</container></did><accessrestrict id="ff906c4305f7b289ec47141f34c41d10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file"><did><unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 October</unitdate><container altrender="Record Storage Box (Paige)" id="c50cab47bee5984040e0a74d7527e24e" label="mixed materials [A0000000075941]" type="box">99</container><container id="9d90ce0c19945d1f8b230d57a29b3376" parent="c50cab47bee5984040e0a74d7527e24e" type="folder">6-12</container></did><accessrestrict id="6db6900a0738aa418a1db1239ba995f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="ef8b77a4a9168df66dbaa1d35328f051" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="dd498522eca7d25d7479733e780dbea9" label="mixed materials [A0000000075941]" type="box">99</container><container id="7c9a3735cbbcefe230621c82aaba10c2" parent="dd498522eca7d25d7479733e780dbea9" type="folder">13-18</container></did><accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="4122c98e47eb1d53ed958233e91ca5d6" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="9d6adbdbc8635238aae4d040e85abb5f" label="mixed materials [A0000000075942]" type="box">100</container><container id="cce9ac41121016f5a9e82f709a615878" parent="9d6adbdbc8635238aae4d040e85abb5f" type="folder">1-3</container></did><accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="1db0c21858cc9e616d5906c203e6860d" level="file"><did><unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle><unitdate type="inclusive">2004 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="3a85c3ec9f479d6ed255c4d9dbe10cc4" label="mixed materials [A0000000075942]" type="box">100</container><container id="e8bae0743f3ad6606ab50ffe0cda9d60" parent="3a85c3ec9f479d6ed255c4d9dbe10cc4" type="folder">4-5</container></did><accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file"><did><unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="4fbfc25454a3c2026038626ed3d8fa2c" label="mixed materials [A0000000075942]" type="box">100</container><container id="79bed782012bb32d7503bbcae226d1cf" parent="4fbfc25454a3c2026038626ed3d8fa2c" type="folder">6-8</container></did><accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file"><did><unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="cb243f5f9c4b40763eca7cc850758046" label="mixed materials [A0000000075942]" type="box">100</container><container id="56d09fc864e0c75a0819338df7ebcf08" parent="cb243f5f9c4b40763eca7cc850758046" type="folder">9-10</container></did><accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="9ea3892837eec8429d01fe1dc14e6b41" level="file"><did><unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle><unitdate type="inclusive">2004 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="93cdf8185169eb8d552881a910ca5123" label="mixed materials [A0000000075942]" type="box">100</container><container id="330bde2d648df2494dc5e35e4fead123" parent="93cdf8185169eb8d552881a910ca5123" type="folder">11-14</container></did><accessrestrict id="7815c3c9e1b402b4a02ed5022e168609"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1703fc66140060139d86d70ac0c3846" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="c235681fac41c2f0228d853cceb96925" label="mixed materials [A0000000075942]" type="box">100</container><container id="10e23cf427fc4018d43bbe2107e0b074" parent="c235681fac41c2f0228d853cceb96925" type="folder">15-18</container></did><accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e8f33c13c32daa15598a2e144e9f900f" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="456d8a0d51ad5a268972fb46798c0699" label="mixed materials [A0000000075943]" type="box">101</container><container id="8985a656b84e746a4d3f4524255aa93d" parent="456d8a0d51ad5a268972fb46798c0699" type="folder">1</container></did><accessrestrict id="81a1621d7a2a2452c30a530869fc9bea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1258ee39d7e2cce0fa124be57ed0634" level="file"><did><unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 March</unitdate><container altrender="Record Storage Box (Paige)" id="3559f9e265aa3a3881332a49540d1f33" label="mixed materials [A0000000075943]" type="box">101</container><container id="4f8341a11e052d6413e256e87f37b60d" parent="3559f9e265aa3a3881332a49540d1f33" type="folder">2-8</container></did><accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="dcf6c003359f1d37afb6b89504a47763" level="file"><did><unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 February</unitdate><container altrender="Record Storage Box (Paige)" id="4a02bea0136c2d923e28270265f28ec2" label="mixed materials [A0000000075943]" type="box">101</container><container id="ac0a964ad72c85d13185d0f54930d156" parent="4a02bea0136c2d923e28270265f28ec2" type="folder">9-17</container></did><accessrestrict id="ee022307e7bb1d19942f259293477255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="65862c2469beda31c7f8327293937f0b" label="mixed materials [A0000000075943]" type="box">101</container><container id="d5d3fa4d44cd5be4d99461e64e9c3ccd" parent="65862c2469beda31c7f8327293937f0b" type="folder">18-19</container></did><accessrestrict id="cae76792326d54b966f74999980f0522"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="499346d5020cece037a74d774986c858" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="2e3fe796c02e10be073095e992c57d8b" label="mixed materials [A0000000075944]" type="box">102</container><container id="def7f3863de91c9c8ea0e6dcc06ab047" parent="2e3fe796c02e10be073095e992c57d8b" type="folder">1-4</container></did><accessrestrict id="78b76f282a6087796d952eea7ca3851b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e2ff3268992aa759f09a842e60822ffb" level="file"><did><unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 July</unitdate><container altrender="Record Storage Box (Paige)" id="d59f43adabb08d053d4ff6ac6a533b5e" label="mixed materials [A0000000075944]" type="box">102</container><container id="2dec836dc2c17dcd67ff83d9cfb926bd" parent="d59f43adabb08d053d4ff6ac6a533b5e" type="folder">5-14</container></did><accessrestrict id="04e11af6b467a1e7c10d7574675c44fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c></dsc>
</archdesc>
</ead>
